e10vk
 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-K
(Mark One)
     
þ   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended: December 31, 2010
OR
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period           to
Commission File Number: 1-11852
HEALTHCARE REALTY TRUST INCORPORATED
(Exact name of Registrant as specified in its charter)
     
Maryland
(State or other jurisdiction of
Incorporation or organization)
  62-1507028
(I.R.S. Employer
Identification No.)
3310 West End Avenue
Suite 700
Nashville, Tennessee 37203

(Address of principal executive offices)
(615) 269-8175
(Registrant’s telephone number, including area code)
Securities Registered Pursuant to Section 12(b) of the Act:
     
Title of Each Class   Name of Each Exchange on Which Registered
Common stock, $0.01 par value per share   New York Stock Exchange
Securities Registered Pursuant to Section 12(g) of the Act:
None
(Title of Class)
     Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ No o
     Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o Noþ
     Indicate by check mark whether the Registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
     Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o
     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in rule 12b -2 of the Exchange Act. (Check one):
             
Large accelerated filer þ   Accelerated filer o   Non-accelerated filer o   Smaller reporting company o
        (Do not check if a smaller reporting company)    
     Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes o No þ
     The aggregate market value of the shares of common stock (based upon the closing price of these shares on the New York Stock Exchange, Inc. on June 30, 2010) of the Registrant held by non-affiliates on June 30, 2010 was approximately $1,353,691,371.
     As of January 31, 2011, 67,205,129 shares of the Registrant’s common stock were outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
     Portions of the Registrant’s definitive Proxy Statement relating to the Annual Meeting of Stockholders to be held on May 17, 2011 are incorporated by reference into Part III of this Report.
 
 

 


 

TABLE OF CONTENTS
         
    Page  
Item 1. Business
    1  
Item 1A. Risk Factors
    17  
Item 1B. Unresolved Staff Comments
    22  
Item 2. Properties
    22  
Item 3. Legal Proceedings
    22  
Item 4. Submission of Matters to a Vote of Security Holders
    23  
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
    24  
Item 6. Selected Financial Data
    25  
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
    26  
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
    43  
Item 8. Financial Statements and Supplementary Data
    44  
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
    80  
Item 9A. Controls and Procedures
    80  
Item 9B. Other Information
    82  
Item 10. Directors, Executive Officers and Corporate Governance
    82  
Item 11. Executive Compensation
    83  
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
    83  
Item 13. Certain Relationships and Related Transactions, and Director Independence
    83  
Item 14. Principal Accountant Fees and Services
    83  
Item 15. Exhibits and Financial Statement Schedules
    83  
SIGNATURES
    87  

 


 

PART I
ITEM 1. BUSINESS
Overview
          Healthcare Realty Trust Incorporated (“Healthcare Realty” or the “Company”) was incorporated in Maryland in 1993 and is a self-managed and self-administered real estate investment trust (“REIT”) that owns, acquires, manages, finances and develops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States.
          The Company operates so as to qualify as a REIT for federal income tax purposes. As a REIT, the Company is not subject to corporate federal income tax with respect to net income distributed to its stockholders. See “Federal Income Tax Information” in Item 1 of this report.
     Real Estate Properties
          As of December 31, 2010, the Company’s real estate property investments, excluding assets held for sale and including an investment in one unconsolidated joint venture, are shown in the table below:
                                         
    Number of     Gross Investment Square Feet  
(Dollars and Square Feet in thousands)   Investments     Amount     %     Footage     %  
 
Owned properties:
                                       
Master leases
                                       
Medical office
    11     $ 100,242       3.8 %     548       4.1 %
Physician clinics
    13       106,209       4.1 %     602       4.6 %
Surgical facilities
    5       70,631       2.7 %     226       1.7 %
Specialty outpatient
    2       4,852       0.2 %     23       0.1 %
Inpatient rehab
    11       178,639       6.8 %     734       5.6 %
Other
    4       31,726       1.2 %     284       2.0 %
     
 
    46       492,299       18.8 %     2,417       18.1 %
 
                                       
Property operating agreements
                                       
Medical office
    8       84,061       3.2 %     624       4.7 %
     
 
    8       84,061       3.2 %     624       4.7 %
 
                                       
Multi-tenanted with occupancy leases
                                       
Medical office
    114       1,460,397       56.0 %     8,057       60.8 %
Medical office - stabilization in progress
    9       253,833       9.7 %     951       7.2 %
Medical office - construction in progress
    3       59,490       2.3 %     405       3.1 %
Physician clinics
    14       46,015       1.8 %     296       2.2 %
Surgical facilities
    5       127,224       4.8 %     368       2.7 %
Specialty outpatient
    1       2,433       0.1 %     10       0.1 %
Other
    1       10,141       0.4 %     126       1.1 %
     
 
    147       1,959,533       75.1 %     10,213       77.2 %
 
                                       
Land held for development
          20,772       0.8 %            
Corporate property
          14,940       0.6 %            
     
 
          35,712       1.4 %            
     
Total owned properties
    201       2,571,605       98.5 %     13,254       100.0 %
     
 
                                       
Mortgage loans:
                                       
Medical office
    5       10,934       0.4 %            
Physician clinics
    1       14,920       0.6 %            
Surgical facilities
    1       10,745       0.4 %            
     
 
    7       36,599       1.4 %            
Unconsolidated joint venture:
                                       
Other
    1       1,266       0.1 %            
     
 
    1       1,266       0.1 %            
     
Total real estate investments
    209     $ 2,609,470       100.0 %     13,254       100.0 %
     

1


 

          The Company provided property management services for 137 healthcare-related properties nationwide, totaling approximately 9.2 million square feet at December 31, 2010. The Company’s portfolio of properties is focused predominantly on the medical office and outpatient sector of the healthcare industry and is diversified by tenant, geographic location and facility type.
          The following table details occupancy of the Company’s owned properties by facility type as of December 31, 2010 and 2009.
                                 
    Investment (1)     Percentage of     Occupancy (1)  
    (in thousands)     Square Feet (1)     2010     2009  
Medical office buildings
  $ 1,958,023       79.9 %     86 %     88 %
Physician clinics
    152,224       6.8 %     83 %     92 %
Inpatient rehab
    178,639       5.6 %     95 %     100 %
Surgical facilities
    197,855       4.4 %     88 %     90 %
Specialty outpatient
    7,285       0.2 %     100 %     63 %
Other
    41,867       3.1 %     80 %     95 %
 
                       
Total
  $ 2,535,893       100.0 %     87 %     90 %
 
                       
 
(1)   The investment and percentage of square feet columns include all owned real estate properties. The occupancy columns represent the percentage of total rentable square feet leased (including month-to-month and holdover leases), excluding nine properties in stabilization, 11 and six properties classified as held for sale and three and two properties in construction in progress as of December 31, 2010 and 2009, respectively. Properties under financial support or master lease agreements are included at 100% occupancy. Upon expiration of these agreements, occupancy reflects underlying tenant leases in the building.
          As of December 31, 2010, the weighted average remaining years to maturity pursuant to the Company’s long-term master leases, financial support agreements, and multi-tenanted occupancy leases was approximately 4.9 years, with expirations through 2029. The table below details the Company’s lease maturities as of December 31, 2010, excluding 11 properties classified as held for sale.
                                 
    Annualized                        
    Minimum                     Average  
Expiration   Rents (1)     Number of     Percentage     Square Feet  
Year   (in thousands)     Leases     of Revenues     Per Lease  
2011
  $ 29,986       326       13.3 %     3,604  
2012
    29,675       294       13.2 %     4,133  
2013
    33,358       268       14.8 %     4,823  
2014
    35,395       287       15.7 %     5,144  
2015
    19,020       192       8.5 %     4,720  
2016
    11,272       61       5.0 %     7,129  
2017
    17,844       68       7.9 %     13,598  
2018
    11,567       78       5.1 %     7,412  
2019
    5,541       28       2.5 %     6,846  
2020
    7,937       30       3.5 %     12,061  
Thereafter
    23,475       56       10.5 %     17,394  
 
(1)   Represents the annualized minimum rents on leases in-place as of December 31, 2010, excluding the impact of potential lease renewals, future step-ups in rent, sponsor support payments under financial support agreements and straight-line rent.
     Mortgage Notes Receivable
          The Company had seven mortgage notes receivable outstanding as of December 31, 2010 and four mortgage notes receivable as of December 31, 2009 with aggregate principal balances totaling $36.6 million and $31.0 million, respectively. Five of the mortgage notes outstanding at December 31, 2010 were construction loans and at December 31, 2009 one was a construction loan. All of the loans were secured by existing buildings or buildings currently under development. See Note 3 to the Consolidated Financial Statements for more information.

2


 

Business Strategy
          Healthcare Realty’s strategy is to own and operate medical office and other medical-related facilities that produce stable and growing rental income. Additionally, the Company provides a broad spectrum of services needed to own, develop, lease, finance and manage its portfolio of healthcare properties.
          The Company focuses its portfolio on outpatient-related facilities located on or near the campuses of large acute care hospitals and associated with leading health systems because management views these facilities as stable, lower-risk real estate investments. According to the Centers for Medicare & Medicaid Services, the nation’s overall healthcare spending in 2009 was $2.5 trillion, representing 17.6% of the nation’s gross domestic product (“GDP”). Total healthcare spending is expected to grow and could reach an estimated 19.6% of GDP by 2019. Historically, more than half of the nation’s healthcare spending has been received by hospitals and outpatient-related facility tenants. In addition to the consistent growth in demand for outpatient services, management believes that the Company’s diversity of tenants, which includes physicians of nearly two-dozen physician specialties, as well as surgery, imaging, and diagnostic centers, lowers the Company’s overall financial and operational risk.
          The Company plans to continue to meet its liquidity needs, including funding additional investments in 2011, paying dividends, repaying maturing debt and funding other debt service, with available cash on hand, cash flows from operations, borrowings under the $550 million unsecured credit facility due 2012 (the “Unsecured Credit Facility”), proceeds from mortgage notes receivable repayments, proceeds from sales of real estate investments, or additional capital market financings, including the Company’s at-the-market equity offering program, or other debt or equity offerings. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources” in Item 7 and “Risk Factors” in Item 1A of this report for more discussion concerning the Company’s liquidity and capital resources.
Acquisitions and Dispositions
     Acquisition Activity
          During 2010, the Company acquired approximately $311.5 million in real estate assets and funded $24.4 million in mortgage notes receivable. These acquisitions and mortgage notes were funded with borrowings on the Unsecured Credit Facility, proceeds from $400 million in senior notes due 2021 issued in December 2010 (the “Senior Notes due 2021”), proceeds from real estate dispositions and mortgage note repayments, proceeds from the Company’s at-the-market equity offering program, and from the assumption of existing mortgage debt related to certain acquired properties. See Note 4 to the Consolidated Financial Statements for more information on these acquisitions.
     Dispositions and Impairments
          During 2010, the Company disposed of nine real estate properties for approximately $34.5 million in net proceeds, received $0.8 million in lease termination fees, and recognized approximately $8.4 million in gains from the sale of the properties. Also, three mortgage notes receivable totaling approximately $8.5 million were repaid. Proceeds from these dispositions were used to repay amounts due under the Unsecured Credit Facility, to fund additional real estate investments, and for general corporate purposes. See Note 4 to the Consolidated Financial Statements for more information on these dispositions.
          During 2010, the Company also recorded impairment charges of approximately $7.5 million on properties sold during the year or held for sale at December 31, 2010.
     2011 Acquisition
          In January 2011, the Company originated with Ladco a $40.0 million mortgage loan that is secured by a multi-tenanted office building located in Iowa that was 94% leased at the time the mortgage was originated. The mortgage loan requires interest only payments through maturity, has a stated fixed interest rate and matures in January 2014.
     2011 Dispositions
          In January 2011, the Company disposed of a medical office building located in Maryland that was previously classified as held for sale and in which the Company had a $3.5 million net investment at December 31, 2010. The Company received approximately $3.4 million in net proceeds, net of expenses incurred at the time of the closing.
          In February 2011, the Company disposed of a physician clinic located in Florida that was previously classified as held for sale and in which the Company had a $3.1 million net investment at December 31, 2010. The Company received approximately $3.1 million in consideration on the sale.

3


 

     2011 Potential Dispositions
          During 2010, the Company received notice from a tenant of its intent to purchase six skilled nursing facilities in Michigan and Indiana pursuant to purchase options contained in its leases with the Company. The Company’s aggregate net investment in the buildings, which were classified as held for sale upon receiving notice of the purchase option exercise, was approximately $8.2 million at December 31, 2010. The aggregate purchase price for the properties is expected to be approximately $17.3 million, resulting in a net gain of approximately $9.1 million. The Company expects the sale to occur during the third quarter of 2011.
Purchase Options
          In addition to the six skilled nursing facilities in Michigan and Indiana discussed above, the Company had $91.3 million in real estate properties at December 31, 2010 that were subject to exercisable purchase options that had not been exercised. On a probability-weighted basis, the Company estimates that less than one-third of these options might be exercised in the future. Purchase options on two properties in which the Company had an aggregate gross investment of approximately $35.5 million at December 31, 2010 become exercisable during 2011 and 2012. The Company does not believe it can reasonably estimate the probability that these purchase options will be exercised in the future.
Construction in Progress and Other Commitments
          As of December 31, 2010, the Company had three medical office buildings under construction in Washington and Colorado with aggregate budgets of $147.1 million and estimated completion dates in the third quarter of 2011. At December 31, 2010, the Company had $59.5 million invested in these construction projects. The Company also has four parcels of land totaling $20.8 million in land held for future development that are included in construction in progress on the Company’s Consolidated Balance Sheet. See Note 14 to the Consolidated Financial Statements for more details on the Company’s construction in progress at December 31, 2010.
          The Company also had approximately $32.3 million in various first-generation tenant improvement budgeted amounts remaining as of December 31, 2010 related to properties that were developed by the Company.
          Further, as of December 31, 2010, the Company had remaining funding commitments totaling $54.6 million on five construction loans that the Company expects will be funded during 2011 and 2012.
Contractual Obligations
          As of December 31, 2010, the Company had long-term contractual obligations of approximately $2.3 billion, consisting primarily of $1.9 billion of long-term debt obligations (including related interest). For a more detailed description of these contractual obligations, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — Contractual Obligations,” in Item 7 of this report.
Competition
          The Company competes for the acquisition and development of real estate properties with private investors, healthcare providers, other healthcare-related REITs, real estate partnerships and financial institutions, among others. The business of acquiring and constructing new healthcare facilities is highly competitive and is subject to price, construction and operating costs, and other competitive pressures.
          The financial performance of all of the Company’s properties is subject to competition from similar properties. The extent to which the Company’s properties are utilized depends upon several factors, including the number of physicians using or referring patients to the healthcare facility, healthcare employment, competitive systems of healthcare delivery, and the area’s population, size and composition. Private, federal and state payment programs and other laws and regulations may also have an effect on the utilization of the properties. Virtually all of the Company’s properties operate in a competitive environment, and patients and referral sources, including physicians, may change their preferences for a healthcare facility from time to time.
Government Regulation
          The facilities owned by the Company are required to comply with extensive regulation at the federal, state, and local levels. These laws and regulations establish, among other things, requirements for state licensure and criteria to participate in government-sponsored reimbursement programs, such as the Medicare and Medicaid programs. Although lease payments to the Company are not directly affected by these laws and regulations, changes in these programs or the loss by a facility of its license or ability to participate in government-sponsored reimbursement programs due to certification deficiencies or program exclusion resulting from violations of law

4


 

would have a material adverse effect on facility revenues and could adversely affect healthcare provider tenants’ ability to make payments to the Company.
          The facilities owned by the Company are also subject to federal laws that are intended to combat fraud and waste such as the Anti-Kickback Statute, Stark Law, False Claims Act, and Health Insurance Portability and Accountability Act of 1996. Although the Company is not a healthcare provider or in a position to refer patients or order services reimbursable by the federal government, violations of these and similar laws would have a material adverse effect on facility revenues and could adversely affect healthcare provider tenants’ abilities to make payments to the Company. The Company’s leases require the lessees to comply with all applicable laws.
          The Medicare and Medicaid programs are highly regulated and subject to frequent evaluation and change. Government healthcare spending has increased over time; however, changes from year to year in reimbursement methodology, rates and other regulatory requirements have resulted in a challenging operating environment for healthcare providers. Spending on government reimbursement programs is expected to continue to rise significantly over the next 20 years, particularly as the government seeks to expand public insurance programs for the uninsured and senior populations.
          In March 2010, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the “Health Reform Law”) was signed into law to provide for comprehensive reform of the United States healthcare system and extend health insurance benefits to the uninsured population, with the potential to alleviate high uncompensated care expense to healthcare providers. However, the law also increases regulatory scrutiny of providers by federal and state administrative authorities, lowers their annual increase in Medicare payment rates, and will gradually implement significant cost-saving measures to lower the growth of healthcare spending, while also requiring improved access and quality of care, thus presenting the industry and its individual participants with uncertainty. The Health Reform Law has been ruled unconstitutional in whole or in part by certain federal district courts, and the degree to which it is implemented, if at all, will ultimately be decided by the United States Supreme Court. These varied reforms could affect the economic performance of some or all of the Company’s tenants and clients. The Company cannot predict the degree to which these changes may affect the economic performance of the Company, positively or negatively.
          The Company expects healthcare providers to continue to adjust to new operating challenges, as they have in the past, by increasing operating efficiency and modifying their strategies for profitable operations and growth. Furthermore, under comprehensive healthcare reform, the Company could benefit from higher demand for medical office space as the newly insured population would require additional healthcare providers and facilities.
          The Company believes its strategic focus on the medical office and outpatient sector of the healthcare industry mitigates risk from changes in public healthcare spending and reimbursement because physician practices generally derive a large portion of their revenue from private insurance and out-of-pocket patient expense. The diversity of the Company’s multi-tenant medical office facilities also provides lower reimbursement risk as payor mix varies from physician to physician, depending on location, specialty, patients, and physician preferences.
Legislative Developments
          Each year, legislative proposals for health policy are introduced in Congress and state legislatures, and regulatory changes are enacted by government agencies. These proposals, individually or in the aggregate, could significantly change the delivery of healthcare services, either nationally or at the state level, if implemented. Examples of significant legislation currently under consideration or recently enacted include:
    the Health Reform Law;
 
    proposals to repeal the Health Reform law in whole or in part;
 
    quality control, cost containment, and payment system refinements for Medicaid, Medicare and other public funding, such as expansion of pay-for-performance criteria and value-based purchasing programs, bundled provider payments, accountable care organizations, increased patient cost-sharing, geographic payment variations, comparative effectiveness research, and lower payments for hospital readmissions;
 
    reform of the Medicare physician fee-for-service reimbursement formula that dictates annual updates in payment rates for physician services, including significant reductions in the sustainable growth rate; however, Congress is expected to continue its annual practice of extending physician payment rates or providing an increase for the fiscal year 2012;
 
    significant cuts to state Medicaid payment rates and benefits due to mounting state budgetary pressures;

5


 

    prohibitions on additional types of contractual relationships between physicians and the healthcare facilities and providers to which they refer, and related information-collection activities;
 
    efforts to increase transparency with respect to pricing and financial relationships among healthcare providers and drug/device manufacturers;
 
    heightened health information technology standards for healthcare providers;
 
    increased scrutiny of medical errors and conditions acquired inside health facilities;
 
    patient and drug safety initiatives;
 
    re-importation of pharmaceuticals;
 
    pharmaceutical drug pricing and compliance activities under Medicare part D;
 
    tax law changes affecting non-profit providers;
 
    immigration reform and related healthcare mandates;
 
    modifications to increase requirements for facility accessibility by persons with disabilities; and
 
    facility requirements related to earthquakes and other disasters, including structural retrofitting.
          The Company cannot predict whether any proposals will be fully implemented, adopted, repealed, or amended, or what effect, whether positive or negative, such proposals would have on the Company’s business.
Environmental Matters
          Under various federal, state and local environmental laws, ordinances and regulations, an owner of real property (such as the Company) may be liable for the costs of removal or remediation of certain hazardous or toxic substances at, under or disposed of in connection with such property, as well as certain other potential costs relating to hazardous or toxic substances (including government fines and injuries to persons and adjacent property). Most, if not all, of these laws, ordinances and regulations contain stringent enforcement provisions including, but not limited to, the authority to impose substantial administrative, civil and criminal fines and penalties upon violators. Such laws often impose liability, without regard to whether the owner knew of, or was responsible for, the presence or disposal of such substances and may be imposed on the owner in connection with the activities of an operator of the property. The cost of any required remediation, removal, fines or personal or property damages and the owner’s liability therefore could exceed the value of the property and/or the aggregate assets of the owner. In addition, the presence of such substances, or the failure to properly dispose of or remediate such substances, may adversely affect the owner’s ability to sell or lease such property or to borrow using such property as collateral. A property can also be negatively impacted either through physical contamination or by virtue of an adverse effect on value, from contamination that has or may have emanated from other properties.
          Operations of the properties owned, developed or managed by the Company are and will continue to be subject to numerous federal, state, and local environmental laws, ordinances and regulations, including those relating to the following: the generation, segregation, handling, packaging and disposal of medical wastes; air quality requirements related to operations of generators, incineration devices, or sterilization equipment; facility siting and construction; disposal of non-medical wastes and ash from incinerators; and underground storage tanks. Certain properties owned, developed or managed by the Company contain, and others may contain or at one time may have contained, underground storage tanks that are or were used to store waste oils, petroleum products or other hazardous substances. Such underground storage tanks can be the source of releases of hazardous or toxic materials. Operations of nuclear medicine departments at some properties also involve the use and handling, and subsequent disposal of, radioactive isotopes and similar materials, activities which are closely regulated by the Nuclear Regulatory Commission and state regulatory agencies. In addition, several of the properties were built during the period that asbestos was commonly used in building construction and other such facilities may be acquired by the Company in the future. The presence of such materials could result in significant costs in the event that any asbestos-containing materials requiring immediate removal and/or encapsulation are located in or on any facilities or in the event of any future renovation activities.
          The Company has had environmental site assessments conducted on substantially all of the properties currently owned. These site assessments are limited in scope and provide only an evaluation of potential environmental conditions associated with the property, not compliance assessments of ongoing operations. While it is the Company’s policy to seek indemnification relating to environmental liabilities or conditions, even where leases and sale and purchase agreements do contain such provisions, there can be no assurances that

6


 

the tenant or seller will be able to fulfill its indemnification obligations. In addition, the terms of the Company’s leases or financial support agreements do not give the Company control over the operational activities of its lessees or healthcare operators, nor will the Company monitor the lessees or healthcare operators with respect to environmental matters.
Insurance
          The Company generally requires its tenants to maintain comprehensive liability and property insurance that covers the Company as well as the tenants. The Company also carries comprehensive liability insurance and property insurance covering its owned and managed properties, including those held under long-term ground leases. In addition, tenants under long-term net master leases are required to carry property insurance covering the Company’s interest in the buildings. The Company has also obtained title insurance with respect to each of the properties it owns, insuring that the Company holds title to each of the properties free and clear of all liens and encumbrances except those approved by the Company.
Employees
          As of December 31, 2010, the Company employed 240 people. The employees are not members of any labor union, and the Company considers its relations with its employees to be excellent.
Federal Income Tax Information
          The Company is and intends to remain qualified as a REIT under the Internal Revenue Code of 1986, as amended (the “Code”). As a REIT, the Company’s net income attributable to common stockholders will not be subject to federal taxation to the extent that it is distributed as dividends to stockholders. Distributions to the Company’s stockholders generally will be includable in their income; however, dividends distributed that are in excess of current and/or accumulated earnings and profits will be treated for tax purposes as a return of capital to the extent of a stockholder’s basis and will reduce the basis of the stockholder’s shares.
     Introduction
          The Company is qualified and intends to remain qualified as a REIT for federal income tax purposes under Sections 856 through 860 of the Code. The following discussion addresses the material federal tax considerations relevant to the taxation of the Company and summarizes certain federal income tax consequences that may be relevant to certain stockholders. However, the actual tax consequences of holding particular securities issued by the Company may vary in light of a securities holder’s particular facts and circumstances. Certain holders, such as tax-exempt entities, insurance companies and financial institutions, are generally subject to special rules. In addition, the following discussion does not address issues under any foreign, state or local tax laws. The tax treatment of a holder of any of the securities issued by the Company will vary depending upon the terms of the specific securities acquired by such holder, as well as the holder’s particular situation, and this discussion does not attempt to address aspects of federal income taxation relating to holders of particular securities of the Company. This summary is qualified in its entirety by the applicable Code provisions, rules and regulations promulgated thereunder, and administrative and judicial interpretations thereof. The Code, rules, regulations, and administrative and judicial interpretations are all subject to change at any time (possibly on a retroactive basis).
          The Company is organized and is operating in conformity with the requirements for qualification and taxation as a REIT and intends to continue operating so as to enable it to continue to meet the requirements for qualification and taxation as a REIT under the Code. The Company’s qualification and taxation as a REIT depends upon its ability to meet, through actual annual operating results, the various income, asset, distribution, stock ownership and other tests discussed below. Accordingly, the Company cannot guarantee that the actual results of operations for any one taxable year will satisfy such requirements.
          If the Company were to cease to qualify as a REIT, and the statutory relief provisions were found not to apply, the Company’s income that it distributed to stockholders would be subject to the “double taxation” on earnings (once at the corporate level and again at the stockholder level) that generally results from an investment in the equity securities of a corporation. The distributions would then qualify for the reduced dividend rates created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. However, the reduced dividend rates are scheduled to expire for taxable years beginning after December 31, 2012. Failure to maintain qualification as a REIT would force the Company to significantly reduce its distributions and possibly incur substantial indebtedness or liquidate substantial investments in order to pay the resulting corporate taxes. In addition, the Company, once having obtained REIT status and having thereafter lost such status, would not be eligible to re-elect REIT status for the four subsequent taxable years, unless its failure to maintain its qualification was due to reasonable cause and not willful neglect and certain other requirements were satisfied. In order to elect again to be taxed as a REIT, just as with its original election, the Company would be required to distribute all of its earnings and profits accumulated in any non-REIT taxable year.

7


 

     Taxation of the Company
          As long as the Company remains qualified to be taxed as a REIT, it generally will not be subject to federal income taxes on that portion of its ordinary income or capital gain that is currently distributed to stockholders.
          However, the Company will be subject to federal income tax as follows:
    The Company will be taxed at regular corporate rates on any undistributed “real estate investment trust taxable income,” including undistributed net capital gains.
 
    Under certain circumstances, the Company may be subject to the “alternative minimum tax” on its items of tax preference, if any.
 
    If the Company has (i) net income from the sale or other disposition of “foreclosure property” that is held primarily for sale to customers in the ordinary course of business, or (ii) other non-qualifying income from foreclosure property, it will be subject to tax on such income at the highest regular corporate rate.
 
    Any net income that the Company has from prohibited transactions (which are, in general, certain sales or other dispositions of property, other than foreclosure property, held primarily for sale to customers in the ordinary course of business) will be subject to a 100% tax.
 
    If the Company should fail to satisfy either the 75% or 95% gross income test (as discussed below), and has nonetheless maintained its qualification as a REIT because certain other requirements have been met, it will be subject to a percentage tax calculated by the ratio of REIT taxable income to gross income with certain adjustments multiplied by the gross income attributable to the greater of the amount by which the Company fails the 75% or 95% gross income test.
 
    If the Company fails to distribute during each year at least the sum of (i) 85% of its REIT ordinary income for such year, (ii) 95% of its REIT capital gain net income for such year, and (iii) any undistributed taxable income from preceding periods, then the Company will be subject to a 4% excise tax on the excess of such required distribution over the amounts actually distributed.
 
    In the event of a more than de minimis failure of any of the asset tests, as described below under “Asset Tests,” as long as the failure was due to reasonable cause and not to willful neglect, the Company files a description of each asset that caused such failure with the Internal Revenue Services (“IRS”), and disposes of the assets or otherwise complies with the asset tests within six months after the last day of the quarter in which the Company identifies such failure, the Company will pay a tax equal to the greater of $50,000 or 35% of the net income from the nonqualifying assets during the period in which the Company failed to satisfy the asset tests.
 
    In the event the Company fails to satisfy one or more requirements for REIT qualification, other than the gross income tests and the asset tests, and such failure is due to reasonable cause and not to willful neglect, the Company will be required to pay a penalty of $50,000 for each such failure.
 
    To the extent that the Company recognizes gain from the disposition of an asset with respect to which there existed “built-in gain” upon its acquisition by the Company from a Subchapter C corporation in a carry-over basis transaction and such disposition occurs within a maximum ten-year recognition period beginning on the date on which it was acquired by the Company, the Company will be subject to federal income tax at the highest regular corporate rate on the amount of its “net recognized built-in gain.”
 
    To the extent that the Company has net income from a taxable REIT subsidiary (“TRS”), the TRS will be subject to federal corporate income tax in much the same manner as other non-REIT Subchapter C corporations, with the exceptions that the deductions for interest expense on debt and rental payments made by the TRS to the Company will be limited and a 100% excise tax may be imposed on transactions between the TRS and the Company or the Company’s tenants that are not conducted on an arm’s length basis. A TRS is a corporation in which a REIT owns stock, directly or indirectly, and for which both the REIT and the corporation have made TRS elections.
     Requirements for Qualification as a REIT
          To qualify as a REIT for a taxable year, the Company must have no earnings and profits accumulated in any non-REIT year. The Company also must elect or have in effect an election to be taxed as a REIT and must meet other requirements, some of which are summarized below, including percentage tests relating to the sources of its gross income, the nature of the Company’s assets and the

8


 

distribution of its income to stockholders. Such election, if properly made and assuming continuing compliance with the qualification tests described herein, will continue in effect for subsequent years.
     Organizational Requirements and Share Ownership Tests
          Section 856(a) of the Code defines a REIT as a corporation, trust or association:
  (1)   that is managed by one or more trustees or directors;
 
  (2)   the beneficial ownership of which is evidenced by transferable shares or by transferable certificates of beneficial interest;
 
  (3)   that would be taxable, but for Sections 856 through 860 of the Code, as a domestic corporation;
 
  (4)   that is neither a financial institution nor an insurance company subject to certain provisions of the Code;
 
  (5)   the beneficial ownership of which is held by 100 or more persons, determined without reference to any rules of attribution (the “share ownership test”);
 
  (6)   that during the last half of each taxable year not more than 50% in value of the outstanding stock of which is owned, directly or indirectly, by five or fewer individuals (as defined in the Code to include certain entities) (the “five or fewer test”); and
 
  (7)   that meets certain other tests, described below, regarding the nature of its income and assets.
          Section 856(b) of the Code provides that conditions (1) through (4), inclusive, must be met during the entire taxable year and that condition (5) must be met during at least 335 days of a taxable year of 12 months, or during a proportionate part of a taxable year of fewer than 12 months. The five or fewer test and the share ownership test do not apply to the first taxable year for which an election is made to be treated as a REIT.
          The Company is also required to request annually (within 30 days after the close of its taxable year) from record holders of specified percentages of its shares written information regarding the ownership of such shares. A list of stockholders failing to fully comply with the demand for the written statements is required to be maintained as part of the Company’s records required under the Code. Rather than responding to the Company, the Code allows the stockholder to submit such statement to the IRS with the stockholder’s tax return.
          The Company has issued shares to a sufficient number of people to allow it to satisfy the share ownership test and the five or fewer test. In addition, to assist in complying with the five or fewer test, the Company’s Articles of Incorporation contain provisions restricting share transfers where the transferee (other than specified individuals involved in the formation of the Company, members of their families and certain affiliates, and certain other exceptions) would, after such transfer, own (a) more than 9.9% either in number or value of the outstanding common stock of the Company or (b) more than 9.9% either in number or value of any outstanding preferred stock of the Company. Pension plans and certain other tax-exempt entities have different restrictions on ownership. If, despite this prohibition, stock is acquired increasing a transferee’s ownership to over 9.9% in value of either the outstanding common stock or any preferred stock of the Company, the stock in excess of this 9.9% in value is deemed to be held in trust for transfer at a price that does not exceed what the purported transferee paid for the stock, and, while held in trust, the stock is not entitled to receive dividends or to vote. In addition, under these circumstances, the Company has the right to redeem such stock.
          For purposes of determining whether the five or fewer test (but not the share ownership test) is met, any stock held by a qualified trust (generally, pension plans, profit-sharing plans and other employee retirement trusts) is, generally, treated as held directly by the trust’s beneficiaries in proportion to their actuarial interests in the trust and not as held by the trust.
     Income Tests
          In order to maintain qualification as a REIT, two gross income requirements must be satisfied annually.
    First, at least 75% of the Company’s gross income (excluding gross income from certain sales of property held as inventory or primarily for sale in the ordinary course of business) must be derived from “rents from real property”; “interest on obligations secured by mortgages on real property or on interests in real property”; gain (excluding gross income from certain sales of property held as inventory or primarily for sale in the ordinary course of business) from the sale or other disposition of, and certain other gross income related to, real property (including interests in real property and in mortgages on real property); and income received or accrued within one year of the Company’s receipt of, and attributable to the temporary investment of,

9


 

      “new capital” (any amount received in exchange for stock other than through a dividend reinvestment plan or in a public offering of debt obligations having maturities of at least five years).
 
    Second, at least 95% of the Company’s gross income (excluding gross income from certain sales of property held as inventory or primarily for sale in the ordinary course of business) must be derived from dividends; interest; “rents from real property”; gain (excluding gross income from certain sales of property held as inventory or primarily for sale in the ordinary course of business) from the sale or other disposition of, and certain other gross income related to, real property (including interests in real property and in mortgages on real property); and gain from the sale or other disposition of stock and securities.
          The Company may temporarily invest its working capital in short-term investments. Although the Company will use its best efforts to ensure that income generated by these investments will be of a type that satisfies the 75% and 95% gross income tests, there can be no assurance in this regard (see the discussion above of the “new capital” rule under the 75% gross income test).
          For an amount received or accrued to qualify for purposes of an applicable gross income test as “rents from real property” or “interest on obligations secured by mortgages on real property or on interests in real property,” the determination of such amount must not depend in whole or in part on the income or profits derived by any person from such property (except that such amount may be based on a fixed percentage or percentages of receipts or sales). In addition, for an amount received or accrued to qualify as “rents from real property,” such amount may not be received or accrued directly or indirectly from a person in which the Company owns directly or indirectly 10% or more of, in the case of a corporation, the total voting power of all voting stock or the total value of all stock, and, in the case of an unincorporated entity, the assets or net profits of such entity (except for certain amounts received or accrued from a TRS in connection with property substantially rented to persons other than a TRS of the Company and other 10%-or-more owned persons or with respect to certain healthcare facilities, if certain conditions are met). The Company leases and intends to lease property only under circumstances such that substantially all, if not all, rents from such property qualify as “rents from real property.” Although it is possible that a tenant could sublease space to a sublessee in whom the Company is deemed to own directly or indirectly 10% or more of the tenant, the Company believes that as a result of the provisions of the Company’s Articles of Incorporation that limit ownership to 9.9%, such occurrence would be unlikely. Application of the 10% ownership rule is, however, dependent upon complex attribution rules provided in the Code and circumstances beyond the control of the Company. Ownership, directly or by attribution, by an unaffiliated third party of more than 10% of the Company’s stock and more than 10% of the stock of any tenant or subtenant would result in a violation of the rule.
          In addition, the Company must not manage its properties or furnish or render services to the tenants of its properties, except through an independent contractor from whom the Company derives no income or through a TRS unless (i) the Company is performing services that are usually or customarily furnished or rendered in connection with the rental of space for occupancy only and the services are of the sort that a tax-exempt organization could perform without being considered in receipt of unrelated business taxable income or (ii) the income earned by the Company for other services furnished or rendered by the Company to tenants of a property or for the management or operation of the property does not exceed a de minimis threshold generally equal to 1% of the income from such property. The Company self-manages some of its properties, but does not believe it provides services to tenants that are outside the exception.
          If rent attributable to personal property leased in connection with a lease of real property is greater than 15% of the total rent received under the lease, then the portion of rent attributable to such personal property will not qualify as “rents from real property.” Generally, this 15% test is applied separately to each lease. The portion of rental income treated as attributable to personal property is determined according to the ratio of the fair market value of the personal property to the total fair market value of the property that is rented. The determination of what fixtures and other property constitute personal property for federal tax purposes is difficult and imprecise. The Company does not have 15% by value of any of its properties classified as personal property. If, however, rent payments do not qualify, for reasons discussed above, as rents from real property for purposes of Section 856 of the Code, it will be more difficult for the Company to meet the 95% and 75% gross income tests and continue to qualify as a REIT.
          The Company is and expects to continue performing third-party management services, and may also perform third-party development services. If the gross income to the Company from this or any other activity producing disqualified income for purposes of the 95% or 75% gross income tests approaches a level that could potentially cause the Company to fail to satisfy these tests, the Company intends to take such corrective action as may be necessary to avoid failing to satisfy the 95% or 75% gross income tests.
          The Company may enter into hedging transactions with respect to one or more of its assets or liabilities. The Company’s hedging activities may include entering into interest rate swaps, caps and floors, options to purchase such items, and futures and forward contracts. Income and gain from “hedging transactions” will be excluded from gross income for purposes of the 95% and 75% gross income tests. A “hedging transaction” includes any transaction entered into in the normal course of the Company’s trade or business primarily to manage the risk of interest rate, price changes or currency fluctuations with respect to borrowings made or to be made, or ordinary obligations incurred or to be incurred, to acquire or carry real estate assets. The Company will be required to clearly identify any such hedging transaction before the close of the day on which it was acquired, originated or entered into. The Company intends to structure any hedging or similar transactions so as not to jeopardize its status as a REIT.

10


 

          If the Company were to fail to satisfy one or both of the 75% or 95% gross income tests for any taxable year, it may nevertheless qualify as a REIT for such year if it is entitled to relief under certain provisions of the Code. These relief provisions would generally be available if (i) the Company’s failure to meet such test or tests was due to reasonable cause and not to willful neglect and (ii) following its identification of its failure to meet these tests, the Company files a description of each item of income that fails to meet these tests in a schedule in accordance with Treasury Regulations. It is not possible, however, to know whether the Company would be entitled to the benefit of these relief provisions since the application of the relief provisions is dependent on future facts and circumstances. If these provisions were to apply, the Company would be subjected to tax equal to a percentage tax calculated by the ratio of REIT taxable income to gross income with certain adjustments multiplied by the gross income attributable to the greater of the amount by which the Company failed either of the 75% or the 95% gross income tests.
     Asset Tests
          At the close of each quarter of its taxable year, the Company must also satisfy four tests relating to the nature of its assets.
    At least 75% of the value of the Company’s total assets must consist of real estate assets (including interests in real property and interests in mortgages on real property as well as its allocable share of real estate assets held by joint ventures or partnerships in which the Company participates), cash, cash items and government securities.
 
    Not more than 25% of the Company’s total assets may be represented by securities other than those includable in the 75% asset class.
 
    Not more than 25% of the Company’s total assets may be represented by securities of one or more TRS.
 
    Of the investments included in the 25% asset class, except for TRS, (i) the value of any one issuer’s securities owned by the Company may not exceed 5% of the value of the Company’s total assets, (ii) the Company may not own more than 10% of any one issuer’s outstanding voting securities and (iii) the Company may not hold securities having a value of more than 10% of the total value of the outstanding securities of any one issuer. Securities issued by affiliated qualified REIT subsidiaries (“QRS”), which are corporations wholly owned by the Company, either directly or indirectly, that are not TRS, are not subject to the 25% of total assets limit, the 5% of total assets limit or the 10% of a single issuer’s voting securities limit or the 10% of a single issuer’s value limit. Additionally, “straight debt” and certain other exceptions are not “securities” for purposes of the 10% of a single issuer’s value test. The existence of QRS are ignored, and the assets, income, gain, loss and other attributes of the QRS are treated as being owned or generated by the Company, for federal income tax purposes. The Company currently has 65 subsidiaries and other affiliates that it employs in the conduct of its business.
          If the Company meets the asset tests described above at the close of any quarter, it will not lose its status as a REIT because of a change in value of its assets unless the discrepancy exists immediately after the acquisition of any security or other property that is wholly or partly the result of an acquisition during such quarter. Where a failure to satisfy the asset tests results from an acquisition of securities or other property during a quarter, the failure can be cured by disposition of sufficient non-qualifying assets within 30 days after the close of such quarter. The Company maintains adequate records of the value of its assets to maintain compliance with the asset tests and to take such action as may be required to cure any failure to satisfy the test within 30 days after the close of any quarter. Nevertheless, if the Company were unable to cure within the 30-day cure period, the Company may cure a violation of the 5% asset test or the 10% asset test so long as the value of the asset causing such violation does not exceed the lesser of 1% of the Company’s assets at the end of the relevant quarter or $10 million and the Company disposes of the asset causing the failure or otherwise complies with the asset tests within six months after the last day of the quarter in which the failure to satisfy the asset test is discovered. For violations due to reasonable cause and not due to willful neglect that are larger than this amount, the Company is permitted to avoid disqualification as a REIT after the 30-day cure period by (i) disposing of an amount of assets sufficient to meet the asset tests, (ii) paying a tax equal to the greater of $50,000 or the highest corporate tax rate times the taxable income generated by the non-qualifying asset and (iii) disclosing certain information to the IRS.
     Distribution Requirement
          In order to qualify as a REIT, the Company is required to distribute dividends (other than capital gain dividends) to its stockholders in an amount equal to or greater than the excess of (a) the sum of (i) 90% of the Company’s “real estate investment trust taxable income” (computed without regard to the dividends paid deduction and the Company’s net capital gain) and (ii) 90% of the net income (after tax on such income), if any, from foreclosure property, over (b) the sum of certain non-cash income (from certain imputed rental income and income from transactions inadvertently failing to qualify as like-kind exchanges). These requirements may be waived by the IRS if the Company establishes that it failed to meet them by reason of distributions previously made to meet the requirements of the 4% excise tax described below. To the extent that the Company does not distribute all of its net long-term capital gain and all of its “real estate investment trust taxable income,” it will be subject to tax thereon. In addition, the Company will be subject to a 4% excise

11


 

tax to the extent it fails within a calendar year to make “required distributions” to its stockholders of 85% of its ordinary income and 95% of its capital gain net income plus the excess, if any, of the “grossed up required distribution” for the preceding calendar year over the amount treated as distributed for such preceding calendar year. For this purpose, the term “grossed up required distribution” for any calendar year is the sum of the taxable income of the Company for the taxable year (without regard to the deduction for dividends paid) and all amounts from earlier years that are not treated as having been distributed under the provision. Dividends declared in the last quarter of the year and paid during the following January will be treated as having been paid and received on December 31 of such earlier year. The Company’s distributions for 2010 were adequate to satisfy its distribution requirement.
          It is possible that the Company, from time to time, may have insufficient cash or other liquid assets to meet the 90% distribution requirement due to timing differences between the actual receipt of income and the actual payment of deductible expenses or dividends on the one hand and the inclusion of such income and deduction of such expenses or dividends in arriving at “real estate investment trust taxable income” on the other hand. The problem of not having adequate cash to make required distributions could also occur as a result of the repayment in cash of principal amounts due on the Company’s outstanding debt, particularly in the case of “balloon” repayments or as a result of capital losses on short-term investments of working capital. Therefore, the Company might find it necessary to arrange for short-term, or possibly long-term, borrowing or new equity financing. If the Company were unable to arrange such borrowing or financing as might be necessary to provide funds for required distributions, its REIT status could be jeopardized.
          Under certain circumstances, the Company may be able to rectify a failure to meet the distribution requirement for a year by paying “deficiency dividends” to stockholders in a later year, which may be included in the Company’s deduction for dividends paid for the earlier year. The Company may be able to avoid being taxed on amounts distributed as deficiency dividends; however, the Company might in certain circumstances remain liable for the 4% excise tax described above.
     Federal Income Tax Treatment of Leases
          The availability to the Company of, among other things, depreciation deductions with respect to the facilities owned and leased by the Company depends upon the treatment of the Company as the owner of the facilities and the classification of the leases of the facilities as true leases, rather than as sales or financing arrangements, for federal income tax purposes. The Company has not requested nor has it received an opinion that it will be treated as the owner of the portion of the facilities constituting real property and that the leases will be treated as true leases of such real property for federal income tax purposes.
     Other Issues
          With respect to property acquired from and leased back to the same or an affiliated party, the IRS could assert that the Company realized prepaid rental income in the year of purchase to the extent that the value of the leased property exceeds the purchase price paid by the Company for that property. In litigated cases involving sale-leasebacks which have considered this issue, courts have concluded that buyers have realized prepaid rent where both parties acknowledged that the purported purchase price for the property was substantially less than fair market value and the purported rents were substantially less than the fair market rentals. Because of the lack of clear precedent and the inherently factual nature of the inquiry, the Company cannot give complete assurance that the IRS could not successfully assert the existence of prepaid rental income in such circumstances. The value of property and the fair market rent for properties involved in sale-leasebacks are inherently factual matters and always subject to challenge.
          Additionally, it should be noted that Section 467 of the Code (concerning leases with increasing rents) may apply to those leases of the Company that provide for rents that increase from one period to the next. Section 467 provides that in the case of a so-called “disqualified leaseback agreement,” rental income must be accrued at a constant rate. If such constant rent accrual is required, the Company would recognize rental income in excess of cash rents and, as a result, may fail to have adequate funds available to meet the 90% dividend distribution requirement. “Disqualified leaseback agreements” include leaseback transactions where a principal purpose of providing increasing rent under the agreement is the avoidance of federal income tax. Since the Section 467 regulations provide that rents will not be treated as increasing for tax avoidance purposes where the increases are based upon a fixed percentage of lessee receipts, additional rent provisions of leases containing such clauses should not result in these leases being disqualified leaseback agreements. In addition, the Section 467 regulations provide that leases providing for fluctuations in rents by no more than a reasonable percentage, which is 15% for long-term real property leases, from the average rent payable over the term of the lease will be deemed to not be motivated by tax avoidance. The Company does not believe it has rent subject to the disqualified leaseback provisions of Section 467.
          Subject to a safe harbor exception for annual sales of up to seven properties (or properties with a basis of up to 10% of the REIT’s assets) that have been held for at least two years, gain from sales of property held for sale to customers in the ordinary course of business is subject to a 100% tax. The simultaneous exercise of options to acquire leased property that may be granted to certain tenants or other events could result in sales of properties by the Company that exceed this safe harbor. However, the Company believes that in such event, it will not have held such properties for sale to customers in the ordinary course of business.

12


 

     Depreciation of Properties
          For federal income tax purposes, the Company’s real property is being depreciated over 31.5, 39 or 40 years, using the straight-line method of depreciation and its personal property over various periods utilizing accelerated and straight-line methods of depreciation.
     Failure to Qualify as a REIT
          If the Company was to fail to qualify for federal income tax purposes as a REIT in any taxable year, and the relief provisions were found not to apply, the Company would be subject to tax on its taxable income at regular corporate rates (plus any applicable alternative minimum tax). Distributions to stockholders in any year in which the Company failed to qualify would not be deductible by the Company nor would they be required to be made. In such event, to the extent of current and/or accumulated earnings and profits, all distributions to stockholders would be taxable as qualified dividend income, including, presumably, subject to the 15% maximum rate on dividends created by the Jobs and Growth Tax Relief Reconciliation Act of 2003, and, subject to certain limitations in the Code, eligible for the 70% dividends received deduction for corporations that are REIT stockholders. However, this reduced rate for dividend income is set to expire for taxable years beginning after December 31, 2012. Unless entitled to relief under specific statutory provisions, the Company would also be disqualified from taxation as a REIT for the following four taxable years. It is not possible to state whether in all circumstances the Company would be entitled to statutory relief from such disqualification. Failure to qualify for even one year could result in the Company’s incurring substantial indebtedness (to the extent borrowings were feasible) or liquidating substantial investments in order to pay the resulting taxes.
     Taxation of Tax-Exempt Stockholders
          The IRS has issued a revenue ruling in which it held that amounts distributed by a REIT to a tax-exempt employees’ pension trust do not constitute “unrelated business taxable income,” even though the REIT may have financed certain of its activities with acquisition indebtedness. Although revenue rulings are interpretive in nature and are subject to revocation or modification by the IRS, based upon the revenue ruling and the analysis therein, distributions made by the Company to a U.S. stockholder that is a tax-exempt entity (such as an individual retirement account (“IRA”) or a 401(k) plan) should not constitute unrelated business taxable income unless such tax-exempt U.S. stockholder has financed the acquisition of its shares with “acquisition indebtedness” within the meaning of the Code, or the shares are otherwise used in an unrelated trade or business conducted by such U.S. stockholder.
          Special rules apply to certain tax-exempt pension funds (including 401(k) plans but excluding IRAs or government pension plans) that own more than 10% (measured by value) of a “pension-held REIT.” Such a pension fund may be required to treat a certain percentage of all dividends received from the REIT during the year as unrelated business taxable income. The percentage is equal to the ratio of the REIT’s gross income (less direct expenses related thereto) derived from the conduct of unrelated trades or businesses determined as if the REIT were a tax-exempt pension fund (including income from activities financed with “acquisition indebtedness”), to the REIT’s gross income (less direct expenses related thereto) from all sources. The special rules will not require a pension fund to recharacterize a portion of its dividends as unrelated business taxable income unless the percentage computed is at least 5%.
          A REIT will be treated as a “pension-held REIT” if the REIT is predominantly held by tax-exempt pension funds and if the REIT would otherwise fail to satisfy the five or fewer test discussed above. A REIT is predominantly held by tax-exempt pension funds if at least one tax-exempt pension fund holds more than 25% (measured by value) of the REIT’s stock or beneficial interests, or if one or more tax-exempt pension funds (each of which owns more than 10% (measured by value) of the REIT’s stock or beneficial interests) own in the aggregate more than 50% (measured by value) of the REIT’s stock or beneficial interests. The Company believes that it will not be treated as a pension-held REIT. However, because the shares of the Company will be publicly traded, no assurance can be given that the Company is not or will not become a pension-held REIT.
     Taxation of Non-U.S. Stockholders
          The rules governing United States federal income taxation of any person other than (i) a citizen or resident of the United States, (ii) a corporation or partnership created in the United States or under the laws of the United States or of any state thereof, (iii) an estate whose income is includable in income for U.S. federal income tax purposes regardless of its source or (iv) a trust if a court within the United States is able to exercise primary supervision over the administration of the trust and one or more United States fiduciaries have the authority to control all substantial decisions of the trust (“Non-U.S. Stockholders”) are highly complex, and the following discussion is intended only as a summary of such rules. Prospective Non-U.S. Stockholders should consult with their own tax advisors to determine the impact of United States federal, state, and local income tax laws on an investment in stock of the Company, including any reporting requirements.
          In general, Non-U.S. Stockholders are subject to regular United States income tax with respect to their investment in stock of the Company in the same manner as a U.S. stockholder if such investment is “effectively connected” with the Non-U.S. Stockholder’s conduct of a trade or business in the United States. A corporate Non-U.S. Stockholder that receives income with respect to its investment in stock of the Company that is (or is treated as) effectively connected with the conduct of a trade or business in the United States also

13


 

may be subject to the 30% branch profits tax imposed by the Code, which is payable in addition to regular United States corporate income tax. The following discussion addresses only the United States taxation of Non-U.S. Stockholders whose investment in stock of the Company is not effectively connected with the conduct of a trade or business in the United States.
     Ordinary Dividends
          Distributions made by the Company that are not attributable to gain from the sale or exchange by the Company of United States real property interests (“USRPI”) and that are not designated by the Company as capital gain dividends will be treated as ordinary income dividends to the extent made out of current or accumulated earnings and profits of the Company. Generally, such ordinary income dividends will be subject to United States withholding tax at the rate of 30% on the gross amount of the dividend paid unless reduced or eliminated by an applicable United States income tax treaty. The Company expects to withhold United States income tax at the rate of 30% on the gross amount of any such dividends paid to a Non-U.S. Stockholder unless a lower treaty rate applies and the Non-U.S. Stockholder has filed an IRS Form W-8BEN with the Company, certifying the Non-U.S. Stockholder’s entitlement to treaty benefits.
     Non-Dividend Distributions
          Distributions made by the Company in excess of its current and accumulated earnings and profits to a Non-U.S. Stockholder who holds 5% or less of the stock of the Company (after application of certain ownership rules) will not be subject to U.S. income or withholding tax. If it cannot be determined at the time a distribution is made whether or not such distribution will be in excess of the Company’s current and accumulated earnings and profits, the distribution will be subject to withholding at the rate applicable to a dividend distribution. However, the Non-U.S. Stockholder may seek a refund from the IRS of any amount withheld if it is subsequently determined that such distribution was, in fact, in excess of the Company’s then current and accumulated earnings and profits.
     Capital Gain Dividends
          As long as the Company continues to qualify as a REIT, distributions made by the Company after December 31, 2005, that are attributable to gain from the sale or exchange by the Company of any USRPI will not be treated as effectively connected with the conduct of a trade or business in the United States. Instead, such distributions will be treated as REIT dividends that are not capital gains and will not be subject to the branch profits tax as long as the Non-U.S. Stockholder does not hold greater than 5% of the stock of the Company at any time during the one-year period ending on the date of the distribution. Non-U.S. Stockholders who hold more than 5% of the stock of the Company will be treated as if such gains were effectively connected with the conduct of a trade or business in the United States and generally subject to the same capital gains rates applicable to U.S. stockholders. In addition, corporate Non-U.S. Stockholders may also be subject to the 30% branch profits tax and to withholding at the rate of 35% of the gross distribution.
     Disposition of Stock of the Company
          Generally, gain recognized by a Non-U.S. Stockholder upon the sale or exchange of stock of the Company will not be subject to United States taxation unless such stock constitutes a USRPI within the meaning of the Foreign Investment in Real Property Tax Act of 1980 (“FIRPTA”). The stock of the Company will not constitute a USRPI so long as the Company is a “domestically controlled REIT.” A “domestically controlled REIT” is a REIT in which at all times during a specified testing period less than 50% in value of its stock or beneficial interests are held directly or indirectly by Non-U.S. Stockholders. The Company believes that it will be a “domestically controlled REIT,” and therefore that the sale of stock of the Company will generally not be subject to taxation under FIRPTA. However, because the stock of the Company is publicly traded, no assurance can be given that the Company is or will continue to be a “domestically controlled REIT.”
          Under “wash sale” rules applicable to certain dispositions of interests in “domestically controlled REITs,” a Non-U.S. Stockholder could be subject to taxation under FIRPTA on the disposition of stock of the Company if certain conditions are met. If the Company is a “domestically controlled REIT,” a Non-U.S. Stockholder will be treated as having disposed of USRPI, if such Non-U.S. Stockholder disposes of an interest in the Company in an “applicable wash sale transaction.” An “applicable wash sale transaction” is any transaction in which a Non-U.S. Stockholder avoids receiving a distribution from a REIT by (i) disposing of an interest in a “domestically controlled REIT” during the 30-day period preceding a distribution, any portion of which distribution would have been treated as gain from the sale of a USRPI if it had been received by the Non-U.S. Stockholder and (ii) acquiring, or entering into a contract or option to acquire, a substantially identical interest in the REIT during the 61-day period beginning the first day of the 30-day period preceding the distribution. The wash sale rule does not apply to a Non-U.S. Stockholder who actually receives the distribution from the Company or, so long as the Company is publicly traded, to any Non-U.S. Stockholder holding greater than 5% of the outstanding stock of the Company at any time during the one-year period ending on the date of the distribution.
          If the Company did not constitute a “domestically controlled REIT,” gain arising from the sale or exchange by a Non-U.S. Stockholder of stock of the Company would be subject to United States taxation under FIRPTA as a sale of a USRPI unless (i) the stock of the Company is “regularly traded” (as defined in the applicable Treasury regulations) and (ii) the selling Non-U.S. Stockholder’s interest (after application of certain constructive ownership rules) in the Company is 5% or less at all times during the five years

14


 

preceding the sale or exchange. If gain on the sale or exchange of the stock of the Company were subject to taxation under FIRPTA, the Non-U.S. Stockholder would be subject to regular United States income tax with respect to such gain in the same manner as a U.S. stockholder (subject to any applicable alternative minimum tax, a special alternative minimum tax in the case of nonresident alien individuals and the possible application of the 30% branch profits tax in the case of foreign corporations), and the purchaser of the stock of the Company (including the Company) would be required to withhold and remit to the IRS 10% of the purchase price. Additionally, in such case, distributions on the stock of the Company to the extent they represent a return of capital or capital gain from the sale of the stock of the Company, rather than dividends, would be subject to a 10% withholding tax.
          Capital gains not subject to FIRPTA will nonetheless be taxable in the United States to a Non-U.S. Stockholder in two cases:
    if the Non-U.S. Stockholder’s investment in the stock of the Company is effectively connected with a U.S. trade or business conducted by such Non-U.S. Stockholder, the Non-U.S. Stockholder will be subject to the same treatment as a U.S. stockholder with respect to such gain; or
 
    if the Non-U.S. Stockholder is a nonresident alien individual who was present in the United States for 183 days or more during the taxable year and has a “tax home” in the United States, the nonresident alien individual will be subject to a 30% tax on the individual’s capital gain.
     Information Reporting Requirements and Backup Withholding Tax
          The Company will report to its U.S. stockholders and to the IRS the amount of dividends paid during each calendar year and the amount of tax withheld, if any, with respect thereto. Under the backup withholding rules, a U.S. stockholder may be subject to backup withholding, currently at a rate of 28% on dividends paid unless such U.S. stockholder:
    is a corporation or falls within certain other exempt categories and, when required, can demonstrate this fact; or
 
    provides a taxpayer identification number, certifies as to no loss of exemption from backup withholding, and otherwise complies with applicable requirements of the backup withholding rules.
          A U.S. stockholder who does not provide the Company with his correct taxpayer identification number also may be subject to penalties imposed by the IRS. Any amount paid as backup withholding will be creditable against the U.S. stockholder’s federal income tax liability. In addition, the Company may be required to withhold a portion of any capital gain distributions made to U.S. stockholders who fail to certify their non-foreign status to the Company.
          Additional issues may arise pertaining to information reporting and backup withholding with respect to Non-U.S. Stockholders, and Non-U.S. Stockholders should consult their tax advisors with respect to any such information reporting and backup withholding requirements.
     State and Local Taxes
          The Company and its stockholders may be subject to state or local taxation in various state or local jurisdictions, including those in which it or they transact business or reside. The state and local tax treatment of the Company and its stockholders may not conform to the federal income tax consequences discussed above. Consequently, prospective holders should consult their own tax advisors regarding the effect of state and local tax laws on an investment in the stock of the Company.
     Real Estate Investment Trust Tax Proposals
          Investors must recognize that the present federal income tax treatment of the Company may be modified by future legislative, judicial or administrative actions or decisions at any time, which may be retroactive in effect, and, as a result, any such action or decision may affect investments and commitments previously made. The rules dealing with federal income taxation are constantly under review by persons involved in the legislative process and by the IRS and the Treasury Department, resulting in statutory changes as well as promulgation of new, or revisions to existing, regulations and revised interpretations of established concepts. No prediction can be made as to the likelihood of the passage of any new tax legislation or other provisions either directly or indirectly affecting the Company or its stockholders.
     Other Legislation
          The Jobs and Growth Tax Relief Reconciliation Act of 2003 reduced the maximum individual tax rate for long-term capital gains generally from 20% to 15% (for sales occurring after May 6, 2003 through December 31, 2008) and for dividends generally from 38.6% to 15% (for tax years from 2003 through 2008). These provisions have been extended through the 2012 tax year. Without future

15


 

congressional action, the maximum tax rate on long-term capital gains will return to 20% in 2013, and the maximum rate on dividends will move to 39.6% in 2013. Because a REIT is not generally subject to federal income tax on the portion of its REIT taxable income or capital gains distributed to its stockholders, distributions of dividends by a REIT are generally not eligible for the 15% tax rate on dividends. As a result, the Company’s ordinary REIT dividends will continue to be taxed at the higher tax rates (currently, a maximum of 35%) applicable to ordinary income.
ERISA Considerations
          The following is a summary of material considerations arising under ERISA and the prohibited transaction provisions of Section 4975 of the Code that may be relevant to a holder of stock of the Company. This discussion does not propose to deal with all aspects of ERISA or Section 4975 of the Code or, to the extent not preempted, state law that may be relevant to particular employee benefit plan stockholders (including plans subject to Title I of ERISA, other employee benefit plans and IRAs subject to the prohibited transaction provisions of Section 4975 of the Code, and governmental plans and church plans that are exempt from ERISA and Section 4975 of the Code but that may be subject to state law requirements) in light of their particular circumstances.
          A fiduciary making the decision to invest in stock of the Company on behalf of a prospective purchaser which is an ERISA plan, a tax-qualified retirement plan, an IRA or other employee benefit plan is advised to consult its own legal advisor regarding the specific considerations arising under ERISA, Section 4975 of the Code, and (to the extent not preempted) state law with respect to the purchase, ownership or sale of stock by such plan or IRA.
     Employee Benefit Plans, Tax-Qualified Retirement Plans and IRAs
          Each fiduciary of an employee benefit plan subject to Title I of ERISA (an “ERISA Plan”) should carefully consider whether an investment in stock of the Company is consistent with its fiduciary responsibilities under ERISA. In particular, the fiduciary requirements of Part 4 of Title I of ERISA require (i) an ERISA Plan’s investments to be prudent and in the best interests of the ERISA Plan, its participants and beneficiaries, (ii) an ERISA Plan’s investments to be diversified in order to reduce the risk of large losses, unless it is clearly prudent not to do so, (iii) an ERISA Plan’s investments to be authorized under ERISA and the terms of the governing documents of the ERISA Plan and (iv) that the fiduciary not cause the ERISA Plan to enter into transactions prohibited under Section 406 of ERISA. In determining whether an investment in stock of the Company is prudent for purposes of ERISA, the appropriate fiduciary of an ERISA Plan should consider all of the facts and circumstances, including whether the investment is reasonably designed, as a part of the ERISA Plan’s portfolio for which the fiduciary has investment responsibility, to meet the objectives of the ERISA Plan, taking into consideration the risk of loss and opportunity for gain (or other return) from the investment, the diversification, cash flow and funding requirements of the ERISA Plan and the liquidity and current return of the ERISA Plan’s portfolio. A fiduciary should also take into account the nature of the Company’s business, the length of the Company’s operating history and other matters described below under “Risk Factors.”
          The fiduciary of an IRA or of an employee benefit plan not subject to Title I of ERISA because it is a governmental or church plan or because it does not cover common law employees (a “Non-ERISA Plan”) should consider that such an IRA or Non-ERISA Plan may only make investments that are authorized by the appropriate governing documents, not prohibited under Section 4975 of the Code and permitted under applicable state law.
     Status of the Company under ERISA
          A prohibited transaction may occur if the assets of the Company are deemed to be assets of the investing Plans and “parties in interest” or “disqualified persons” as defined in ERISA and Section 4975 of the Code, respectively, deal with such assets. In certain circumstances where a Plan holds an interest in an entity, the assets of the entity are deemed to be Plan assets (the “look-through rule”). Under such circumstances, any person that exercises authority or control with respect to the management or disposition of such assets is a Plan fiduciary. Plan assets are not defined in ERISA or the Code, but the United States Department of Labor issued regulations in 1987 (the “Regulations”) that outline the circumstances under which a Plan’s interest in an entity will be subject to the look-through rule.
          The Regulations apply only to the purchase by a Plan of an “equity interest” in an entity, such as common stock or common shares of beneficial interest of a REIT. However, the Regulations provide an exception to the look-through rule for equity interests that are “publicly-offered securities.”
          Under the Regulations, a “publicly-offered security” is a security that is (i) freely transferable, (ii) part of a class of securities that is widely held and (iii) either (a) part of a class of securities that is registered under section 12(b) or 12(g) of the Securities Exchange Act of 1934, as amended (the “Securities Exchange Act”), or (b) sold to a Plan as part of an offering of securities to the public pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”) and the class of securities of which such security is a part of is registered under the Securities Act within 120 days (or such longer period allowed by the Securities and Exchange Commission (“SEC”)) after the end of the fiscal year of the issuer during which the offering of such securities to the public occurred. Whether a security is considered “freely transferable” depends on the facts and circumstances of each case. Generally, if the

16


 

security is part of an offering in which the minimum investment is $10,000 or less, any restriction on or prohibition against any transfer or assignment of such security for the purposes of preventing a termination or reclassification of the entity for federal or state tax purposes will not of itself prevent the security from being considered freely transferable. A class of securities is considered “widely held” if it is a class of securities that is owned by 100 or more investors independent of the issuer and of one another.
          Management believes that the stock of the Company will meet the criteria of the publicly offered securities exception to the look-through rule in that the stock of the Company is freely transferable, the minimum investment is less than $10,000 and the only restrictions upon its transfer are those required under federal income tax laws to maintain the Company’s status as a REIT. Second, stock of the Company is held by 100 or more investors and at least 100 or more of these investors are independent of the Company and of one another. Third, the stock of the Company has been and will be part of offerings of securities to the public pursuant to an effective registration statement under the Securities Exchange Act and will be registered under the Securities Exchange Act within 120 days after the end of the fiscal year of the Company during which an offering of such securities to the public occurs. Accordingly, management believes that if a Plan purchases stock of the Company, the Company’s assets should not be deemed to be Plan assets and, therefore, that any person who exercises authority or control with respect to the Company’s assets should not be treated as a Plan fiduciary for purposes of the prohibited transaction rules of ERISA and Section 4975 to the Code.
Available Information
          The Company makes available to the public free of charge through its internet website the Company’s Proxy Statement, Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after the Company electronically files such reports with, or furnishes such reports to, the SEC. The Company’s internet website address is www.healthcarerealty.com.
          The public may read and copy any materials that the Company files with the SEC at the SEC’s Public Reference Room located at 100 F Street, NE, Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains electronic versions of the Company’s reports on its website at www.sec.gov.
Corporate Governance Principles
          The Company has adopted Corporate Governance Principles relating to the conduct and operations of the Board of Directors. The Corporate Governance Principles are posted on the Company’s website (www.healthcarerealty.com) and are available in print to any stockholder who requests a copy.
Committee Charters
          The Board of Directors has an Audit Committee, Compensation Committee, Corporate Governance Committee and Executive Committee. The Board of Directors has adopted written charters for each committee except for the Executive Committee, which are posted on the Company’s website (www.healthcarerealty.com) and are available in print to any stockholder who requests a copy.
Executive Officers
          Information regarding the executive officers of the Company is set forth in Part III, Item 10 of this report and is incorporated herein by reference.
ITEM 1A. RISK FACTORS
          The following are some of the risks and uncertainties that could negatively affect the Company’s financial condition, results of operations, business and prospects. These risks, as well as the risks described in Item 1 under the headings “Competition,” “Government Regulation,” “Legislative Developments,” “Environmental Matters,” and “Federal Income Tax Information” and in Item 7 under the heading “Disclosure Regarding Forward-Looking Statements” should be carefully considered before making an investment decision regarding the Company. The risks and uncertainties described below are not the only ones facing the Company, and there may be additional risks that the Company does not presently know of or that the Company currently considers not likely to have a significant impact. If any of the events underlying the following risks actually occurred, the Company’s business, financial condition and operating results could suffer, and the trading price of its common stock could decline.

17


 

The Company has recently incurred additional debt obligations and leverage may remain at higher levels.
          As of December 31, 2010, the Company had approximately $1.4 billion of outstanding indebtedness. The Company’s leverage ratio [debt divided by (debt plus stockholders’ equity less intangible assets plus accumulated depreciation)] increased from 46.5% at December 31, 2009 to 51.7% at December 31, 2010. Covenants under the Unsecured Credit Facility and the indenture governing the Company’s senior notes permit the Company to incur substantial additional debt, and the Company may borrow additional funds, which may include secured borrowings. A high level of indebtedness would require the Company to dedicate a substantial portion of its cash flow from operations to the payment of indebtedness, thereby reducing the funds available to implement the Company’s business strategy and to make distributions to stockholders. A high level of indebtedness could also:
    Potentially limit the Company’s ability to adjust rapidly to changing market conditions in the event of a downturn in general economic conditions or in the real estate and/or healthcare industries;
 
    Potentially impair the Company’s ability to obtain additional financing for its business strategy; and
 
    Potentially downgrade the rating of the Company’s debt securities by one or more rating agencies, which would increase the costs of borrowing under the Unsecured Credit Facility and the cost of issuance of new debt securities, among other things.
          In addition, from time to time the Company mortgages properties to secure payment of indebtedness. If the Company is unable to meet its mortgage payments, then the encumbered properties could be foreclosed upon or transferred to the mortgagee with a consequent loss of income and asset value. A foreclosure on one or more of our properties could have a material adverse effect on the Company’s financial condition and results of operations.
The unavailability of equity and debt capital, volatility in the credit markets, increases in interest rates, or changes in the Company’s debt ratings could have an adverse effect on the Company’s ability to meet its debt payments, make dividend payments to stockholders or engage in acquisition and development activity.
          A REIT is required by IRS regulations to make dividend distributions, thereby retaining less of its capital for growth. As a result, a REIT typically grows through steady investments of new capital in real estate assets. Presently, the Company has sufficient capital availability. However, there may be times when the Company will have limited access to capital from the equity and/or debt markets. Changes in the Company’s debt ratings could have a material adverse effect on its interest costs and financing sources. The Company’s debt rating can be materially influenced by a number of factors including, but not limited to, acquisitions, investment decisions, and capital management activities. In recent years, the capital and credit markets have experienced volatility and at times have limited the availability of funds. The Company’s ability to access the capital and credit markets may be limited by these or other factors, which could have an impact on its ability to refinance maturing debt, fund dividend payments and operations, acquire healthcare properties and complete construction projects. If the Company is unable to refinance or extend principal payments due at maturity of its various debt instruments, its cash flow may not be sufficient to repay maturing debt and, consequently, make dividend payments to stockholders. If the Company defaults in paying any of its debts or honoring its debt covenants, it could experience cross-defaults among debt instruments, the debts could be accelerated and the Company could be forced to liquidate assets for less than the values it would otherwise receive.
The Company is exposed to increases in interest rates, which could adversely impact its ability to refinance existing debt, sell assets or engage in acquisition and development activity.
          The Company receives a significant portion of its revenues by leasing its assets under long-term leases in which the rental rate is generally fixed, subject to annual rent escalators. A significant portion of the Company’s debt may be from time to time subject to floating rates, based on LIBOR or other indices. The generally fixed nature of revenues and the variable rate of certain debt obligations create interest rate risk for the Company. Increases in interest rates could make the financing of any acquisition or investment activity more costly. Rising interest rates could limit the Company’s ability to refinance existing debt when it matures or cause the Company to pay higher rates upon refinancing. An increase in interest rates also could have the effect of reducing the amounts that third parties might be willing to pay for real estate assets, which could limit the Company’s ability to sell assets at times when it might be advantageous to do so.
The Company may be required to sell certain properties to tenants or sponsors whose leases or financial support agreements provide for options to purchase. The Company may not be able to reinvest the proceeds from sale at rates of return equal to the return received on the properties sold.
          At December 31, 2010, the Company had approximately $91.3 million in real estate properties, or 3.5% of the Company real estate property investments, that are subject to exercisable purchase options held by lessees or financial support agreement sponsors that had not been exercised. Other properties have purchase options that will become exercisable in the future. The exercise of these purchase

18


 

options exposes the Company to reinvestment risk. Certain properties subject to purchase options are producing returns above the rates of return the Company expects to achieve with new investments. If the Company is unable to reinvest the proceeds of sale at rates of return equal to the return received on the properties that are sold, it may experience a decline in lease revenues and a corresponding material adverse effect on the Company’s business and financial condition, the Company’s ability to make distributions to its stockholders, and the market price of its common stock.
The Company is subject to risks associated with the development of properties.
          The Company is subject to certain risks associated with the development of properties including the following:
    The construction of properties generally requires various government and other approvals that may not be received when expected, or at all, which could delay or preclude commencement of construction;
 
    Development opportunities that the Company pursued but later abandoned could result in the expensing of pursuit costs, which could impact the Company’s results of operations;
 
    Construction costs could exceed original estimates, which could impact the building’s profitability to the Company;
 
    Operating expenses could be higher than forecasted;
 
    Time required to initiate and complete the construction of a property and lease up a completed development property may be greater than originally anticipated, thereby adversely affecting the Company’s cash flow and liquidity;
 
    Occupancy rates and rents of a completed development property may not be sufficient to make the property profitable to the Company; and
 
    Favorable capital sources to fund the Company’s development activities may not be available when needed.
From time to time the Company may make material acquisitions and developments that may involve the expenditure of significant funds and may be unsuccessful in operating new and existing real estate properties.
          The Company regularly pursues potential transactions to acquire or develop additional assets in order to grow stockholder value and believes that there are currently numerous acquisition and development opportunities for the Company to invest in additional medical office and other outpatient-related facilities. Future acquisitions could require the Company to issue equity securities, incur debt, contingent liabilities or amortize expenses related to other intangible assets, any of which could adversely impact the Company’s financial condition or results of operations. In addition, equity or debt financing required for such acquisitions may not be available at times or at favorable rates.
          The Company’s acquired, developed and existing real estate properties may not perform in accordance with management’s expectations because of many factors including the following:
    The Company’s purchase price for acquired facilities may be based upon a series of market or building-specific judgments which may be incorrect;
 
    The costs of any maintenance or improvements for properties might exceed budgeted costs;
 
    The Company may incur unexpected costs in the acquisition, construction or maintenance of real estate assets that could impact its expected returns on such assets; and
 
    Leasing of real estate properties may not occur within expected timeframes or at expected rental rates.
          Further, the Company can give no assurance that acquisition and development opportunities that will meet management’s investment criteria will be available when needed or anticipated.
The Company may incur impairment charges on its real estate properties or other assets.
          The Company performs an annual impairment review on its real estate properties in the third quarter of every fiscal year. In addition, the Company assesses the potential for impairment of identifiable intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the recorded value might not be fully recoverable. At some

19


 

future date, the Company may determine that an impairment has occurred in the value of one or more of its real estate properties or other assets. In such an event, the Company may be required to recognize an impairment loss which could have a material adverse effect on the Company’s financial condition and results of operations.
The Company’s long-term master leases and financial support agreements may expire and not be extended.
          Long-term master leases and financial support agreements that are expiring may not be extended. To the extent these properties have vacancies or subleases at lower rates upon expiration, income may decline if the Company is not able to re-let the properties at rental rates that are as high as the former rates.
Covenants in the Company’s debt instruments limit its operational flexibility, and a breach of these covenants could materially affect the Company’s financial condition and results of operations.
          The terms of the Unsecured Credit Facility, the indentures governing the Company’s outstanding senior notes and other debt instruments that the Company may enter into in the future are subject to customary financial and operational covenants. The Company’s continued ability to incur debt and operate its business is subject to compliance with these covenants, which limit operational flexibility. Breaches of these covenants could result in defaults under applicable debt instruments, even if payment obligations are satisfied. Financial and other covenants that limit the Company’s operational flexibility, as well as defaults resulting from a breach of any of these covenants in its debt instruments, could have a material adverse effect on the Company’s financial condition and results of operations.
The Company’s business operations may not generate the cash needed to service debt or fund planned capital expenditures.
          The Company’s ability to make payments on its indebtedness and to fund planned capital expenditures will depend on its ability to generate cash in the future. There can be no assurance that the Company’s business will generate sufficient cash flow from operations or that future borrowings will be available in amounts sufficient to enable the Company to pay its indebtedness or to fund other liquidity needs.
The Company’s revenues depend on the ability of its tenants and sponsors under its leases and financial support agreements to generate sufficient income from their operations to make loan, rent and support payments to the Company.
          The Company’s revenues are subject to the financial strength of its tenants and sponsors. The Company has no operational control over the business of these tenants and sponsors who face a wide range of economic, competitive, government reimbursement and regulatory pressures and constraints. The slowdown in the economy, decline in the availability of financing from the capital markets, and changes in healthcare regulations have affected, or may in the future adversely affect, the businesses of the Company’s tenants and sponsors to varying degrees. Such conditions may further impact such tenants’ and sponsors’ abilities to meet their obligations to the Company and, in certain cases, could lead to restructurings, disruptions, or bankruptcies of such tenants and sponsors. In turn, these conditions could adversely affect the Company’s revenues and could increase allowances for losses and result in impairment charges, which could decrease net income attributable to common stockholders and equity, and reduce cash flows from operations.
If a healthcare tenant loses its licensure or certification, becomes unable to provide healthcare services, cannot meet its financial obligations to the Company or otherwise vacates a facility, the Company would have to obtain another tenant for the affected facility.
          If the Company loses a tenant or sponsor and is unable to attract another healthcare provider on a timely basis and on acceptable terms, the Company’s cash flows and results of operations could suffer. In addition, many of the Company’s properties are special purpose healthcare facilities that may not be easily adaptable to other uses. Transfers of operations of healthcare facilities are often subject to regulatory approvals not required for transfers of other types of commercial operations and real estate.
Many of the Company’s properties are held under long-term ground leases. These ground leases contain provisions that may limit the Company’s ability to lease, sell, or finance these properties.
          The Company’s ground lease agreements with hospitals and health systems typically contain restrictions that limit building occupancy to physicians on the medical staff of an affiliated hospital and prohibit physician tenants from providing services that compete with the services provided by the affiliated hospital. Ground leases may also contain consent requirements or other restrictions on sale or assignment of the Company’s leasehold interest, including rights of first offer and first refusal in favor of the lessor. These ground lease provisions may limit the Company’s ability to lease, sell, or obtain mortgage financing secured by such properties which, in turn, could adversely affect the income from operations or the proceeds received from a sale. As a ground lessee, the Company is also exposed to the risk of reversion of the property upon expiration of the ground lease term, or an earlier breach by the Company of the ground lease, which may have a material adverse effect on the Company’s business, financial condition and results of operations, the Company’s ability to make distributions to the Company’s stockholders and the trading price of the Company’s common stock.

20


 

If the Company is unable to promptly re-let its properties, if the rates upon such re-letting are significantly lower than expected or if the Company is required to undertake significant capital expenditures to attract new tenants, then the Company’s business, financial condition and results of operations would be adversely affected.
          A portion of the Company’s leases will mature over the course of any year. The Company may not be able to re-let space on terms that are favorable to the Company or at all. Further, the Company may be required to make significant capital expenditures to renovate or reconfigure space to attract new tenants. If it is unable to promptly re-let its properties, if the rates upon such re-letting are significantly lower than expected, or if the Company is required to undertake significant capital expenditures in connection with re-letting units, the Company’s business, financial condition and results of operations, the Company’s ability to make distributions to the Company’s stockholders and the trading price of the Company’s common stock may be materially and adversely affected.
Certain of the Company’s properties are special purpose healthcare facilities and may not be easily adaptable to other uses.
          Some of the Company’s properties are specialized medical facilities. If the Company or the Company’s tenants terminate the leases for these properties or the Company’s tenants lose their regulatory authority to operate such properties, the Company may not be able to locate suitable replacement tenants to lease the properties for their specialized uses. Alternatively, the Company may be required to spend substantial amounts to adapt the properties to other uses. Any loss of revenues and/or additional capital expenditures occurring as a result may have a material adverse effect on the Company’s business, financial condition and results of operations, the Company’s ability to make distributions to its stockholders, and the market price of the Company’s common stock.
The market price of the Company’s stock may be affected adversely by changes in the Company’s dividend policy.
          The ability of the Company to pay dividends is dependent upon its ability to maintain funds from operations and cash flow, to make accretive new investments and to access capital. A failure to maintain dividend payments at current levels could result in a reduction of the market price of the Company’s stock.
Adverse trends in the healthcare service industry may negatively affect the Company’s lease revenues and the values of its investments.
          The healthcare service industry may be affected by the following:
    Regulatory and government reimbursement uncertainty resulting from the Health Reform Law;
 
    Federal and state government focus on reducing deficits while also providing more public health benefits to address the expanding uninsured and senior populations and the forthcoming insolvency of the Medicare Trust Fund Part A;
 
    Reductions in the growth of Medicare and Medicaid payment rates, to be offset, in whole or in part, by higher revenue from an increase in the insured population;
 
    Pressure from private and governmental payors on healthcare providers to contain costs while increasing patients’ access to quality healthcare services;
 
    Trends in the method of delivery of healthcare services;
 
    Competition among healthcare providers;
 
    Reimbursement rates from government and commercial payors, high uncompensated care expense and limited admissions growth pressuring operating profit margins in an uncertain economy;
 
    Investment losses;
 
    Availability of capital;
 
    Credit downgrades;
 
    Liability insurance expense; and
 
    Scrutiny and formal investigations by federal and state authorities.

21


 

          These changes, among others, can adversely affect the economic performance of some or all of the tenants and sponsors who provide financial support to the Company’s investments and, in turn, negatively affect the lease revenues and the value of the Company’s property investments.
The Company is exposed to risks associated with entering new geographic markets.
          The Company’s acquisition and development activities may involve entering geographic markets where the Company has not previously had a presence. The construction and/or acquisition of properties in new geographic areas involves risks, including the risk that the property will not perform as anticipated and the risk that any actual costs for site development and improvements identified in the pre-construction or pre-acquisition due diligence process will exceed estimates. There is, and it is expected that there will continue to be, significant competition for investment opportunities that meet management’s investment criteria, as well as risks associated with obtaining financing for acquisition activities, if necessary.
The Company may experience uninsured or underinsured losses related to casualty or liability.
          The Company generally requires its tenants to maintain comprehensive liability and property insurance that covers the Company as well as the tenants. The Company also carries comprehensive liability insurance and property insurance covering its owned and managed properties. In addition, tenants under long-term master leases are required to carry property insurance covering the Company’s interest in the buildings. Some types of losses, however, either may be uninsurable or too expensive to insure against. Should an uninsured loss or a loss in excess of insured limits occur, the Company could lose all or a portion of the capital it has invested in a property, as well as the anticipated future revenue from the property. In such an event, the Company might remain obligated for any mortgage debt or other financial obligation related to the property. The Company cannot give assurance that material losses in excess of insurance proceeds will not occur in the future.
Failure to maintain its status as a REIT, even in one taxable year, could cause the Company to reduce its dividends dramatically.
          The Company intends to qualify at all times as a REIT under the Code. If in any taxable year the Company does not qualify as a REIT, it would be taxed as a corporation. As a result, the Company could not deduct its distributions to the stockholders in computing its taxable income. Depending upon the circumstances, a REIT that loses its qualification in one year may not be eligible to re-qualify during the four succeeding years. Further, certain transactions or other events could lead to the Company being taxed at rates ranging from four to 100 percent on certain income or gains. For more information about the Company’s status as a REIT, see “Federal Income Tax Information” in Item 1 of this Annual Report on Form 10-K.
If lenders under the Unsecured Credit Facility fail to meet their funding commitments, the Company’s financial position would be negatively impacted.
          Access to external capital on favorable terms is critical to the Company’s success in growing and maintaining its portfolio. If financial institutions within the Unsecured Credit Facility were unwilling or unable to meet their respective funding commitments to the Company, any such failure would have a negative impact on the Company’s operations, financial condition and ability to meet its obligations, including the payment of dividends to stockholders.
ITEM 1B. UNRESOLVED STAFF COMMENTS
          None.
ITEM 2. PROPERTIES
          In addition to the properties described under Item 1, “Business,” in Note 2 to the Consolidated Financial Statements, and in Schedule III of Item 15 of this Annual Report on Form 10-K, the Company leases office space for its headquarters. The Company’s headquarters, located in offices at 3310 West End Avenue in Nashville, Tennessee, are leased from an unrelated third party. The Company amended its current lease agreement during 2010 which extended the expiration date through October 31, 2020, provided amended base rental payments through the expiration date, reset the base year for operating expense reimbursements, and provided the Company with a right of first offer to purchase the building in which the Company is headquartered if the current landlord were to decide to sell the property. The amended lease covers approximately 30,934 square feet of rented space with base rent escalations of approximately 3.25% annually, with an additional base rental increase possible in the fifth year depending on changes in CPI. The Company’s base rent for 2010 was approximately $671,783.

22


 

ITEM 3. LEGAL PROCEEDINGS
          Two affiliates of the Company, HR Acquisition of Virginia Limited Partnership and HRT Holdings, Inc., are defendants in a lawsuit brought by Fork Union Medical Investors Limited Partnership, Goochland Medical Investors Limited Partnership, and Life Care Centers of America, Inc., as plaintiffs, in the Circuit Court of Davidson County, Tennessee. The plaintiffs allege that they overpaid rent between 1991 and 2003 under leases for two skilled nursing facilities in Virginia and seek a refund of such overpayments. Plaintiffs have not specified their damages in the complaint, but based on written discovery responses, the Company estimates the plaintiffs are seeking up to $2.0 million, plus pre- and post-judgment interest. The two leases were terminated by agreement with the plaintiffs in 2003. The Company denies that it is liable to the plaintiffs for any refund of rent paid and will continue to defend the case vigorously. A trial is scheduled for April 2011.
          The Company is, from time to time, involved in litigation arising out of the ordinary course of business or which is expected to be covered by insurance. The Company is not aware of any other pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company’s consolidated financial position, results of operations, or cash flows.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
          No matter was submitted to a vote of stockholders during the fourth quarter of 2010.

23


 

PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
          Shares of the Company’s common stock are traded on the New York Stock Exchange under the symbol “HR.” As of December 31, 2010, there were approximately 1,219 stockholders of record. The following table sets forth the high and low sales prices per share of common stock and the dividend declared and paid per share of common stock related to the periods indicated.
                         
                    Dividends Declared  
2010 
  High     Low     and Paid per Share  
First Quarter
  $ 24.57     $ 19.61     $ 0.300  
Second Quarter
    25.24       20.47       0.300  
Third Quarter
    24.69       21.36       0.300  
Fourth Quarter (Payable on March 3, 2011)
    25.00       20.06       0.300  
 
                       
2009  
                       
First Quarter
  $ 23.59     $ 12.06     $ 0.385  
Second Quarter
    18.35       13.93       0.385  
Third Quarter
    23.26       15.78       0.385  
Fourth Quarter
    22.77       19.75       0.300  
          Future dividends will be declared and paid at the discretion of the Board of Directors. The Company’s ability to pay dividends is dependent upon its ability to generate funds from operations, cash flows, and to make accretive new investments.
Equity Compensation Plan Information
          The following table provides information as of December 31, 2010 about the Company’s common stock that may be issued upon grants of restricted stock and the exercise of options, warrants and rights under all of the Company’s existing compensation plans, including the 2007 Employees Stock Incentive Plan and the 2000 Employee Stock Purchase Plan.
                         
                    Number of  
                    Securities  
                    Remaining Available  
    Number of             for Future Issuance  
    Securities to be             Under Equity  
    Issued upon     Weighted Average     Compensation Plans  
    Exercise of     Exercise Price of     (Excluding  
    Outstanding     Outstanding     Securities  
    Options, Warrants     Options, Warrants     Reflected in the  
Plan Category   and Rights (1)     and Rights (1)     First Column)  
Equity compensation plans approved by security holders
    392,517             1,578,063  
Equity compensation plans not approved by security holders
                 
 
                 
Total
    392,517             1,578,063  
 
                 
 
(1)   The Company’s outstanding rights relate only to its 2000 Employee Stock Purchase Plan. The Company is unable to ascertain with specificity the number of securities to be used upon exercise of outstanding rights under the 2000 Employee Stock Purchase Plan or the weighted average exercise price of outstanding rights under that plan. The 2000 Employee Stock Purchase Plan provides that shares of common stock may be purchased at a per share price equal to 85% of the fair market value of the common stock at the beginning of the offering period or a purchase date applicable to such offering period, whichever is lower.

24


 

ITEM 6. SELECTED FINANCIAL DATA
          The following table sets forth financial information for the Company, which is derived from the Consolidated Financial Statements of the Company:
                                         
    Years Ended December 31,  
(Dollars in thousands except per share data)   2010     2009 (1)     2008 (1)     2007 (1) (2)     2006 (1)  
Statement of Income Data:
                                       
Total revenues
  $ 258,394     $ 246,838     $ 206,394     $ 190,191     $ 190,895  
Total expenses
  $ 190,602     $ 182,368     $ 155,488     $ 136,096     $ 133,978  
Other income (expense)
  $ (63,771 )   $ (39,280 )   $ (35,586 )   $ (46,849 )   $ (49,749 )
 
                             
Income from continuing operations
  $ 4,021     $ 25,190     $ 15,320     $ 7,246     $ 7,168  
Discontinued operations
  $ 4,226     $ 25,958     $ 26,440     $ 52,834     $ 32,628  
 
                             
Net income
  $ 8,247     $ 51,148     $ 41,760     $ 60,080     $ 39,796  
Less: Net income attributable to noncontrolling interests
  $ (47 )   $ (57 )   $ (68 )   $ (18 )   $ (77 )
 
                             
Net income attributable to common stockholders
  $ 8,200     $ 51,091     $ 41,692     $ 60,062     $ 39,719  
 
                             
 
Per Share Data:
                                       
Basic earnings per common share:
                                       
Income from continuing operations
  $ 0.06     $ 0.43     $ 0.30     $ 0.15     $ 0.15  
Discontinued operations
  $ 0.07     $ 0.45     $ 0.51     $ 1.11     $ 0.70  
 
                             
Net income attributable to common stockholders
  $ 0.13     $ 0.88     $ 0.81     $ 1.26     $ 0.85  
 
                             
Diluted earnings per common share:
                                       
Income from continuing operations
  $ 0.06     $ 0.43     $ 0.29     $ 0.15     $ 0.15  
Discontinued operations
  $ 0.07     $ 0.44     $ 0.50     $ 1.09     $ 0.69  
 
                             
Net income attributable to common stockholders
  $ 0.13     $ 0.87     $ 0.79     $ 1.24     $ 0.84  
 
                             
Weighted average common shares outstanding — Basic
    61,722,786       58,199,592       51,547,279       47,536,133       46,527,857  
 
                             
Weighted average common shares outstanding — Diluted
    62,770,826       59,047,314       52,564,944       48,291,330       47,498,937  
 
                             
 
Balance Sheet Data (as of the end of the period):
                                       
Real estate properties, net
  $ 2,086,964     $ 1,791,693     $ 1,634,364     $ 1,351,173     $ 1,554,620  
Mortgage notes receivable
  $ 36,599     $ 31,008     $ 59,001     $ 30,117     $ 73,856  
Assets held for sale and discontinued operations, net
  $ 23,915     $ 17,745     $ 90,233     $ 15,639     $  
Total assets
  $ 2,357,309     $ 1,935,764     $ 1,864,780     $ 1,495,492     $ 1,736,603  
Notes and bonds payable
  $ 1,407,855     $ 1,046,422     $ 940,186     $ 785,289     $ 849,982  
Total stockholders’ equity
  $ 839,010     $ 786,766     $ 794,820     $ 631,995     $ 825,672  
Noncontrolling interests
  $ 3,730     $ 3,382     $ 1,427     $     $  
Total equity
  $ 842,740     $ 790,148     $ 796,247     $ 631,995     $ 825,672  
 
Other Data:
                                       
Funds from operations — Basic and Diluted (3)
  $ 71,573     $ 97,882     $ 85,437     $ 73,156     $ 101,106  
Funds from operations per common share - Basic (3)
  $ 1.16     $ 1.68     $ 1.66     $ 1.54     $ 2.17  
Funds from operations per common share - Diluted (3)
  $ 1.14     $ 1.66     $ 1.63     $ 1.51     $ 2.13  
Quarterly dividends declared and paid per common share
  $ 1.20     $ 1.54     $ 1.54     $ 2.09     $ 2.64  
Special dividend declared and paid per common share
  $     $     $     $ 4.75     $  
 
(1)   The years ended December 31, 2009, 2008, 2007 and 2006 are restated to conform to the discontinued operations presentation for 2010. See Note 5 to the Consolidated Financial Statements for more information on the Company’s discontinued operations at December 31, 2010.
 
(2)   The Company completed the sale of its senior living assets in 2007 and paid a $4.75 per share special dividend with a portion of the proceeds.
 
(3)   See “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for a discussion of funds from operations (“FFO”), including why the Company presents FFO and a reconciliation of net income attributable to common stockholders to FFO.

25


 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Disclosure Regarding Forward-Looking Statements
          This report and other materials Healthcare Realty has filed or may file with the Securities and Exchange Commission, as well as information included in oral statements or other written statements made, or to be made, by senior management of the Company, contain, or will contain, disclosures that are “forward-looking statements.” Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as “may,” “will,” “expect,” “believe,” “anticipate,” “target,” “intend,” “plan,” “estimate,” “project,” “continue,” “should,” “could” and other comparable terms. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of risks and uncertainties that could significantly affect the Company’s current plans and expectations and future financial condition and results.
          Such risks and uncertainties include, among other things, the following:
    The Company has recently incurred additional debt obligations and leverage may remain at higher levels;
 
    The unavailability of equity and debt capital, volatility in the credit markets, increases in interest rates, or changes in the Company’s debt ratings;
 
    The Company is exposed to increases in interest rates, which could adversely impact its ability to refinance existing debt, sell assets or engage in acquisition and development activity;
 
    The Company may be required to sell certain properties to tenants or sponsors who hold purchase options and may not be able to reinvest the proceeds at comparable rates of return;
 
    The Company is subject to risks associated with the development of properties;
 
    From time to time, the Company may make material acquisitions and developments that could involve the expenditure of significant funds and may be unsuccessful in operating new and existing real estate properties;
 
    The Company may incur impairment charges on its assets;
 
    The Company’s long-term master leases and financial support agreements may expire and not be extended;
 
    Covenants in the Company’s debt instruments limit its operational flexibility, and a breach of these covenants could materially affect the Company’s financial condition and results of operations;
 
    The Company’s business operations may not generate the cash needed to service debt or fund planned capital expenditures;
 
    The Company’s revenues depend on the ability of its tenants and sponsors under its leases and financial support agreements to generate sufficient income from their operations to make loan, rent and support payments to the Company;
 
    If a tenant loses its licensure or certification, becomes unable to provide healthcare services, cannot meet its financial obligations to the Company or otherwise vacates a facility, the Company would have to obtain another tenant for the affected facility;
 
    Many of the Company’s properties are held under long-term ground leases containing provisions that may limit the Company’s ability to lease, sell, or finance these properties;
 
    If the Company is unable to re-let its properties, if the rates upon such re-letting are significantly lower than expected or if the Company is required to undertake significant capital expenditures to attract new tenants, then the Company’s business, financial condition and results of operations would be adversely affected;
 
    Certain of the Company’s properties are special purpose healthcare facilities and may not be easily adapted to other uses;
 
    The market price of the Company’s stock may be affected adversely by changes in the Company’s dividend policy;
 
    Adverse trends in the healthcare services industry may negatively affect the Company’s lease revenues and the value of its investments;

26


 

    The Company is exposed to risks associated with entering new geographic markets;
 
    The Company may experience uninsured or underinsured losses related to casualty or liability;
 
    Failure to maintain its status as a REIT could cause the Company to reduce its dividends dramatically; and
 
    The ability and willingness of the Company’s lenders to make their funding commitments to the Company.
          Other risks, uncertainties and factors that could cause actual results to differ materially from those projected are detailed in Item 1A “Risk Factors” of this report and in other reports filed by the Company with the SEC from time to time.
          The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company’s filings and reports, including, without limitation, estimates and projections regarding the performance of development projects the Company is pursuing.
Overview
     Business Overview
          The Company is a self-managed and self-administered REIT that owns, acquires, manages, finances, and develops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. Management believes that by providing a complete spectrum of real estate services, the Company can differentiate its competitive market position, expand its asset base and increase revenues over time.
          The Company’s revenues are primarily derived from rentals on its healthcare real estate properties. The Company incurs operating and administrative expenses, including compensation, office rent and other related occupancy costs, as well as various expenses incurred in connection with managing its existing portfolio and acquiring additional properties. The Company also incurs interest expense on its various debt instruments and depreciation and amortization expense on its real estate portfolio.
          The Company’s real estate portfolio, diversified by facility type, geography and tenancy, helps mitigate its exposure to fluctuating economic conditions, tenant and sponsor credit risks and changes in clinical practice and reimbursement patterns.
     Executive Overview
          The Company acquired or funded $335.9 million in real estate properties and mortgage notes during 2010. Management continues to see investment opportunities across the country, some of which involve healthcare systems seeking outside capital and expertise and others involving third-parties or developers monetizing their holdings or seeking a capital partner.
          Income from continuing operations, net income attributable to common stockholders, funds from operations and cash flows were negatively impacted in 2010 compared to the prior year mainly due to two factors:
    Interest expense from continuing operations increased $22.6 million in 2010 compared to 2009. The property acquisitions in late 2008 were initially funded with the Company’s unsecured credit facility due 2012 (the “Unsecured Credit Facility”) that bore interest at a low, variable rate. However, in the latter part of 2009, the Company completed several capital financing transactions, including the renewal of the Unsecured Credit Facility that contributed to higher interest expense in 2010. Also, in December 2010, the Company issued $400 million in new 5.75% senior notes (the “Senior Notes due 2021”). The Company used a portion of the proceeds from the Senior Notes due 2021 to repay the outstanding balance on the Unsecured Credit Facility and created capacity for the repayment of the $278.2 million of senior notes due 2011 (the “Senior Notes due 2011”). Until such time that the Senior Notes due 2011 are repaid, the Company’s operating results will reflect interest expense on both senior note issuances.
 
    The Company recorded non-cash impairment charges totaling $7.5 million in 2010 relating to properties sold or held for sale. Also, gains recognized from the sale of properties were $8.4 million in 2010 compared to $20.1 million in 2009.
          At December 31, 2010, the Company’s leverage ratio [debt divided by (debt plus stockholders’ equity less intangible assets plus accumulated depreciation)] was approximately 51.7%. At December 31, 2010, the Company had $113.3 million in cash and had full capacity available on its $550.0 million Unsecured Credit Facility.

27


 

Trends and Matters Impacting Operating Results
          Management monitors factors and trends important to the Company and REIT industry in order to gauge the potential impact on the operations of the Company. Discussed below are some of the factors and trends that management believes may impact future operations of the Company.
      Interest Expense
          In December 2010, the Company issued the Senior Notes due 2021 bearing interest at 5.75%. The proceeds from the offering were used to repay the outstanding balance on the Unsecured Credit Facility, to fund acquisitions and to provide advanced funding for the repayment of the Senior Notes due 2011. The Company’s results of operations will temporarily be negatively impacted by the interest paid on the Senior Notes due 2011 until they are repaid.
          As disclosed in more detail in Note 9 to the Consolidated Financial Statements, the Company intends to redeem the 8.125% Senior Notes due 2011 on March 28, 2011. Upon redemption, the Company will be required to pay an aggregate of $289.4 million to the holders of the notes consisting of: a) outstanding principal, b) accrued but unpaid interest and c) a “make-whole amount” per the provisions of the indenture, which is approximately equal to the interest that would otherwise be due through the stated maturity date. The Company will use available cash on hand and the Unsecured Credit Facility to fund the redemption of the notes and expects to record a one-time charge of approximately $1.9 million in the first quarter of 2011 for early extinguishment of debt. As a result of the redemption, all interest expense for 2011 related to these notes will be recognized in the first quarter of 2011.
      Acquisition Activity
          During 2010, the Company acquired approximately $311.5 million in real estate assets and funded $24.4 million in mortgage notes receivable. These acquisitions and mortgage notes were funded with borrowings on the Unsecured Credit Facility, proceeds from the Senior Notes due 2021, proceeds from real estate dispositions and mortgage note repayments, proceeds from the Company’s at-the-market equity offering program, and from the assumption of existing mortgage debt related to certain acquired properties. See Note 4 to the Consolidated Financial Statements for more information on these acquisitions.
      Development Activity
          One medical office building in Hawaii with a budget of approximately $86.0 million commenced operations during 2010. The building is currently in stabilization, which generally takes two to three years.
          During 2010, the Company began construction of two medical office buildings in Colorado with aggregate budgets totaling approximately $54.9 million and continued construction on a third medical office building in Washington with a budget of approximately $92.2 million. The Company expects completion of the core and shell of these buildings during the third quarter of 2011.
          The Company’s ability to complete and stabilize these facilities in a given period of time will impact the Company’s results of operations and cash flows. More favorable completion dates, stabilization periods and rental rates will result in improved results of operations and cash flows, while lagging completion dates, stabilization periods and rental rates will result in less favorable results of operations and cash flows. The Company’s disclosures regarding projections or estimates of completion dates and leasing may not reflect actual results. See Note 14 to the Consolidated Financial Statements for more information on the Company’s development activities.
          In addition to the projects currently under construction, the Company has remaining funding commitments totaling $54.6 million as of December 31, 2010 on five construction loans. The Company expects that these remaining commitments will be funded during 2011 and 2012.
      Dispositions and Impairments
          During 2010, the Company disposed of nine real estate properties for approximately $34.5 million in net proceeds, received $0.8 million in lease termination fees, and recognized approximately $8.4 million in gains from the sale of the properties. Also, three mortgage notes receivable totaling approximately $8.5 million were repaid. Proceeds from these dispositions were used to repay amounts due under the Unsecured Credit Facility, to fund additional real estate investments, and for general corporate purposes. See Note 4 to the Consolidated Financial Statements for more information on these dispositions.
          During 2010, the Company also recorded impairment charges of approximately $7.5 million on properties sold during the year or held for sale at December 31, 2010.

28


 

      2011 Acquisition
          In January 2011, the Company originated with Ladco a $40.0 million mortgage loan that is secured by a multi-tenanted office building located in Iowa that was 94% leased at the time the mortgage was originated. The mortgage loan requires interest only payments through maturity, has a stated fixed interest rate and matures in January 2014.
      2011 Dispositions
          In January 2011, the Company disposed of a medical office building located in Maryland that was previously classified as held for sale and in which the Company had a $3.5 million net investment at December 31, 2010. The Company received approximately $3.4 million in net proceeds, net of expenses incurred at the time of the closing.
          In February 2011, the Company disposed of a physician clinic located in Florida that was previously classified as held for sale and in which the Company had a $3.1 million net investment at December 31, 2010. The Company received approximately $3.1 million in consideration on the sale.
      2011 Potential Dispositions
          During 2010, the Company received notice from a tenant of its intent to purchase six skilled nursing facilities in Michigan and Indiana pursuant to purchase options contained in its leases with the Company. The Company’s aggregate net investment in the buildings, which were classified as held for sale upon receiving notice of the purchase option exercise, was approximately $8.2 million at December 31, 2010. The aggregate purchase price for the properties is expected to be approximately $17.3 million, resulting in a net gain of approximately $9.1 million. The Company expects the sale to occur during the third quarter of 2011.
      Purchase Options
          As discussed in “Liquidity and Capital Resources,” certain of the Company’s leases include purchase option provisions, which if exercised, could require the Company to sell a property to a lessee or operator, which could have a negative impact on the Company’s future results of operations and cash flows.
      Expiring Leases
          Master leases on three of the Company’s properties that were set to expire during 2011 have been renewed. Leases on three other master-leased properties are set to expire during 2011. The Company expects that it will not renew the three remaining master leases but will assume any tenant leases in the buildings and manage the operations of those buildings.
          The Company also has 320 leases in its multi-tenanted buildings that will expire during 2011, with each occupying an average of approximately 2,723 square feet. Approximately 81% of these leases are located in on-campus buildings, which traditionally have a higher probability of renewal. The 2011 expirations are widely distributed throughout the portfolio and are not concentrated with one tenant, health system or location.
          The Company expects there could be a short-term negative impact to its results of operations from leases that are not renewed but anticipates that over time it will be able to re-lease the properties or increase tenant rents to offset any short-term decline in revenue.
      Discontinued Operations
          As discussed in more detail in Note 1 to the Consolidated Financial Statements, a company must present the results of operations of real estate assets disposed of or held for sale as discontinued operations. Therefore, the results of operations from such assets are classified as discontinued operations for the current period, and all prior periods presented are restated to conform to the current period presentation. Readers of the Company’s Consolidated Financial Statements should be aware that each future disposal will result in a change to the presentation of the Company’s operations in the historical Consolidated Statements of Income as previously filed. Such reclassifications to the Consolidated Statements of Income will have no impact on previously reported net income attributable to common stockholders.
Funds from Operations
          Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT’s operating performance equal to “net income (computed in accordance with GAAP), excluding gains (or losses) from sales of property, plus depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.” Impairment

29


 

charges may not be added back to net income attributable to common stockholders in calculating FFO, which have the effect of decreasing FFO in the period recorded.
          The comparability of FFO for the three years ended December 31, 2010 was affected by the various acquisitions and dispositions of the Company’s real estate portfolio and the results of operations of the portfolio from period to period, as well as from the commencement of operations of properties that were previously under construction. Other items also impacted the comparability of FFO between the three years as discussed below and in Results of Operations:
    Interest expense, including interest expense from discontinued operations, increased $22.0 million, or $0.35 per diluted common share in 2010 compared to 2009 due to debt financings;
 
    Impairment charges totaling $7.5 million, or $0.12 per diluted common share, were recorded in 2010 relating to five properties classified to held for sale and one property sold during the year. Impairment charges totaling $2.5 million, or $0.05 per diluted common share, were recorded in 2008 relating to properties sold or held for sale and certain patient receivables assigned to the Company as part of a lease termination and debt restructuring;
 
    A re-measurement gain totaling $2.7 million, or $0.05 per diluted common share, was recognized in 2009 in connection with the acquisition of the remaining interests in a joint venture; and
 
    A net gain of approximately $4.1 million, or $0.08 per diluted common share, was recognized in 2008 and a net loss of approximately $0.5 million, or $0.01 per diluted common share, was recognized in 2010 from the repurchase of a portion of the Senior Notes due 2011 and the senior notes due 2014 (the “Senior Notes due 2014”).
          Management believes FFO and FFO per share to be supplemental measures of a REIT’s performance because they provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, primarily depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with generally accepted accounting principles (“GAAP”) assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization and gains from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, FFO and FFO per share can facilitate comparisons of operating performance between periods. The Company reports FFO and FFO per share because these measures are observed by management to also be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because FFO per share is consistently reported, discussed, and compared by research analysts in their notes and publications about REITs. For these reasons, management has deemed it appropriate to disclose and discuss FFO and FFO per share. However, FFO does not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs. FFO should not be considered as an alternative to net income attributable to common stockholders as an indicator of the Company’s operating performance or as an alternative to cash flow from operating activities as a measure of liquidity.
          The table below reconciles net income attributable to common stockholders to FFO for the three years ended December 31, 2010.
                         
    Year Ended December 31,  
(Dollars in thousands, except per share data)   2010     2009     2008  
Net income attributable to common stockholders
  $ 8,200     $ 51,091     $ 41,692  
 
                       
Gain on sales of real estate properties
    (8,352 )     (20,136 )     (10,227 )
Real estate depreciation and amortization
    71,725       66,927       53,972  
 
                 
Total adjustments
    63,373       46,791       43,745  
 
                 
 
                       
Funds from Operations — Basic and Diluted
  $ 71,573     $ 97,882     $ 85,437  
 
                 
 
                       
Funds from Operations per Common Share — Basic
  $ 1.16     $ 1.68     $ 1.66  
 
                 
Funds from Operations per Common Share — Diluted
  $ 1.14     $ 1.66     $ 1.63  
 
                 
 
                       
Weighted Average Common Shares Outstanding — Basic
    61,722,786       58,199,592       51,547,279  
 
                 
Weighted Average Common Shares Outstanding — Diluted
    62,770,826       59,047,314       52,564,944  
 
                 

30


 

Results of Operations
2010 Compared to 2009
          The Company’s results of operations for 2010 compared to 2009 were most significantly impacted by higher interest expense in 2010 resulting from financing activities that occurred in late 2009 and 2010. The results of operations were also impacted by impairments and gains on sales related to properties sold or classified as held for sale, which are included in discontinued operations.
                                 
      Change  
(Dollars in thousands, except per share data)   2010     2009     $     %  
REVENUES
                               
Master lease rent
  $ 54,659     $ 53,340     $ 1,319       2.5 %
Property operating
    190,205       177,849       12,356       6.9 %
Straight-line rent
    2,509       2,052       457       22.3 %
Mortgage interest
    2,377       2,646       (269 )     (10.2 )%
Other operating
    8,644       10,951       (2,307 )     (21.1 )%
     
 
    258,394       246,838       11,556       4.7 %
 
                               
EXPENSES
                               
General and administrative
    16,894       22,478       (5,584 )     (24.8 )%
Property operating
    101,355       93,249       8,106       8.7 %
Bad debt, net
    (429 )     535       (964 )     (180.2 )%
Depreciation
    67,440       60,847       6,593       10.8 %
Amortization
    5,342       5,259       83       1.6 %
     
 
    190,602       182,368       8,234       4.5 %
 
                               
OTHER INCOME (EXPENSE)
                               
Loss on extinguishment of debt
    (480 )           (480 )      
Re-measurement gain of equity interest upon acquisition
          2,701       (2,701 )     (100.0 )%
Interest expense
    (65,710 )     (43,080 )     (22,630 )     (52.5 )%
Interest and other income, net
    2,419       1,099       1,320       120.1 %
     
 
    (63,771 )     (39,280 )     (24,491 )     62.3 %
     
 
                               
INCOME FROM CONTINUING OPERATIONS
    4,021       25,190       (21,169 )     (84.0 )%
 
                               
DISCONTINUED OPERATIONS
                               
Income from discontinued operations
    3,385       5,844       (2,459 )     (42.1 )%
Impairments
    (7,511 )     (22 )     (7,489 )     34,040.9 %
Gain on sales of real estate properties
    8,352       20,136       (11,784 )     (58.5 )%
     
INCOME FROM DISCONTINUED OPERATIONS
    4,226       25,958       (21,732 )     (83.7 )%
     
 
                               
NET INCOME
    8,247       51,148       (42,901 )     (83.9 )%
 
                               
Less: Net income attributable to noncontrolling interests
    (47 )     (57 )     10       (17.5 )%
     
 
                               
NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS
  $ 8,200     $ 51,091     $ (42,891 )     (84.0 )%
     
 
                               
EARNINGS PER COMMON SHARE
                               
Net income attributable to common stockholders — Basic
  $ 0.13     $ 0.88     $ (0.75 )     (85.2 )%
     
 
                               
Net income attributable to common stockholders — Diluted
  $ 0.13     $ 0.87     $ (0.74 )     (85.1 )%
     
          Total revenues from continuing operations for the twelve months ended December 31, 2010 increased $11.6 million, or 4.7%, compared to the same period in 2009, mainly for the reasons discussed below:
           Master lease rental income increased $1.3 million, or 2.5%. Master lease rental income increased approximately $2.3 million as a result of the timing of the Company’s 2009 acquisitions. The Company also recognized master lease income of $1.6 million related to a new master lease agreement executed during 2009 on a property whose income was previously reported in property operating income and recognized a $1.2 million increase in annual contractual rent increases. These increases to master lease rent were partially offset by a reduction of approximately $3.5 million related to 13 properties whose master leases expired during 2009 and 2010. The Company began recognizing the underlying tenant rents, generally in property operating income, for the underlying tenant leased space and is in the process of locating new tenants for any unoccupied space.
           Property operating income increased $12.4 million, or 6.9%, due mainly to the recognition of additional revenue of approximately $11.5 million from the Company’s 2009 and 2010 real estate acquisitions and approximately $0.8 million from properties

31


 

that were previously under construction that commenced operations during 2009. Also, the Company began recognizing the underlying tenant rental income on properties whose master leases had expired, resulting in approximately $0.6 million in additional property operating income in 2010. Annual contractual rent increases, rent increases related to lease renewals and new leases executed with various tenants resulted in an additional $1.7 million of income in 2010. These increases in property operating income were partially offset by a $2.1 million decrease related to a property whose revenues were previously reported in property operating income, but are now reported in master lease income upon execution of a new master lease agreement with the tenant.
           Straight-line rent increased $0.5 million, or 22.3%, due mainly to recognition of straight-line rental revenue on new leases from the Company’s 2009 and 2010 real estate acquisitions.
           Other operating income decreased $2.3 million, or 21.1%, due mainly to the expiration of five property operating agreements totaling approximately $0.8 million and the expiration of an agreement with one operator in 2009 which provided to the Company replacement rent totaling approximately $1.3 million.
          Total expenses for the twelve months ended December 31, 2010 increased $8.2 million, or 4.5%, compared to the same period in 2009, mainly for the reasons discussed below:
           General and administrative expenses decreased $5.6 million, or 24.8%. A $3.6 million reduction resulted from changes in benefits upon retirement for the named executive officers and an additional $1.9 million reduction related to certain general and administrative expenses from recent acquisitions that were classified to property operating expense.
           Property operating expense increased $8.1 million, or 8.7%, due mainly to the recognition of additional expenses of approximately $4.2 million from the Company’s 2009 and 2010 real estate acquisitions and $2.4 million from properties that were previously under construction that commenced operations during 2009 and 2010. Property operating expense also increased approximately $1.3 million for properties whose master leases expired, and the Company began incurring the underlying operating expenses of the buildings. Further, certain additional general and administrative expenses allocated to recent real estate acquisitions totaling approximately $1.9 million were classified to property operating expense. These increases were partially offset by a decrease in legal fees and property taxes of approximately $1.2 million. Also, expenses of approximately $0.5 million that were recognized in 2009 related to a property were not recognized in 2010 due to the execution of a master lease agreement in the fourth quarter of 2009.
           Bad debt expense decreased $1.0 million due mainly to collections or reversals of reserves that were previously included in bad debt expense.
           Depreciation expense increased $6.6 million, or 10.8%, due mainly to additional depreciation recognized of approximately $2.7 million related to the Company’s real estate acquisitions in 2009 and 2010 and approximately $2.1 million related to properties previously under construction that commenced operations in 2009. The remaining $1.8 million increase was due mainly to additional depreciation expense recognized related to various building and tenant improvement expenditures.
          Other income (expense) for the twelve months ended December 31, 2010 changed unfavorably by $24.5 million, or 62.3%, compared to the same period in 2009 mainly due to the reasons below:
           The Company recognized a $0.5 million loss on the early extinguishment of debt in 2010 relating to the repurchase of a portion of the Senior Notes due 2011.
           The Company recognized a $2.7 million gain in 2009 related to the valuation and re-measurement of the Company’s equity interest in a joint venture in connection with the Company’s acquisition of the remaining equity interest in the joint venture.
           Interest expense increased $22.6 million, or 52.5%, from 2009 to 2010. The increase is mainly attributable to interest of approximately $18.5 million on the Senior Notes due 2017 issued in December 2009, interest of approximately $5.3 million on $80 million of mortgage debt entered into in December 2009, and interest of approximately $1.2 million on the Senior Notes due 2021 issued in December 2010. These increases were partially offset by decreases in interest of approximately $1.6 million from a lower average principal balance on the Unsecured Credit Facility, $0.6 million from the repurchases of a portion of the Senior Notes due 2011 and 2014 and $0.3 million from an increase in capitalized interest on development properties.
          Income from discontinued operations totaled $4.2 million and $26.0 million, respectively, for the twelve months ended December 31, 2010 and 2009, which includes the results of operations, impairments and gains on sale related to assets classified as held for sale or disposed of as of December 31, 2010. The Company disposed of nine properties in 2010 and seven properties in 2009 and had 11 properties classified as held for sale at December 31, 2010.

32


 

2009 Compared to 2008
          The Company’s income from continuing operations and net income attributable to common stockholders for 2009 compared to 2008 was significantly impacted by the Company’s acquisitions of real estate properties in the latter half of 2008 of approximately $337.1 million and in 2009 of approximately $106.4 million. The acquisitions of the real estate properties were temporarily funded at a relatively low interest rate on the Unsecured Credit Facility until the Company completed its capital financing transactions in the latter part of 2009.
                                 
      Change  
(Dollars in thousands, except per share data)   2009     2008     $     %  
REVENUES
                               
Master lease rent
  $ 53,340     $ 52,472     $ 868       1.7 %
Property operating
    177,849       134,746       43,103       32.0 %
Straight-line rent
    2,052       717       1,335       186.2 %
Mortgage interest
    2,646       2,207       439       19.9 %
Other operating
    10,951       16,252       (5,301 )     (32.6 )%
     
 
    246,838       206,394       40,444       19.6 %
 
                               
EXPENSES
                               
General and administrative
    22,478       23,514       (1,036 )     (4.4 )%
Property operating
    93,249       79,732       13,517       17.0 %
Impairment of long-lived assets
          1,600       (1,600 )     (100.0 )%
Bad debt, net
    535       1,252       (717 )     (57.3 )%
Depreciation
    60,847       46,541       14,306       30.7 %
Amortization
    5,259       2,849       2,410       84.6 %
     
 
    182,368       155,488       26,880       17.3 %
 
                               
OTHER INCOME (EXPENSE)
                               
Gain on extinguishment of debt
          4,102       (4,102 )     (100.0 )%
Re-measurement gain of equity interest upon acquisition
    2,701             2,701        
Interest expense
    (43,080 )     (42,126 )     (954 )     2.3 %
Interest and other income, net
    1,099       2,438       (1,339 )     (54.9 )%
     
 
    (39,280 )     (35,586 )     (3,694 )     10.4 %
     
INCOME FROM CONTINUING OPERATIONS
    25,190       15,320       9,870       64.4 %
 
                               
DISCONTINUED OPERATIONS
                               
Income from discontinued operations
    5,844       17,483       (11,639 )     (66.6 )%
Impairments
    (22 )     (886 )     864       (97.5 )%
Gain on sales of real estate properties
    20,136       9,843       10,293       104.6 %
     
INCOME FROM DISCONTINUED OPERATIONS
    25,958       26,440       (482 )     (1.8 )%
     
NET INCOME
    51,148       41,760       9,388       22.5 %
 
                               
Less: Net income attributable to noncontrolling interests
    (57 )     (68 )     11       (16.2 )%
     
 
                               
NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS
  $ 51,091     $ 41,692     $ 9,399       22.5 %
     
 
                               
EARNINGS PER COMMON SHARE
                               
Net income attributable to common stockholders — Basic
  $ 0.88     $ 0.81     $ 0.07       8.6 %
     
 
                               
Net income attributable to common stockholders — Diluted
  $ 0.87     $ 0.79     $ 0.08       10.1 %
     
          Total revenues from continuing operations for the twelve months ended 2009 increased $40.4 million, or 19.6%, compared to the same period in 2008, mainly for the reasons discussed below:
           Master lease income increased $0.9 million, or 1.7%, from 2008 to 2009. Master lease income increased approximately $2.7 million related to 2009 acquisitions and a $2.2 million increase related mainly to annual contractual rental increases. Partially offsetting this increase, master lease income decreased $4.0 million from properties whose master leases had expired and the Company began recognizing the underlying tenant rents in property operating income.
           Property operating income increased $43.1 million, or 32.0%, from 2008 to 2009. The Company’s acquisitions of real estate properties during 2009 and 2008 resulted in additional property operating income in 2009 compared to 2008 of approximately $36.4 million. Also, properties previously under construction that commenced operations during 2008 and 2009 resulted in approximately $1.4 million in additional property operating income from 2008 to 2009, and for properties, whose master leases had expired, the Company

33


 

began recognizing the underlying tenant rents totaling approximately $3.1 million. The remaining increase of approximately $2.2 million was mainly related to annual contractual rent increases, rental increases related to lease renewals and new leases executed with various tenants.
           Straight-line rent increased $1.3 million, or 186.2%, from 2008 to 2009. Additional straight-line rent recognized on leases subject to straight-lining from properties acquired in 2008 and 2009 was approximately $2.6 million, partially offset by reduction in straight-line rent on leases with contractual rent increases of approximately $1.1 million.
           Mortgage interest increased $0.4 million, or 19.9%, from 2008 to 2009 due mainly to additional fundings on construction mortgage notes.
           Other operating income decreased $5.3 million, or 32.6%, from 2008 to 2009. The decrease is due primarily to the expirations in 2008 and 2009 of five property operating agreements totaling approximately $3.7 million with one operator and the expiration of replacement rent received from an operator of approximately $1.2 million.
          Total expenses for the twelve months ended 2009 increased $26.9 million, or 17.3%, compared to the same period in 2008, mainly for the reasons discussed below:
           General and administrative expenses decreased $1.0 million, or 4.4%, from 2008 to 2009. This decrease was mainly attributable to lower pension costs in 2009 of approximately $1.5 million, net of additional pension expense recorded in 2009 related to the partial settlement of an officer’s pension benefit, and a decrease in acquisition and development costs of approximately $0.7 million. These amounts were partially offset by an increase in other compensation related items of approximately $1.3 million. See Note 11 to the Consolidated Financial Statements for more details on the Company’s pension plans.
           Property operating expense increased $13.5 million, or 17.0%, from 2008 to 2009. The Company’s real estate acquisitions during 2008 and 2009 resulted in additional property operating expense in 2009 of approximately $13.7 million. Also, the Company recognized additional expense in 2009 of approximately $2.1 million related to properties that were previously under construction and commenced operations during 2008 and 2009 and approximately $1.6 million related to properties whose master leases have expired and the Company began incurring underlying operating expenses. Partially offsetting these increases were reductions in legal expenses of approximately $3.1 million in 2009 compared to 2008 and in real estate taxes of approximately $0.8 million.
           An impairment charge totaling $1.6 million was recognized in 2008 on patient accounts receivable assigned to the Company as part of a lease termination and debt restructuring in late 2005 related to a physician clinic owned by the Company.
           Bad debt expense decreased $0.7 million from 2008 to 2009 mainly due to a reserve recorded by the Company in 2008 related to additional rental income due from an operator on four properties.
           Depreciation expense increased $14.3 million, or 30.7%, from 2008 to 2009 mainly due to increases of approximately $9.8 million related to the Company’s real estate acquisitions, approximately $1.6 million related to the commencement of operations during 2008 and 2009 of buildings that were previously under construction, as well as approximately $2.9 million related to additional building and tenant improvement expenditures during 2008 and 2009.
           Amortization expense increased $2.4 million, or 84.6% from 2008 to 2009, mainly due to the amortization of lease intangibles associated with properties acquired during 2008 and 2009, partially offset by a decrease in amortization of lease intangibles becoming fully amortized on properties acquired during 2003 and 2004.
          Other income (expense) for the twelve months ended December 31, 2009 changed unfavorably by $3.7 million, or 10.4%, compared to the same period in 2008, mainly for the reasons discussed below:
           The Company recognized a net gain on extinguishment of debt in 2008 of approximately $4.1 million related to repurchases of the Senior Notes due 2011 and 2014, which is discussed in more detail in Note 9 to the Consolidated Financial Statements.
           The Company recognized a $2.7 million gain related to the valuation and re-measurement of the Company’s equity interest in a joint venture in connection with the Company’s acquisition of the remaining equity interests in the joint venture in 2009.
           Interest expense increased $1.0 million, or 2.3%, from 2008 to 2009. The increase was mainly attributable to additional interest expense of approximately $3.8 million related to mortgage notes payable assumed in the 2008 and 2009 real estate acquisitions, a higher average outstanding balance on the unsecured credit facility of approximately $0.4 million, as well as interest incurred on the Senior Notes due 2017 of approximately $1.5 million and interest on $80 million of mortgage debt entered into during 2009 of approximately $0.6 million. These amounts are partially offset by interest savings of approximately $1.9 million related to the

34


 

repurchases of the Senior Notes due 2011 and 2014 in 2008, as well as an increase in capitalized interest of approximately $3.4 million on development projects during 2009.
           Interest and other income decreased $1.3 million, or 54.9%, from 2008 to 2009. The decrease is primarily a result of additional equity income recognized in 2008 of approximately $1.0 million related to a joint venture investment that the Company accounted for under the equity method until it acquired the remaining interests in the joint venture in 2009, at which time the Company began to consolidate the accounts of the joint venture.
          Income from discontinued operations totaled $26.0 million and $26.4 million, respectively, for the twelve months ended December 31, 2009 and 2008, which includes the results of operations, impairments, and net gains and impairments related to property disposals and properties classified as held for sale. The Company disposed of seven properties in 2009 and seven properties and two parcels of land in 2008. Six properties were classified as held for sale at December 31, 2009. Income from discontinued operations for 2008 also included a $7.2 million fee received from an operator to terminate its financial support agreement with the Company in connection with the disposition of the property.
Liquidity and Capital Resources
          The Company derives most of its revenues from its real estate property and mortgage portfolio based on contractual arrangements with its tenants, sponsors and borrowers. The Company may, from time to time, also generate funds from capital market financings, sales of real estate properties or mortgages, borrowings under the Unsecured Credit Facility, or from other private debt or equity offerings. For the twelve months ended December 31, 2010, the Company generated approximately $80.8 million in cash from operations and generated approximately $26.6 million in net cash from investing and financing activities as detailed in the Company’s Consolidated Statements of Cash Flows.
     Interest Expense
          In December 2010, the Company issued the Senior Notes due 2021 bearing interest at 5.75%. The proceeds from the offering were used to repay the outstanding balance on the Unsecured Credit Facility, to fund acquisitions and to provide advanced funding for the repayment of the Senior Notes due 2011. The Company’s results of operations will temporarily be negatively impacted by the interest paid on the Senior Notes due 2011 until they are repaid.
          As disclosed in more detail in Note 9 to the Consolidated Financial Statements, the Company intends to redeem the 8.125% Senior Notes due 2011 on March 28, 2011. Upon redemption, the Company will be required to pay an aggregate of $289.4 million to the holders of the notes consisting of outstanding principal, accrued but unpaid interest and a “make-whole amount” per the provisions of the indenture, which is approximately equal to the interest that would otherwise be due through the stated maturity date. The Company will use available cash on hand and the Unsecured Credit Facility to fund the redemption of the notes and expects to record a one-time charge of approximately $1.9 million in the first quarter of 2011 for early extinguishment of debt. As a result of the redemption, all interest expense for 2011 related to these notes will be recognized in the first quarter of 2011.
     Key Indicators
          The Company monitors its liquidity and capital resources and relies on several key indicators in its assessment of capital markets for financing acquisitions and other operating activities as needed, including the following:
           Debt metrics;
           Dividend payout percentage; and
           Interest rates, underlying treasury rates, debt market spreads and equity markets.
          The Company uses these indicators and others to compare its operations to its peers and to help identify areas in which the Company may need to focus its attention.

35


 

     Contractual Obligations
          The Company monitors its contractual obligations to ensure funds are available to meet obligations when due. The following table represents the Company’s long-term contractual obligations for which the Company was making payments at December 31, 2010, including interest payments due where applicable. At December 31, 2010, the Company had no long-term capital lease or purchase obligations.
                                         
    Payments Due by Period  
(Dollars in thousands)   Total     Less than 1 Year     1 -3 Years     3 - 5 Years     More than 5 Years  
Long-term debt obligations, including interest (1)
  $ 1,902,040     $ 350,821     $ 155,441     $ 411,360     $ 984,418  
Operating lease commitments (2)
    277,659       5,139       8,633       8,867       255,020  
Construction in progress (3)
    96,853       78,278       14,105       4,470        
Tenant improvements (4)
                             
Pension obligations (5)
                             
Construction loan obligation (6)
    54,607       44,708       9,899              
 
                             
Total contractual obligations
  $ 2,331,159     $ 478,946     $ 188,078     $ 424,697     $ 1,239,438  
 
                             
 
(1)   The amounts shown include estimated interest on total debt other than the Unsecured Credit Facility. Excluded from the table above are the premium on the Senior Notes due 2011 of $0.1 million, the discount on the Senior Notes due 2014 of $0.5 million, the discount on the Senior Notes due 2017 of $1.8 million, and the discount on the Senior Notes due 2021 of $3.2 million which are included in notes and bonds payable on the Company’s Consolidated Balance Sheet as of December 31, 2010. Also excluded from the table above are discounts and premiums on six mortgage notes payable, totaling approximately $6.4 million. The Company’s long-term debt principal obligations are presented in more detail in the table below.
                                                 
                            Contractual              
    Principal Balance     Principal Balance             Interest Rates at              
(In thousands)   at Dec. 31, 2010     at Dec. 31, 2009     Maturity Date     December 31, 2010     Principal Payments     Interest Payments  
Unsecured Credit Facility due 2012
  $     $ 50.0       9/12     LIBOR + 2.80%   At maturity   Quarterly
Senior Notes due 2011
    278.2       286.3       5/11       8.125 %   At maturity   Semi-Annual
Senior Notes due 2014
    264.7       264.7       4/14       5.125 %   At maturity   Semi-Annual
Senior Notes due 2017
    300.0       300.0       1/17       6.500 %   At maturity   Semi-Annual
Senior Notes due 2021
    400.0             1/21       5.750 %   At maturity   Semi-Annual
Mortgage Notes Payable
    176.7       155.4       4/13-10/30       5.000%-7.765 %   Monthly   Monthly
 
                                           
 
  $ 1,419.6     $ 1,056.4                                  
 
                                           
 
(2)   Includes primarily the corporate office and ground leases, with expiration dates through 2101, related to various real estate investments for which the Company is currently making payments. Also, 2011 includes an obligation of approximately $0.9 million related to connecting one of the Company’s buildings with an adjacent hospital.
 
(3)   Includes cash flow projections related to the construction of three buildings, a portion of which relates to tenant improvements that will generally be funded after the core and shell of the building is completed. This amount includes $9.2 million of invoices that were accrued and included in the construction in progress on the Company’s Consolidated Balance Sheet as of December 31, 2010.
 
(4)   The Company has various first-generation tenant improvements budgeted amounts remaining as of December 31, 2010 of approximately $32.3 million related to properties developed by the Company that the Company may fund for tenant improvements as leases are signed. The Company cannot predict when or if these amounts will be expended and, therefore, has not included estimated fundings in the table above.
 
(5)   At December 31, 2010, one employee, the Company’s chief executive officer, was eligible to retire under the Executive Retirement Plan. If the chief executive officer retired and received full retirement benefits based upon the terms of the plan, the future benefits to be paid are estimated to be approximately $29.9 million as of December 31, 2010. Because the Company does not know when its chief executive officer will retire, it has not projected when the retirement benefits would be paid in the table above. At December 31, 2010, the Company had recorded a $15.5 million liability, included in other liabilities, related to its pension plan obligations.
 
(6)   Includes the Company’s remaining funding commitment on five construction mortgage loans as of December 31, 2010.

36


 

          The Company has a $550.0 million Unsecured Credit Facility with a syndicate of 16 lenders. Loans outstanding under the Unsecured Credit Facility bear interest at a rate equal to (x) LIBOR or the base rate (defined as the highest of (i) the Federal Funds Rate plus 0.5%; (ii) the Bank of America prime rate and (iii) LIBOR) plus (y) a margin ranging from 2.15% to 3.20% (2.80% at December 31, 2010) for LIBOR-based loans and 0.90% to 1.95% (1.55% at December 31, 2010) for base rate loans, based upon the Company’s unsecured debt ratings. In addition, the Company pays a facility fee per annum on the aggregate amount of commitments. The facility fee is 0.40% per annum, unless the Company’s credit rating falls below a BBB-/Baa3, at which point the facility fee would be 0.50%. As of December 31, 2010, the Company had no outstanding borrowings on its Unsecured Credit Facility, its only variable rate debt. Also, at December 31, 2010, 80.1% of the Company’s debt balances were due after 2011. The Unsecured Credit Facility contains certain representations, warranties, and financial and other covenants customary in such loan agreements.
          For the year ended December 31, 2010, the Company’s stockholders’ equity totaled approximately $839.0 million and its leverage ratio [debt divided by (debt plus stockholders’ equity less intangible assets plus accumulated depreciation)] was approximately 51.7%. Also, at December 31, 2010, the Company’s earnings from continuing operations were insufficient to cover its fixed charges by approximately $6.3 million, with a ratio of 0.92 to 1.00. This fixed charge ratio, calculated in accordance with Item 503 of Regulation S-K, includes only income from continuing operations which is reduced by depreciation and amortization and the operating results of properties currently classified as held for sale (see Note 5 to the Consolidated Financial Statements), as well as other income from discontinued operations. Also, in December 2010, the Company issued $400 million of its Senior Notes due 2021. A portion of the proceeds from this issuance will be used to repay the Senior Notes due 2011 which are due in May 2011. Until such time that the Senior Notes due 2011 are repaid, the Company is recognizing interest expense on both senior notes, resulting in a lower fixed charge ratio. The Company plans to redeem the Senior Notes due 2011 on March 28, 2011.
          As of December 31, 2010, the Company was in compliance with its financial covenant provisions under its various debt instruments.
     At-The-Market Equity Offering Program
          Since December 31, 2008, the Company has had in place an at-the-market equity offering program to sell shares of the Company’s common stock from time to time in at-the-market sales transactions. During 2010, the Company sold 5,258,700 shares of common stock under this program at prices ranging from $20.23 per share to $25.16 per share, generating approximately $117.7 million in net proceeds, and during 2009 sold 1,201,600 shares of common stock at prices ranging from $21.62 per share to $22.50 per share, generating approximately $25.7 million in net proceeds.
          During January 2011, the Company sold an additional 1,056,678 shares of common stock under this program for net proceeds totaling approximately $21.6 million, resulting in 2,383,322 authorized shares remaining to be sold under the program.
     Security Deposits and Letters of Credit
          As of December 31, 2010, the Company held approximately $6.5 million in letters of credit, security deposits, and capital replacement reserves for the benefit of the Company in the event the obligated lessee or borrower fails to perform under the terms of its respective lease or mortgage. Generally, the Company may, at its discretion and upon notification to the operator or tenant, draw upon these instruments if there are any defaults under the leases or mortgage notes.
     Acquisition Activity
          During 2010, the Company acquired approximately $311.5 million in real estate assets and funded $24.4 million in mortgage notes receivable. These acquisitions and mortgage notes were funded with borrowings on the Unsecured Credit Facility, proceeds from the Senior Notes due 2021, proceeds from real estate dispositions and mortgage note repayments, proceeds from the Company’s at-the-market equity offering program, and from the assumption of existing mortgage debt related to certain acquired properties. See Note 4 to the Consolidated Financial Statements for more information on these acquisitions.
     Dispositions and Impairments
          During 2010, the Company disposed of nine real estate properties for approximately $34.5 million in net proceeds, received $0.8 million in lease termination fees, and recognized approximately $8.4 million in gains from the sale of the properties. Also, three mortgage notes receivable totaling approximately $8.5 million were repaid. Proceeds from these dispositions were used to repay amounts due under the Unsecured Credit Facility, to fund additional real estate investments, and for general corporate purposes. See Note 4 to the Consolidated Financial Statements for more information on these dispositions.
          During 2010, the Company also recorded impairment charges of approximately $7.5 million on properties sold during the year or held for sale at December 31, 2010.

37


 

     2011 Acquisition
          In January 2011, the Company originated with Ladco a $40.0 million mortgage loan that is secured by a multi-tenanted office building located in Iowa that was 94% leased at the time the mortgage was originated. The mortgage loan requires interest only payments through maturity, has a stated fixed interest rate and matures in January 2014.
     2011 Dispositions
          In January 2011, the Company disposed of a medical office building located in Maryland that was previously classified as held for sale and in which the Company had a $3.5 million net investment at December 31, 2010. The Company received approximately $3.4 million in net proceeds, net of expenses incurred at the time of the closing.
     In February 2011, the Company disposed of a physician clinic located in Florida that was previously classified as held for sale and in which the Company had a $3.1 million net investment at December 31, 2010. The Company received approximately $3.1 million in consideration on the sale.
     2011 Potential Dispositions
          During 2010, the Company received notice from a tenant of its intent to purchase six skilled nursing facilities in Michigan and Indiana pursuant to purchase options contained in its leases with the Company. The Company’s aggregate net investment in the buildings, which were classified as held for sale upon receiving notice of the purchase option exercise, was approximately $8.2 million at December 31, 2010. The aggregate purchase price for the properties is expected to be approximately $17.3 million, resulting in a net gain of approximately $9.1 million. The Company expects the sale to occur during the third quarter of 2011.
     Purchase Options
          In addition to the six skilled nursing facilities in Michigan and Indiana discussed above, the Company had $91.3 million in real estate properties at December 31, 2010 that were subject to exercisable purchase options that had not been exercised. On a probability-weighted basis, the Company estimates that less than one-third of these options might be exercised in the future. Purchase options on two properties in which the Company had an aggregate gross investment of approximately $35.5 million at December 31, 2010 become exercisable during 2011 and 2012. The Company does not believe it can reasonably estimate the probability that these purchase options will be exercised in the future.
     Construction in Progress and Other Commitments
          As of December 31, 2010, the Company had three medical office buildings under construction in Washington and Colorado with aggregate budgets of $147.1 million and estimated completion dates in the third quarter of 2011. At December 31, 2010, the Company had $59.5 million invested in these construction projects. The Company also has four parcels of land totaling $20.8 million in land held for future development that are included in construction in progress on the Company’s Consolidated Balance Sheet. See Note 14 to the Consolidated Financial Statements for more details on the Company’s construction in progress at December 31, 2010.
          The Company also had approximately $32.3 million in various first-generation tenant improvement budgeted amounts remaining as of December 31, 2010 related to properties that were developed by the Company.
          Further, as of December 31, 2010, the Company had remaining funding commitments totaling $54.6 million on five construction loans that the Company expects will be funded during 2011 and 2012.
          The Company intends to fund these commitments with available cash on hand, cash flows from operations, proceeds from the Unsecured Credit Facility, proceeds from the sale of real estate properties, proceeds from repayments of mortgage notes receivable, proceeds from secured debt, capital market financings, including the Company’s at-the-market equity offering program, or private debt or equity offerings.
     Operating Leases
          As of December 31, 2010, the Company was obligated under operating lease agreements consisting primarily of the Company’s corporate office lease and ground leases related to 45 real estate investments, excluding leases the Company has prepaid. These operating leases have expiration dates through 2101. Rental expense relating to the operating leases for the years ended December 31, 2010, 2009 and 2008 was $4.0 million, $3.8 million, and $3.3 million, respectively.

38


 

     Dividends
          The Company is required to pay dividends to its stockholders at least equal to 90% of its taxable income in order to maintain its qualification as a REIT. Common stock cash dividends paid during or related to 2010 are shown in the table below:
                                 
Quarter   Quarterly Dividend   Date of Declaration   Date of Record   Date Paid/*Payable
4th Quarter 2009
  $ 0.30     February 2, 2010   February 18, 2010   March 4, 2010
1st Quarter 2010
  $ 0.30     May 4, 2010   May 20, 2010   June 3, 2010
2nd Quarter 2010
  $ 0.30     August 3, 2010   August 19, 2010   September 2, 2010
3rd Quarter 2010
  $ 0.30     November 2, 2010   November 18, 2010   December 2, 2010
4th Quarter 2010
  $ 0.30     February 1, 2011   February 17, 2011   * March 3, 2011
          The ability of the Company to pay dividends is dependent upon its ability to generate funds from operations and cash flows and to make accretive new investments.
     Liquidity
          Net cash provided by operating activities was $80.8 million, $103.2 million and $105.3 million for 2010, 2009 and 2008, respectively. The Company’s cash flows are dependent upon rental rates on leases, occupancy levels of the multi-tenanted buildings, acquisition and disposition activity during the year, and the level of operating expenses, among other factors.
          The Company plans to continue to meet its liquidity needs, including funding additional investments in 2011, paying dividends, repaying maturing debt and funding other debt service, with available cash on hand, cash flows from operations, borrowings under the Unsecured Credit Facility (full capacity available at December 31, 2010), proceeds from mortgage notes receivable repayments, proceeds from sales of real estate investments, or additional capital market financings, including the Company’s at-the-market equity offering program, or other debt or equity offerings. The Company also had unencumbered real estate assets with a cost of approximately $2.3 billion at December 31, 2010, which could serve as collateral for secured mortgage financing. The Company believes that its liquidity and sources of capital are adequate to satisfy its cash requirements. The Company cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to the Company in sufficient amounts to meet its liquidity needs.
          The Company has some exposure to variable interest rates and its stock price has been impacted by the volatility in the stock markets. However, the Company’s leases, which provide its main source of income and cash flow, have terms of approximately one to 15 years and have lease rates that generally increase on an annual basis at fixed rates or based on consumer price indices.
     Impact of Inflation
          Inflation has not significantly affected the Company’s earnings due to the moderate inflation rate in recent years and the fact that most of the Company’s leases and financial support arrangements require tenants and sponsors to pay all or some portion of the increases in operating expenses, thereby reducing the Company’s risk to the adverse effects of inflation. In addition, inflation has the effect of increasing gross revenue the Company is to receive under the terms of certain leases and financial support arrangements. Leases and financial support arrangements vary in the remaining terms of obligations, further reducing the Company’s risk to any adverse effects of inflation. Interest payable under the Unsecured Credit Facility is calculated at a variable rate; therefore, the amount of interest payable under the Unsecured Credit Facility is influenced by changes in short-term rates, which tend to be sensitive to inflation. During periods where interest rate increases outpace inflation, the Company’s operating results should be negatively impacted. Conversely, when increases in inflation outpace increases in interest rates, the Company’s operating results should be positively impacted.
     New Accounting Pronouncements
          Note 1 to the Consolidated Financial Statements provides a discussion of new accounting standards. The Company does not believe these new standards will have a significant impact on the Company’s Consolidated Financial Statements or results of operations.
     Market Risk
          The Company is exposed to market risk in the form of changing interest rates on its debt and mortgage notes receivable. Management uses regular monitoring of market conditions and analysis techniques to manage this risk.
          At December 31, 2010, all of the Company’s debt totaling $1.4 billion bore interest at fixed rates. Additionally, $36.0 million of the Company’s mortgage notes and other notes receivable bore interest at fixed rates.

39


 

          The following table provides information regarding the sensitivity of certain of the Company’s financial instruments, as described above, to market conditions and changes resulting from changes in interest rates. For purposes of this analysis, sensitivity is demonstrated based on hypothetical 10% changes in the underlying market interest rates.
                                 
                    Impact on Earnings and Cash Flows  
    Outstanding             Assuming 10%     Assuming 10%  
    Principal Balance     Calculated Annual     Increase in Market     Decrease in Market  
(Dollars in thousands)   As of 12/31/10     Interest (1)     Interest Rates     Interest Rates  
Variable Rate Receivables:
                               
Mortgage Notes Receivable
  $ 4,371     $ 284     $ 1     $ (1 )
 
                       
                                         
            Fair Value  
                    Assuming 10%     Assuming 10%        
    Carrying Value at             Increase in Market     Decrease in Market     December 31, 2009  
(Dollars in thousands)   December 31, 2010     December 31, 2010     Interest Rates     Interest Rates     (2)  
Fixed Rate Debt:
                                       
Senior Notes due 2011, including premium
  $ 278,311     $ 286,856     $ 286,835     $ 286,875     $ 307,568  
Senior Notes due 2014, net of discount
    264,227       282,824       281,757       283,930       282,883  
Senior Notes due 2017, net of discount
    298,218       320,539       316,490       324,697       297,988  
Senior Notes due 2021, net of discount
    396,812       396,812       386,173       408,670        
Mortgage Notes Payable
    170,287       173,190       169,831       177,526       150,115  
 
                             
 
  $ 1,407,855     $ 1,460,221     $ 1,441,086     $ 1,481,698     $ 1,038,554  
 
                             
 
                                       
Fixed Rate Receivables:
                                       
Mortgage Notes Receivable
  $ 32,228     $ 31,521     $ 30,586     $ 32,488     $ 26,485  
Other Notes Receivable
    3,821       3,803       3,776       3,829       3,276  
 
                             
 
  $ 36,049     $ 35,324     $ 34,362     $ 36,317     $ 29,761  
 
                             
 
(1)   Annual interest on the variable rate receivables was calculated using a constant principal balance and the December 31, 2010 market rate of 6.50%. The increase or decrease in market interest rate is based on the variable LIBOR portion of the interest rate which is 0.26% as of December 31, 2010.
 
(2)   Fair values as of December 31, 2009 represent fair values of obligations or receivables that were outstanding as of that date, and do not reflect the effect of any subsequent changes in principal balances and/or additions or extinguishments of instruments.
     Off-Balance Sheet Arrangements
          The Company has no off-balance sheet arrangements that are reasonably likely to have a current or future material effect on its financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.
Application of Critical Accounting Policies to Accounting Estimates
          The Company’s Consolidated Financial Statements are prepared in accordance with GAAP and the rules and regulations of the SEC. In preparing the Consolidated Financial Statements, management is required to exercise judgment and make assumptions that impact the carrying amount of assets and liabilities and the reported amounts of revenues and expenses reflected in the Consolidated Financial Statements.
          Management routinely evaluates the estimates and assumptions used in the preparation of its Consolidated Financial Statements. These regular evaluations consider historical experience and other reasonable factors and use the seasoned judgment of management personnel. Management has reviewed the Company’s critical accounting policies with the Audit Committee of the Board of Directors.
          Management believes the following paragraphs in this section describe the application of critical accounting policies by management to arrive at the critical accounting estimates reflected in the Consolidated Financial Statements. The Company’s accounting policies are more fully discussed in Note 1 to the Consolidated Financial Statements.

40


 

     Valuation of Long-Lived and Intangible Assets and Goodwill
          The Company assesses the potential for impairment of identifiable intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the recorded value might not be fully recoverable. Important factors that could cause management to review for impairment include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; or significant negative economic trends or negative industry trends for the Company or its operators. In addition, the Company reviews for possible impairment those assets subject to purchase options and those impacted by casualties, such as hurricanes. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property. The Company recorded impairment charges totaling $7.5 million, $22,000 and $2.5 million, respectively, for the years ended December 31, 2010, 2009 and 2008 related to real estate properties and other long-lived assets. The impairment charges in 2010 included $1.0 million related to one property sold in 2010 and $6.5 million related to five properties classified as held for sale in 2010, reducing the Company’s carrying values on the properties to the estimated fair values of the properties less costs to sell. The impairment charge in 2009 was recorded in connection with the sale of a property in Washington. The impairment charges in 2008 included $1.6 million related to a long-lived asset, $0.1 million related to two properties sold in 2008, and $0.8 million related to two properties classified as held for sale in 2008, reducing the Company’s carrying values on the properties to the estimated fair values of the properties less costs to sell.
          The Company also performs an annual goodwill impairment review. The Company’s reviews are performed as of December 31 of each year. The Company’s 2010 and 2009 reviews indicated that no impairment had occurred with the respect to the Company’s $3.5 million goodwill asset.
     Capitalization of Costs
          GAAP generally allows for the capitalization of various types of costs. The rules and regulations on capitalizing costs and the subsequent depreciation or amortization of those costs versus expensing them in the period incurred vary depending on the type of costs and the reason for capitalizing the costs.
          Direct costs of a development project generally include construction costs, professional services such as architectural and legal costs, travel expenses, land acquisition costs as well as other types of fees and expenses. These costs are capitalized as part of the basis of an asset to which such costs relate. Indirect costs include capitalized interest and overhead costs. The Company’s overhead costs are based on overhead load factors that are charged to a project based on direct time incurred. The Company computes the overhead load factors annually for its acquisition and development departments, which have employees who are involved in the projects. The overhead load factors are computed to absorb that portion of indirect employee costs (payroll and benefits, training, occupancy and similar costs) that are attributable to the productive time the employee incurs working directly on projects. The employees in the Company’s acquisitions and development departments who work on these projects maintain and report their hours daily, by project. Employee costs that are administrative, such as vacation time, sick time, or general and administrative time, are expensed in the period incurred.
          Acquisition-related costs of an existing building include finder’s fees, advisory, legal, accounting, valuation, other professional or consulting fees, and certain general and administrative costs. These costs are also expensed in the period incurred.
          Management’s judgment is also exercised in determining whether costs that have been previously capitalized to a project should be reserved for or written off if or when the project is abandoned or circumstances otherwise change that would call the project’s viability into question. The Company follows a standard and consistently applied policy of classifying pursuit activity as well as reserving for these types of costs based on their classification.
          The Company classifies its pursuit projects into four categories, of which three relate to development and one relates to acquisitions. The first category includes pursuits of developments that have a remote chance of producing new business. Costs for these projects are expensed in the period incurred. The second category includes pursuits of developments that might reasonably be expected to produce new business opportunities although there can be no assurance that they will result in a new project or contract. Costs for these projects are capitalized but, due to the uncertainty of projects in this category, these costs are reserved at 50%, which means that 50% of the costs are expensed in the period incurred. The third category includes those pursuits of developments that are either highly probable to result in a project or contract or already have resulted in a project or contract in which the contract requires the operator to reimburse the Company’s costs. Many times, these are pursuits involving operators with which the Company is already doing business. Since the Company believes it is probable that these pursuits will result in a project or contract, it capitalizes these costs in full and records no reserve. The fourth category includes pursuits that involve the acquisition of existing buildings. As discussed above, costs related to acquisitions of existing buildings are expensed in the period incurred.

41


 

          Each quarter, all capitalized pursuit costs are again reviewed carefully for viability or a change in classification, and a management decision is made as to whether any additional reserve is deemed necessary. If necessary and considered appropriate, management would record an additional reserve at that time. Capitalized pursuit costs, net of the reserve, are carried in other assets in the Company’s Consolidated Balance Sheets, and any reserve recorded is charged to general and administrative expenses on the Consolidated Statements of Income. All pursuit costs will ultimately be written off to expense or capitalized as part of the constructed real estate asset.
          As of December 31, 2010 and 2009, the Company had capitalized pursuit costs totaling $1.1 million and $2.2 million, respectively, and had provided reserves against its capitalized pursuit costs of $1.0 million and $2.1 million, respectively.
     Depreciation of Real Estate Assets and Amortization of Related Intangible Assets
          As of December 31, 2010, the Company had investments of approximately $2.4 billion in depreciable real estate assets and related intangible assets. When real estate assets and related intangible assets are acquired or placed in service, they must be depreciated or amortized. Management’s judgment involves determining which depreciation method to use, estimating the economic life of the building and improvement components of real estate assets, and estimating the value of intangible assets acquired when real estate assets are purchased that have in-place leases.
          As described in more detail in Note 1 to the Consolidated Financial Statements, when the Company acquires real estate properties with in-place leases, the cost of the acquisition must be allocated between the acquired tangible real estate assets “as if vacant” and any acquired intangible assets. Such intangible assets could include above- (or below-) market in-place leases and at-market in-place leases, which could include the opportunity costs associated with absorption period rentals, direct costs associated with obtaining new leases such as tenant improvements, and customer relationship assets. Any remaining excess purchase price is then allocated to goodwill. The identifiable tangible and intangible assets are then subject to depreciation and amortization. Goodwill is evaluated for impairment on an annual basis unless circumstances suggest that a more frequent evaluation is warranted.
          If assumptions used to estimate the “as if vacant” value of the building or the intangible asset values prove to be inaccurate, the pro-ration of the purchase price between building and intangibles and resulting depreciation and amortization could be incorrect. The amortization period for the intangible assets is the average remaining term of the actual in-place leases as of the acquisition date. To help prevent errors in its estimates from occurring, management applies consistent assumptions with regard to the elements of estimating the “as if vacant” values of the building and the intangible assets, including the absorption period, occupancy increases during the absorption period, and tenant improvement amounts. The Company uses the same absorption period and occupancy assumptions for similar building types, adding the future cash flows expected to occur over the next 10 years as a fully occupied building. The net present value of these future cash flows, discounted using a market rate of return, becomes the estimated “as if vacant” value of the building.
          With respect to the building components, there are several depreciation methods available under GAAP. Some methods record relatively more depreciation expense on an asset in the early years of the asset’s economic life, and relatively less depreciation expense on the asset in the later years of its economic life. The straight-line method of depreciating real estate assets is the method the Company follows because, in the opinion of management, it is the method that most accurately and consistently allocates the cost of the asset over its estimated life. The Company assigns a useful life to its owned buildings based on many factors, including the age of the property when acquired.
     Allowance for Doubtful Accounts and Credit Losses
          Many of the Company’s investments are subject to long-term leases or other financial support arrangements with hospital systems and healthcare providers affiliated with the properties. Due to the nature of the Company’s agreements, the Company’s accounts receivable, notes receivable and interest receivables result mainly from monthly billings of contractual tenant rents, lease guaranty amounts, principal and interest payments due on notes and mortgage notes receivable, late fees and additional rent.
          Payments on the Company’s accounts receivable are normally collected within 30 days of billing. When receivables remain uncollected, management must decide whether it believes the receivable is collectible and whether to provide an allowance for all or a portion of these receivables. Unlike a financial institution with a large volume of homogeneous retail receivables such as credit card loans or automobile loans that have a predictable loss pattern over time, the Company’s receivable losses have historically been infrequent, and are tied to a unique or specific event. The Company’s allowance for doubtful accounts is generally based on specific identification and is recorded for a specific receivable amount once determined that such an allowance is needed.
          The Company also evaluates collectability of its mortgage notes and notes receivable. A loan is impaired when it is probable that a creditor will be unable to collect all amounts due according to the contractual terms of the loan as scheduled, including both contractual interest and principal payments. The Company did not record any provisions for doubtful accounts on its mortgage notes or notes receivable during the three years ended December 31, 2010.

42


 

          Management monitors the age and collectibility of receivables on an ongoing basis. At least monthly, a report is produced whereby all receivables are “aged” or placed into groups based on the number of days that have elapsed since the receivable was billed. Management reviews the aging report for evidence of deterioration in the timeliness of payments from tenants, sponsors or borrowers. Whenever deterioration is noted, management investigates and determines the reason(s) for the delay, which may include discussions with the delinquent tenant, sponsor or borrower. Considering all information gathered, management’s judgment must be exercised in determining whether a receivable is potentially uncollectible and, if so, how much or what percentage may be uncollectible. Among the factors management considers in determining uncollectibility are the following:
    type of contractual arrangement under which the receivable was recorded, e.g., a mortgage note, a triple net lease, a gross lease, a sponsor guaranty agreement or some other type of agreement;
 
    tenant’s or debtor’s reason for slow payment;
 
    industry influences and healthcare segment under which the tenant or debtor operates;
 
    evidence of willingness and ability of the tenant or debtor to pay the receivable;
 
    credit-worthiness of the tenant or debtor;
 
    collateral, security deposit, letters of credit or other monies held as security;
 
    tenant’s or debtor’s historical payment pattern;
 
    other contractual agreements between the tenant or debtor and the Company;
 
    relationship between the tenant or debtor and the Company;
 
    state in which the tenant or debtor operates; and
 
    existence of a guarantor and the willingness and ability of the guarantor to pay the receivable.
          Considering these factors and others, management must conclude whether all or some of the aged receivable balance is likely uncollectible. If management determines that some portion of a receivable is likely uncollectible, the Company records a provision for bad debt expense for the amount expected to be uncollectible. There is a risk that management’s estimate is over- or under-stated; however, management believes that this risk is mitigated by the fact that it re-evaluates the allowance at least once each quarter and bases its estimates on the most current information available. As such, any over- or under-stated estimates in the allowance should be adjusted for as soon as new and better information becomes available.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
          See “Market Risk” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” incorporated herein by reference to Item 7 of this report.

43


 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Report of
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of Directors and Stockholders
Healthcare Realty Trust Incorporated
Nashville, Tennessee
          We have audited the accompanying consolidated balance sheets of Healthcare Realty Trust Incorporated as of December 31, 2010 and 2009 and the related consolidated statements of income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2010. In connection with our audits of the financial statements, we have also audited the financial statement schedules listed in the accompanying index. These financial statements and schedules are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedules based on our audits.
          We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and schedules. We believe that our audits provide a reasonable basis for our opinion.
          In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Healthcare Realty Trust Incorporated at December 31, 2010 and 2009, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2010, in conformity with accounting principles generally accepted in the United States of America.
          Also, in our opinion, the financial statement schedules, when considered in relation to the basic consolidated financial statements as a whole, present fairly, in all material respects, the information set forth therein.
          We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Healthcare Realty Trust Incorporated’s internal control over financial reporting as of December 31, 2010, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) and our report dated February 22, 2011 expressed an unqualified opinion thereon.
         
     
  /s/ BDO USA, LLP    
     
Nashville, Tennessee
February 22, 2011

44


 

Consolidated
BALANCE SHEETS
                 
    December 31,  
(Dollars in thousands, except per share amounts)   2010     2009  
ASSETS
               
Real estate properties:
               
Land
  $ 163,020     $ 135,495  
Buildings, improvements and lease intangibles
    2,310,404       1,977,264  
Personal property
    17,919       17,509  
Construction in progress
    80,262       95,059  
 
           
 
    2,571,605       2,225,327  
Less accumulated depreciation
    (484,641 )     (433,634 )
 
           
Total real estate properties, net
    2,086,964       1,791,693  
Cash and cash equivalents
    113,321       5,851  
Mortgage notes receivable
    36,599       31,008  
Assets held for sale and discontinued operations, net
    23,915       17,745  
Other assets, net
    96,510       89,467  
 
           
Total assets
  $ 2,357,309     $ 1,935,764  
 
           
 
               
LIABILITIES AND EQUITY
               
Liabilities:
               
Notes and bonds payable
  $ 1,407,855     $ 1,046,422  
Accounts payable and accrued liabilities
    62,652       55,043  
Liabilities of discontinued operations
    423       251  
Other liabilities
    43,639       43,900  
 
           
Total liabilities
    1,514,569       1,145,616  
Commitments and contingencies
               
Equity:
               
Preferred stock, $.01 par value; 50,000,000 shares authorized; none issued and outstanding
           
Common stock, $.01 par value; 150,000,000 shares authorized; 66,071,424 and 60,614,931 shares issued and outstanding at December 31, 2010 and December 31, 2009, respectively
    661       606  
Additional paid-in capital
    1,641,379       1,520,893  
Accumulated other comprehensive loss
    (5,269 )     (4,593 )
Cumulative net income attributable to common stockholders
    796,165       787,965  
Cumulative dividends
    (1,593,926 )     (1,518,105 )
 
           
Total stockholders’ equity
    839,010       786,766  
Noncontrolling interests
    3,730       3,382  
 
           
Total equity
    842,740       790,148  
 
           
Total liabilities and equity
  $ 2,357,309     $ 1,935,764  
 
           
See accompanying notes.

45


 

Consolidated
STATEMENTS OF INCOME
                         
    Year Ended December 31,  
(Dollars in thousands, except per share data)   2010     2009     2008  
REVENUES
                       
Master lease rent
  $ 54,659     $ 53,340     $ 52,472  
Property operating
    190,205       177,849       134,746  
Straight-line rent
    2,509       2,052       717  
Mortgage interest
    2,377       2,646       2,207  
Other operating
    8,644       10,951       16,252  
 
                 
 
    258,394       246,838       206,394  
 
                       
EXPENSES
                       
General and administrative
    16,894       22,478       23,514  
Property operating
    101,355       93,249       79,732  
Impairment of long-lived assets
                1,600  
Bad debt, net
    (429 )     535       1,252  
Depreciation
    67,440       60,847       46,541  
Amortization
    5,342       5,259       2,849  
 
                 
 
    190,602       182,368       155,488  
 
                       
OTHER INCOME (EXPENSE)
                       
Gain (loss) on extinguishment of debt
    (480 )           4,102  
Re-measurement gain of equity interest upon acquisition
          2,701        
Interest expense
    (65,710 )     (43,080 )     (42,126 )
Interest and other income, net
    2,419       1,099       2,438  
 
                 
 
    (63,771 )     (39,280 )     (35,586 )
 
                 
 
                       
INCOME FROM CONTINUING OPERATIONS
    4,021       25,190       15,320  
 
                       
DISCONTINUED OPERATIONS
                       
Income from discontinued operations
    3,385       5,844       17,483  
Impairments
    (7,511 )     (22 )     (886 )
Gain on sales of real estate properties
    8,352       20,136       9,843  
 
                 
INCOME FROM DISCONTINUED OPERATIONS
    4,226       25,958       26,440  
 
                 
 
                       
NET INCOME
    8,247       51,148       41,760  
 
                       
Less: Net income attributable to noncontrolling interests
    (47 )     (57 )     (68 )
 
                 
 
                       
NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS
  $ 8,200     $ 51,091     $ 41,692  
 
                 
 
                       
BASIC EARNINGS PER COMMON SHARE:
                       
Income from continuing operations
  $ 0.06     $ 0.43     $ 0.30  
Discontinued operations
    0.07       0.45       0.51  
 
                 
Net income attributable to common stockholders
  $ 0.13     $ 0.88     $ 0.81  
 
                 
 
                       
DILUTED EARNINGS PER COMMON SHARE:
                       
Income from continuing operations
  $ 0.06     $ 0.43     $ 0.29  
Discontinued operations
    0.07       0.44       0.50  
 
                 
Net income attributable to common stockholders
  $ 0.13     $ 0.87     $ 0.79  
 
                 
 
                       
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING — BASIC
    61,722,786       58,199,592       51,547,279  
 
                 
 
                       
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING — DILUTED
    62,770,826       59,047,314       52,564,944  
 
                 
 
                       
See accompanying notes.

46


 

Consolidated
STATEMENTS OF STOCKHOLDERS’ EQUITY
                                                                         
                            Accumulated                                  
                    Additional     Other     Cumulative             Total     Non-        
    Preferred     Common     Paid-In     Comprehensive     Net     Cumulative     Stockholders’     controlling     Total  
(Dollars in thousands, except per share data)   Stock     Stock     Capital     Loss     Income     Dividends     Equity     Interests     Equity  
Balance at December 31, 2007
  $     $ 507     $ 1,286,071     $ (4,346 )   $ 695,182     $ (1,345,419 )   $ 631,995     $     $ 631,995  
 
                                                                       
Issuance of stock, net of costs
          83       201,968                         202,051             202,051  
Common stock redemption
                (282 )                       (282 )           (282 )
Stock-based compensation
          2       2,778                         2,780             2,780  
Net income
                            41,692             41,692       68       41,760  
Other comprehensive loss
                      (2,115 )                   (2,115 )           (2,115 )
 
                                                                     
Comprehensive income
                                                                  39,645  
Dividends to common stockholders ($1.54 per share)
                                  (81,301 )     (81,301 )           (81,301 )
Distributions to noncontrolling interests
                                              (110 )     (110 )
Proceeds from noncontrolling interests
                                              1,469       1,469  
 
                                                     
Balance at December 31, 2008
          592       1,490,535       (6,461 )     736,874       (1,426,720 )     794,820       1,427       796,247  
 
                                                                       
Issuance of stock, net of costs
          13       26,656                         26,669             26,669  
Common stock redemption
                (8 )                       (8 )           (8 )
Stock-based compensation
          1       3,710                         3,711             3,711  
Net income
                            51,091             51,091       57       51,148  
Other comprehensive income
                      1,868                   1,868             1,868  
 
                                                                     
Comprehensive income
                                                                  53,016  
Dividends to common stockholders ($1.54 per share)
                                  (91,385 )     (91,385 )           (91,385 )
Distributions to noncontrolling interests
                                              (330 )     (330 )
Proceeds from noncontrolling interests
                                              2,228       2,228  
 
                                                     
Balance at December 31, 2009
          606       1,520,893       (4,593 )     787,965       (1,518,105 )     786,766       3,382       790,148  
 
Issuance of stock, net of costs
          53       118,077                         118,130             118,130  
Stock-based compensation
          2       2,409                         2,411             2,411  
Net income
                            8,200             8,200       47       8,247  
Other comprehensive loss
                      (676 )                 (676 )           (676 )
 
                                                                     
Comprehensive income
                                                                7,571  
Dividends to common stockholders ($1.20 per share)
                                  (75,821 )     (75,821 )           (75,821 )
Distributions to noncontrolling interests
                                              (467 )     (467 )
Proceeds from noncontrolling interests
                                              768       768  
 
                                                     
Balance at December 31, 2010
  $     $ 661     $ 1,641,379     $ (5,269 )   $ 796,165     $ (1,593,926 )   $ 839,010     $ 3,730     $ 842,740  
 
                                                     
See accompanying notes.

47


 

Consolidated
STATEMENTS OF CASH FLOWS
                         
    Year Ended December 31,  
(Dollars in thousands)   2010     2009     2008  
OPERATING ACTIVITIES
                       
Net income
  $ 8,247     $ 51,148     $ 41,760  
Adjustments to reconcile net income to cash provided by operating activities:
                       
Depreciation and amortization
    77,894       70,921       54,748  
Stock-based compensation
    2,411       3,711       2,780  
Straight-line rent receivable
    (2,472 )     (1,925 )     (643 )
Straight-line rent liability
    92       444       423  
Gain on sales of real estate properties
    (8,352 )     (20,136 )     (9,843 )
Gain on sales of land
                (384 )
(Gain) loss on extinguishment of debt
    480             (4,102 )
Re-measurement gain of equity interest upon acquisition
          (2,701 )      
Impairments
    7,511       22       2,486  
Equity in (income) losses from unconsolidated joint ventures
          2       (1,021 )
Provision for bad debt, net
    (409 )     517       1,904  
State income taxes paid, net of refunds
    (533 )     (674 )     (612 )
Payment of partial pension settlement
    (2,582 )     (2,300 )      
Changes in operating assets and liabilities:
                       
Other assets
    (9,137 )     (1,017 )     6,794  
Accounts payable and accrued liabilities
    6,367       5,127       3,097  
Other liabilities
    1,318       75       7,864  
 
                 
Net cash provided by operating activities
    80,835       103,214       105,251  
 
                       
INVESTING ACTIVITIES
                       
Acquisition and development of real estate properties
    (369,034 )     (170,520 )     (383,702 )
Funding of mortgages and notes receivable
    (25,109 )     (23,391 )     (36,970 )
Investments in unconsolidated joint venture
          (184 )      
Distributions from unconsolidated joint ventures
                882  
Partial redemption of preferred equity investment in an unconsolidated joint venture
                5,546  
Proceeds from sales of real estate
    34,512       83,441       37,133  
Proceeds from mortgages and notes receivable repayments
    9,201       12,893       8,236  
 
                 
Net cash used in investing activities
    (350,430 )     (97,761 )     (368,875 )
 
                       
FINANCING ACTIVITIES
                       
Net borrowings (repayments) on unsecured credit facilities
    (50,000 )     (279,000 )     193,000  
Borrowings on notes and bonds payable
    396,800       377,969        
Repayments on notes and bonds payable
    (2,516 )     (28,433 )     (3,813 )
Repurchase of notes payable
    (8,556 )           (45,460 )
Quarterly dividends paid
    (75,821 )     (91,385 )     (81,301 )
Proceeds from issuance of common stock
    118,235       26,467       197,255  
Common stock redemptions
          (8 )     (282 )
Capital contributions received from noncontrolling interests
    633       2,228       1,469  
Distributions to noncontrolling interest holders
    (481 )     (282 )     (110 )
Credit facility amendment and extension fees
                (1,126 )
Equity issuance costs
    (30 )     (3 )     (389 )
Debt issuance and assumption costs
    (1,199 )     (11,293 )      
 
                 
Net cash provided by (used in) financing activities
    377,065       (3,740 )     259,243  
 
                 
 
                       
Increase (decrease) in cash and cash equivalents
    107,470       1,713       (4,381 )
Cash and cash equivalents, beginning of year
    5,851       4,138       8,519  
 
                 
Cash and cash equivalents, end of year
  $ 113,321     $ 5,851     $ 4,138  
 
                 
 
                       
Supplemental Cash Flow Information:
                       
Interest paid
  $ 62,274     $ 50,052     $ 49,997  
Capitalized interest
  $ 10,315     $ 10,087     $ 6,679  
Invoices accrued for construction, tenant improvement and other capitalized costs
  $ 13,555     $ 16,266     $ 12,500  
Mortgage notes payable assumed upon acquisition (adjusted to fair value)
  $ 24,268     $ 11,716     $ 50,825  
Mortgage note payable disposed of upon sale of joint venture interest
  $     $ 5,425     $  
See accompanying notes.

48


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Summary of Significant Accounting Policies
     Business Overview
          Healthcare Realty Trust Incorporated (the “Company”) is a real estate investment trust that owns, acquires, manages, finances, and develops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of December 31, 2010, excluding assets classified as held for sale and including an investment in one unconsolidated joint venture, the Company had investments of approximately $2.6 billion in 209 real estate properties and mortgages. The Company’s 201 owned real estate properties, excluding assets classified as held for sale, are located in 28 states, totaling approximately 13.3 million square feet. In addition, the Company provided property management services to approximately 9.2 million square feet nationwide. Square footage disclosures in this Annual Report on Form 10-K are unaudited.
     Principles of Consolidation
          The Consolidated Financial Statements include the accounts of the Company, its wholly-owned subsidiaries, joint ventures and partnerships where the Company controls the operating activities.
          The Company consolidates two joint ventures with the same joint venture partner, Ladco MPF I, LLC, in which it has a controlling interest. The Company also does business with Ladco MPF I, LLC and its affiliates (“Ladco”) that are not part of the joint ventures. The Company’s Consolidated Financial Statements at December 31, 2010 included approximately $102.1 million in real estate investments, including mortgage notes receivable, related to these consolidated joint ventures. Information on these joint ventures is as follows:
    The Company holds an 80% interest in the HR Ladco Holdings, LLC joint venture, formed during 2008. This joint venture owned $87.6 million and $72.9 million in real estate properties as of December 31, 2010 and 2009, respectively. A substantial number of properties held in this joint venture were developed by Ladco with the Company providing construction financing. Upon the properties’ completion and stabilization, the joint venture had the option to acquire the properties. The Company’s construction financings were converted to its equity contribution with additional mortgage financing (eliminated in consolidation) provided by the Company. As of December 31, 2010, the Company had funded $15.9 million of the total $60.6 million in funding commitments under four construction loans to Ladco for projects under development. Ladco is responsible for asset and property management services for which it receives a fee from the revenues of the joint venture.
 
    The Company also holds a 98.75% interest in the Lakewood MOB, LLC joint venture, formed during 2010 that is currently developing two medical office buildings and a parking garage in Colorado for $54.9 million. As of December 31, 2010, the Company has funded $14.5 million for the medical office buildings and garage, which are expected to be completed during 2011. Ladco is developing the properties and will be responsible for asset and property management services upon completion. The joint venture agreement allows Ladco to expand its ownership to a maximum of 5% via a cash contribution.
          The Company reports noncontrolling interests in subsidiaries as equity and the related net income attributable to the noncontrolling interests as part of consolidated net income in its financial statements.
          The Company has other mortgage and notes receivable with Ladco that are not part of these joint ventures.
          The Company also had an investment in one unconsolidated joint venture at December 31, 2010 and 2009 and an investment in two unconsolidated joint ventures at December 31, 2008. The Company’s investment in its unconsolidated joint ventures is included in other assets and the related equity income is recognized in other income (expense) on the Company’s Consolidated Financial Statements.
          All significant intercompany accounts, transactions and balances have been eliminated in the Consolidated Financial Statements.
     Use of Estimates in the Consolidated Financial Statements
          Preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.

49


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
     Segment Reporting
          The Company owns, acquires, manages, finances and develops outpatient healthcare-related properties. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single segment.
     Reclassifications
          Certain reclassifications for discontinued operations have been made to the Consolidated Financial Statements for the years ended December 31, 2009 and 2008 to conform to the 2010 presentation. The operating results for assets classified as held for sale as of December 31, 2010 or sold during 2010 have been reclassified from continuing operations to discontinued operations on the Consolidated Financial Statements for the years ended December 31, 2009 and 2008.
     Real Estate Properties
          Real estate properties are recorded at cost. Cost at the time of the acquisition is allocated between land, buildings, tenant improvements, lease and other intangibles, and personal property based upon estimated fair values at the time of acquisition. The Company’s gross real estate assets, on a book-basis, totaled approximately $2.6 billion and $2.3 billion, respectively, as of December 31, 2010 and 2009.
          Depreciation and amortization of real estate assets and liabilities in place as of December 31, 2010, is provided for on a straight-line basis over the asset’s estimated useful life:
         
Land improvements
    15.0 years  
Buildings and improvements
    1.3 to 39 years  
Lease intangibles (including ground lease intangibles)
    2.6 to 93.1 years  
Personal property
    3.0 to 15.8 years  
     Land Held for Development
          Included in construction in progress (“CIP”) on the Company’s Consolidated Balance Sheets are four parcels of land held for future development. As of December 31, 2010 and 2009, the Company’s investment in land held for development totaled approximately $20.8 million and $17.3 million, respectively.
     Accounting for Acquisitions of Real Estate Properties with In-Place Leases
          When a building is acquired with in-place leases, the cost of the acquisition must be allocated between the tangible real estate assets and the intangible real estate assets related to in-place leases based on their estimated fair values. Where appropriate, the intangible assets recorded could include goodwill or customer relationship assets. The values related to above- or below-market in-place lease intangibles are amortized to rental income where the Company is the lessor, are amortized to property operating expense where the Company is the lessee, and are amortized over the average remaining term of the leases upon acquisition. The values of at-market in-place leases and other intangible assets, such as customer relationship assets, are amortized and reflected in amortization expense in the Company’s Consolidated Statements of Income.
          The Company’s approach to estimating the value of in-place leases is a multi-step process.
    First, the Company considers whether any of the in-place lease rental rates are above- or below-market. An asset (if the actual rental rate is above-market) or a liability (if the actual rental rate is below-market) is calculated and recorded in an amount equal to the present value of the future cash flows that represent the difference between the actual lease rate and the average market rate.
    Second, the Company estimates an absorption period assuming the building is vacant and must be leased up to the actual level of occupancy when acquired. During that absorption period the owner would incur direct costs, such as tenant improvements, and would suffer lost rental income. Likewise, the owner would have acquired a measurable asset in that, assuming the building was vacant, certain fixed costs would be avoided because the actual in-place lessees would reimburse a certain portion of fixed costs through expense reimbursements during the absorption period. All of these assets (tenant improvement costs avoided, rental income lost, and fixed costs recovered through in-place lessee reimbursements) are estimated and recorded in amounts equal to the present value of future cash flows.

50


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
    Third, the Company estimates the value of the building “as if vacant.” The Company uses the same absorption period and occupancy assumptions used in step two, adding to those the future cash flows expected in a fully occupied building. The net present value of these future cash flows, discounted at a market rate of return, becomes the estimated “as if vacant” value of the building.
 
    Fourth, the actual purchase price is allocated based on the various asset fair values described above. The building and tenant improvement components of the purchase price are depreciated over the estimated useful life of the building or the average remaining term of the in-places leases. The above- or below-market rental rate assets or liabilities are amortized to rental income or property operating expense over the remaining term of the leases. The at-market, in-place leases are amortized to amortization expense over the average remaining term of the leases, customer relationship assets are amortized to amortization expense over terms applicable to each acquisition, and any goodwill recorded would be reviewed for impairment at least annually.
          See Note 8 for more details on the Company’s intangible assets as of December 31, 2010 and 2009.
     Fair Value Measurements
          Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements.
          A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:
    Level 1 — quoted prices for identical instruments in active markets;
 
    Level 2 — quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and
 
    Level 3 — fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
          In connection with its acquisition of real estate assets during 2010 and 2009, the Company assumed mortgage notes payable. The valuation of the mortgage notes payable was determined using level two inputs. Levels 2 and 3 were used to determine the fair value of the assets classified as held for sale at December 31, 2010, which is discussed in more detail in Note 6.
     Cash and Cash Equivalents
          Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. At December 31, 2010, the Company had $99.0 million invested in a short-term money market fund, bearing interest at 0.18% and with a weighted average maturity of assets in the fund of 46 days at December 31, 2010. The cash in the money market fund was generated from a portion of the proceeds from the Senior Notes due 2021 issued in late December 2010. The Company expects to use these funds to repay the Senior Notes due 2011 or for other general corporate purposes.
     Allowance for Doubtful Accounts and Credit Losses
          Accounts Receivable
          Management monitors the aging and collectibility of its accounts receivable balances on an ongoing basis. At least monthly, a report is produced whereby all receivables are “aged” or placed into groups based on the number of days that have elapsed since the receivable was billed. Management reviews the aging report for evidence of deterioration in the timeliness of payment from a tenant or sponsor. Whenever deterioration is noted, management investigates and determines the reason(s) for the delay, which may include discussions with the delinquent tenant or sponsor. Considering all information gathered, management’s judgment is exercised in determining whether a receivable is potentially uncollectible and, if so, how much or what percentage may be uncollectible. Among the

51


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
factors management considers in determining collectibility are the type of contractual arrangement under which the receivable was recorded, e.g., a triple net lease, a gross lease, a sponsor guaranty agreement, or some other type of agreement; the tenant’s reason for slow payment; industry influences under which the tenant operates; evidence of willingness and ability of the tenant to pay the receivable; credit-worthiness of the tenant; collateral, security deposit, letters of credit or other monies held as security; tenant’s historical payment pattern; other contractual agreements between the tenant and the Company; relationship between the tenant and the Company; the state in which the tenant operates; and the existence of a guarantor and the willingness and ability of the guarantor to pay the receivable.
          Considering these factors and others, management concludes whether all or some of the aged receivable balance is likely uncollectible. Upon determining that some portion of the receivable is likely uncollectible, the Company records a provision for bad debts for the amount it expects will be uncollectible. When efforts to collect a receivable are exhausted, the receivable amount is charged off against the allowance. The Company does not hold any accounts receivable for sale.
          Mortgage Notes and Notes Receivable
          The Company had seven mortgage notes receivable outstanding as of December 31, 2010 and four mortgage notes receivable as of December 31, 2009 with aggregate principal balances totaling $36.6 million and $31.0 million, respectively. The weighted average maturity of the notes was approximately 3.9 years and 4.7 years, respectively, with interest rates ranging from 6.5% to 11.0% and 6.2% to 8.5%, respectively, as of December 31, 2010 and 2009.
          The Company also had notes receivable outstanding as of December 31, 2010 and 2009 of approximately $3.8 million and $3.3 million, respectively. Interest rates on the notes were fixed, ranging from 8.0% to 11.6% with maturity dates ranging from 2011 through 2016 as of December 31, 2010 and 2009.
          Management believes that its mortgage notes and notes receivable outstanding as of December 31, 2010 and 2009 were collectible, and therefore, did not record any allowances or reserves related to its notes during 2010 or 2009. The Company evaluates collectibility of its mortgage notes and notes receivable and records allowances on the notes as necessary. A loan is impaired when it is probable that a creditor will be unable to collect all amounts due according to the contractual terms of the loan as scheduled, including both contractual interest and principal payments. If a mortgage loan or note receivable becomes past due, the Company will review the specific circumstances and may discontinue the accrual of interest on the loan. The loan is not returned to accrual status until the debtor has demonstrated the ability to continue debt service in accordance with the contractual terms. As of December 31, 2010 and 2009, there were no recorded investments in mortgage notes or notes receivable that were either on non-accrual status or were past due more than ninety days and continued to accrue interest. Also, as of December 31, 2010, the Company did not hold any of its mortgage notes or notes receivable available for sale.
     Goodwill and Other Intangible Assets
          Goodwill and intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present.
          Identifiable intangible assets of the Company are comprised of enterprise goodwill, in-place lease intangible assets, customer relationship intangible assets, and deferred financing costs. In-place lease and customer relationship intangible assets are amortized on a straight-line basis over the applicable lives of the assets. Deferred financing costs are amortized over the term of the related credit facility or other debt instrument under the straight-line method, which approximates amortization under the effective interest method. Goodwill is not amortized but is evaluated annually on December 31 for impairment. The 2010 and 2009 impairment evaluations each indicated that no impairment had occurred with respect to the $3.5 million goodwill asset. See Note 8 for more detail on the Company’s intangible assets.
     Contingent Liabilities
          From time to time, the Company may be subject to loss contingencies arising from legal proceedings, which are discussed in Note 14. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or underinsured damages.
          The Company continually monitors any matters that may present a contingent liability, and, on a quarterly basis, management reviews the Company’s reserves and accruals in relation to each of them, adjusting provisions as necessary in view of changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be

52


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
reasonably estimated. Changes in estimates regarding the exposure to a contingent loss are reflected as adjustments to the related liability in the periods when they occur.
          Because of uncertainties inherent in the estimation of contingent liabilities, it is possible that management’s provision for contingent losses could change materially in the near term. To the extent that any losses, in addition to amounts recognized, are at least reasonably possible, such amounts will be disclosed in the notes to the Consolidated Financial Statements.
     Accounting for Defined Benefit Pension Plans
          The Company has a pension plan under which certain designated officers may receive retirement benefits upon retirement and the completion of five years of service with the Company. The plan is unfunded and benefits will be paid from earnings of the Company. The Company recognizes pension expense on an accrual basis over an estimated service period. The Company calculates pension expense and the corresponding liability annually on the measurement date (December 31) which requires certain assumptions, such as a discount rate and the recognition of actuarial gains and losses.
          The Company historically has also had a pension plan for its non-employee outside directors (the “Outside Director Plan”). The Company terminated the Outside Director Plan in November 2009 and paid to each outside director who participated in the plan a lump-sum payment, which aggregated to approximately $2.6 million, during 2010 in full settlement of the directors’ benefits payable under the Outside Director Plan. See Note 11 for further discussion.
     Incentive Plans
          The Company has various employee stock-based awards outstanding. These awards include common stock issued to employees pursuant to the 2007 Employees Stock Incentive Plan and its predecessor plan (the “Incentive Plan”), the Optional Deferral Plan and the 2000 Employee Stock Purchase Plan (the “Employee Stock Purchase Plan”). See Note 12 for details on the Company’s stock-based awards. The Employee Stock Purchase Plan features a “look-back” provision which enables the employee to purchase a fixed number of common shares at the lesser of 85% of the market price on the date of grant or 85% of the market price on the date of exercise, with optional purchase dates occurring once each quarter for 27 months.
          The Company accounts for awards to its employees based on fair value, using the Black-Scholes model, and generally recognizes expense over the award’s vesting period, net of estimated forfeitures. Since the options granted under the Employee Stock Purchase Plan immediately vest, the Company records compensation expense for those options when they are granted in the first quarter of each year. In each of the first quarters of 2010, 2009 and 2008, the Company recognized in general and administrative expenses approximately $0.2 million, $0.3 million and $0.2 million of compensation expense, respectively, related to the annual grant of options to its employees to purchase shares under the Employee Stock Purchase Plan.
     Accumulated Other Comprehensive Loss
          Certain items must be included in comprehensive income, including items such as foreign currency translation adjustments, minimum pension liability adjustments, and unrealized gains or losses on available-for-sale securities. The Company’s accumulated other comprehensive loss includes the cumulative pension liability adjustments, which are generally recognized in the fourth quarter of each year.
     Revenue Recognition
          The Company recognizes revenue when it is realized or realizable and earned. There are four criteria that must all be met before a Company may recognize revenue, including persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered (i.e., the tenant has taken possession of and controls the physical use of the leased asset), the price has been fixed or is determinable, and collectibility is reasonably assured.
          The Company derives most of its revenues from its real estate property and mortgage notes receivable portfolio. The Company’s rental and mortgage interest income is recognized based on contractual arrangements with its tenants, sponsors or borrowers. These contractual arrangements fall into three categories: leases, mortgage notes receivable, and property operating agreements as described in the following paragraphs. The Company may accrue late fees based on the contractual terms of a lease or note. Such fees, if accrued, are included in master lease income, property operating income, or mortgage interest income on the Company’s Consolidated Statements of Income, based on the type of contractual agreement.
          Income received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities on the Consolidated Balance Sheets, was $17.3 million and $18.4 million, respectively, at December 31, 2010 and 2009.

53


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
          Rental Income
          Rental income related to non-cancelable operating leases is recognized as earned over the life of the lease agreements on a straight-line basis. Rental income from properties under a master lease arrangement with the tenant is included in master lease rental income and rental income from properties under various tenant lease arrangements, including operating expense recoveries, is included in property operating income on the Company’s Consolidated Statements of Income. Included in income from continuing operations were operating expense recoveries of approximately $23.0 million, $20.8 million and $10.3 million, respectively, for the years ended December 31, 2010, 2009 and 2008.
          Additional rent, generally defined in most lease agreements as the cumulative increase in a Consumer Price Index (“CPI”) from the lease start date to the CPI as of the end of the previous year, is calculated as of the beginning of each year, and is then billed and recognized as income during the year as provided for in the lease. Included in income from continuing operations was additional rental income, net of reserves, of approximately $2.3 million, $2.5 million and $1.7 million, respectively, for the years ended December 31, 2010, 2009 and 2008.
          Mortgage Interest Income
          Interest income on the Company’s mortgage notes receivable is recognized based on the interest rates, maturity dates and amortization periods in accordance with each note agreement. Interest rates on five of its mortgage notes receivable outstanding as of December 31, 2010 were fixed and interest rates on two notes were variable. The Company amortizes any fees paid related to its mortgage notes receivable to mortgage interest income over the term of the loan on a straight-line basis.
     Other Operating Income
          Other operating income on the Company’s Consolidated Statements of Income generally includes shortfall income recognized under its property operating agreements, interest income on notes receivable, replacement rent from an operator, management fee income, and prepayment penalty income.
          Applicable to eight of the Company’s 201 owned real estate properties as of December 31, 2010, property operating agreements between the Company and sponsoring health systems contractually obligate the sponsoring health system to provide to the Company a minimum return on the Company’s investment in the property in exchange for the right to be involved in the operating decisions of the property, including tenancy. If the minimum return is not achieved through normal operations of the property, the Company will calculate and accrue any shortfalls as income that the sponsor is responsible to pay to the Company under the terms of the property operating agreement.
          The Company also receives management fees related to property management services it provides to third parties. Management fees related to the Company’s owned properties are eliminated in consolidation. Management fees are generally calculated, accrued and billed monthly based on a percentage of cash collections of tenant receivables for the month.
          Other operating income for the years ended December 31, 2010, 2009 and 2008 is detailed in the table below:
                         
    Year Ended December 31,  
(Dollars in millions)   2010     2009     2008  
 
Property lease guaranty revenue
  $ 7.5     $ 8.2     $ 12.8  
Interest income on notes receivable
    0.8       0.6       0.6  
Management fee income
    0.2       0.2       0.2  
Replacement rent
          1.3       2.5  
Other
    0.1       0.7       0.2  
     
 
  $ 8.6     $ 11.0     $ 16.3  
     
     Federal Income Taxes
          No provision has been made for federal income taxes. The Company intends at all times to qualify as a real estate investment trust under Sections 856 through 860 of the Internal Revenue Code of 1986 (the “Code”), as amended. The Company must distribute at least 90% per annum of its real estate investment trust taxable income to its stockholders and meet other requirements to continue to qualify as a real estate investment trust. See Note 15 for further discussion.

54


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
          The Company classifies interest and penalties related to uncertain tax positions, if any, in the Consolidated Financial Statements as a component of general and administrative expense. No such amounts were recognized during the three years ended December 31, 2010.
          Federal tax returns for the years 2007, 2008 and 2009 are currently subject to examination by taxing authorities.
     State Income Taxes
          The Company must pay certain state income taxes and the provisions are generally included in general and administrative expense on the Company’s Consolidated Statements of Income. See Note 15 for further discussion.
     Sales and Use Taxes
          The Company must pay sales and use taxes to certain state tax authorities based on rents collected from tenants in properties located in those states. The Company is generally reimbursed for these taxes by the tenant. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis in the Company’s Consolidated Statements of Income.
     Discontinued Operations
          The Company sells properties from time to time due to a variety of factors, such as market conditions or the exercise of purchase options by tenants. The operating results of properties that have been sold or are held for sale are reported as discontinued operations in the Company’s Consolidated Statements of Income. A company must report discontinued operations when a component of an entity has either been disposed of or is deemed to be held for sale if (i) both the operations and cash flows of the component have been or will be eliminated from ongoing operations as a result of the disposal transaction, and (ii) the entity will not have any significant continuing involvement in the operations of the component after the disposal transaction. Long-lived assets held for sale are reported at the lower of their carrying amount or their fair value less cost to sell. Further, depreciation of these assets ceases at the time the assets are classified as discontinued operations. Losses resulting from the sale of such properties are characterized as impairment losses relating to discontinued operations in the Consolidated Statements of Income.
          In the Company’s Consolidated Statements of Income for the years ended December 31, 2010, 2009 and 2008, income related to properties sold or held for sale as of December 31, 2010 was included in discontinued operations for each of the three years totaling approximately $4.2 million, $26.0 million, and $26.4 million, respectively.
          Assets held for sale at December 31, 2010 and 2009 included 11 and six properties, respectively.
     Earnings per Share
          Basic earnings per common share is calculated using weighted average shares outstanding less issued and outstanding but unvested restricted shares of common stock. Diluted earnings per common share is calculated using weighted average shares outstanding plus the dilutive effect of the outstanding stock options from the Employee Stock Purchase Plan and restricted shares of common stock, using the treasury stock method and the average stock price during the period. See Note 13 for the calculations of earnings per share.
     New Accounting Pronouncements
          Accounting Standards Update 2010-20, “Disclosures about the Credit Quality of Financing Receivables and the Allowance for Credit Losses,” (“ASU 2010-20”), issued in July 2010, became effective for the Company as of December 31, 2010. ASU 2010-20 requires new qualitative and quantitative disclosures in the notes to the financial statements relating to a Company’s financing receivables, such as a rollforward of the allowance for credit losses, credit quality information, impaired loan information, modification information and nonaccrual and past due information. The adoption of ASU 2010-20 did not have a material impact on the Company’s Consolidated Financial Statements.

55


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
2. Property Investments
     The Company invests in healthcare-related properties and mortgages located throughout the United States. The Company provides management, leasing and development services, and capital for the construction of new facilities, as well as for the acquisition of existing properties. The Company had investments of approximately $2.6 billion in 209 real estate properties and mortgage notes receivable as of December 31, 2010, excluding assets classified as held for sale and including an investment in one unconsolidated joint venture. The following table summarizes the Company’s investments.
                                                 
                    Buildings,                      
                    Improvements,                      
    Number of             Lease Intangibles     Personal             Accumulated  
(Dollars in thousands)   Facilities (1)     Land     and CIP     Property     Total     Depreciation  
Medical Office:
                                               
California
    7     $ 15,903     $ 81,487     $ 106     $ 97,496     $ (31,865 )
Florida
    14       9,152       127,336       171       136,659       (49,110 )
Hawaii
    3       8,314       98,057       42       106,413       (7,526 )
North Carolina
    14       28       142,845       91       142,964       (12,780 )
Tennessee
    18       6,177       159,691       165       166,033       (46,052 )
Texas
    37       40,521       548,384       1,111       590,016       (87,534 )
Washington
    5       2,200       102,309       1       104,510       (4,553 )
Other states
    47       38,305       575,248       379       613,932       (91,430 )
 
                                   
 
    145       120,600       1,835,357       2,066       1,958,023       (330,850 )
Physician Clinics:
                                               
Florida
    7       9,732       40,674       2       50,408       (14,630 )
Virginia
    3       1,623       29,169       127       30,919       (10,846 )
Other states
    17       5,091       65,544       262       70,897       (17,783 )
 
                                   
 
    27       16,446       135,387       391       152,224       (43,259 )
Surgical Facilities:
                                               
Indiana
    1       1,071       42,335             43,406       (4,885 )
Texas
    4       11,334       123,396       83       134,813       (15,889 )
Other states
    5       5,219       14,399       18       19,636       (7,053 )
 
                                   
 
    10       17,624       180,130       101       197,855       (27,827 )
Specialty Outpatient:
                                               
Alabama
    1             2,698             2,698       (1,042 )
Iowa
    1       180       1,974             2,154       (175 )
Virginia
    1       80       2,353             2,433       (881 )
 
                                   
 
    3       260       7,025             7,285       (2,098 )
Inpatient Rehab:
                                               
Pennsylvania
    6       1,214       112,653             113,867       (40,651 )
Texas
    2       1,623       17,713             19,336       (6,927 )
Other states
    3       3,641       41,795             45,436       (9,649 )
 
                                   
 
    11       6,478       172,161             178,639       (57,227 )
Other:
                                               
California
    1             12,688             12,688       (5,329 )
Virginia
    2       1,178       10,629       5       11,812       (4,314 )
Other states
    2       434       16,517       416       17,367       (6,322 )
 
                                   
 
    5       1,612       39,834       421       41,867       (15,965 )
Land Held for Development
                20,772             20,772       (13 )
Corporate Property
                      14,940       14,940       (7,402 )
 
                                   
Total owned properties
    201       163,020       2,390,666       17,919       2,571,605       (484,641 )
 
                                   
Mortgage notes receivable
    7                         36,599        
Unconsolidated joint venture investment
    1                         1,266        
 
                                   
Total real estate investments
    209     $ 163,020     $ 2,390,666     $ 17,919     $ 2,609,470     $ (484,641 )
 
                                   
 
(1)   Includes three properties under construction.

56


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
3. Real Estate Leases and Mortgage Notes Receivable
     Real Estate Leases
          The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases or are supported through other financial support arrangements with expiration dates through 2029. Some leases and financial arrangements provide for fixed rent renewal terms of five years, or multiples thereof, in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease and for a short period thereafter, with an option or a right of first refusal to purchase the leased property. The Company’s portfolio of master leases generally requires the lessee to pay minimum rent, additional rent based upon fixed percentage increases or increases in the Consumer Price Index and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.
          Future minimum lease payments under the non-cancelable operating leases and guaranteed amounts due to the Company under property operating agreements as of December 31, 2010 are as follows (in thousands):
         
2011
  $ 221,731  
2012
    195,620  
2013
    167,041  
2014
    136,291  
2015
    108,167  
2016 and thereafter
    436,239  
 
     
 
  $ 1,265,089  
 
     
     Customer Concentrations
          The Company’s real estate portfolio is leased to a diverse tenant base. The Company did not have any customers that accounted for 10% or more of the Company’s revenues, including revenues from discontinued operations, for the years ended December 31, 2010 and 2009, and had only one customer that accounted for 10% or more of the Company’s revenues for the year ended December 31, 2008 (HealthSouth at 11%).
     Purchase Option Provisions
          Certain of the Company’s leases include purchase option provisions. The provisions vary from lease to lease but generally allow the lessee to purchase the property covered by the lease at the greater of fair market value or an amount equal to the Company’s gross investment. As of December 31, 2010, the Company had a gross investment of approximately $91.3 million in real estate properties that were subject to outstanding, exercisable contractual options to purchase, with various conditions and terms, that had not been exercised.
     Mortgage Notes Receivable
          The Company had seven mortgage notes receivable outstanding as of December 31, 2010 and four mortgage notes receivable as of December 31, 2009 with aggregate principal balances totaling $36.6 million and $31.0 million, respectively. Five of the mortgage notes outstanding at December 31, 2010 were construction loans and one outstanding at December 31, 2009 was a construction loan. Also, five of the Company’s seven mortgage notes receivable, having an aggregate principal balance of $19.6 million or 54% of the Company’s outstanding loan balances at December 31, 2010, were with Ladco. All of the loans were secured by existing buildings or buildings currently under development.
4. Acquisitions and Dispositions and Mortgage Repayments
     2010 Real Estate and Mortgage Note Acquisitions
          During 2010, the Company acquired the following properties:
    a 68,534 square foot medical office building in Iowa was acquired by the HR Ladco Holdings, LLC joint venture for a total purchase price of approximately $13.8 million. The building was 100% leased at the time of the acquisition with lease expirations through 2017. The Company had provided $9.9 million in mortgage financing on the building prior to the acquisition by the joint venture. Upon acquisition, the mortgage note was refinanced with a permanent mortgage note payable to the Company, which is eliminated in consolidation;

57


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
    a 73,331 square foot medical office building in Ohio, adjacent to a 287-bed acute-care hospital, for a purchase price of approximately $14.5 million. The Company assumed a $4.2 million mortgage note payable with this acquisition, which has a fixed interest rate of 5.53% and matures in 2018. The building was 100% leased at the time of the acquisition, with lease expirations through 2017;
 
    a 134,032 square foot, on-campus medical office building in Indiana for a purchase price of $23.3 million, including a $0.3 million prepaid ground lease payment. The building was 100% leased at the time of the acquisition, with lease expirations through 2020;
 
    two adjacent medical office buildings in Colorado, aggregating 112,155 square feet, for a purchase price of $30.0 million. In the aggregate, the buildings were 89% leased at the time of the acquisition, with lease expirations through 2020. The Company assumed a mortgage note payable related to one of the buildings totaling $15.7 million ($15.2 million with a $0.5 million fair value adjustment) which bears a contractual interest rate of 6.75% and matures in 2013;
 
    five medical office buildings, either on or adjacent to two acute-care hospitals, in Texas for a purchase price of $76.4 million. The portfolio includes 302,094 square feet and was approximately 98% leased at the time of the acquisitions, with lease expirations through 2022. The Company assumed a mortgage note payable related to one of the buildings totaling $4.4 million which bears a contractual interest rate of 5.25% and matures in 2015;
 
    an 80,125 square foot, on-campus medical office building in Colorado for a purchase price of $19.4 million. The building was 94% leased at the time of the acquisition, with lease expirations through 2021; and
 
    two medical office buildings, a 68-bed surgical facility, and two parcels of unimproved land in Texas for a purchase price of $133.5 million. The buildings included an aggregate of approximately 311,710 square feet, including 155,465 square feet in the two medical office buildings, and were 85% leased at the time of the acquisition and with lease expirations through 2027. The properties are located on 23 acres of land, including 4.3 undeveloped acres, providing room for additional expansion.
     Also, during 2010, the Company:
    began funding in January 2010 a $2.7 million loan for the construction of a medical office building in Iowa by Ladco. The Company had funded $2.3 million when it was repaid in August 2010;
 
    began funding in July 2010 to Ladco a $40.0 million loan for the construction of a 48-bed surgical facility in South Dakota. At December 31, 2010, the Company had funded approximately $11.2 million of the loan and expects to fund the remaining $28.8 million in 2011 and 2012. The Company received an origination fee of $0.6 million in conjunction with this loan that will be amortized to mortgage interest income over the term of the loan. As of December 31, 2010, the Company had amortized $0.2 million of the loan origination fee to mortgage interest. At completion, the surgical facility will be operated by Sanford Health under a long-term lease with an option to purchase the facility. Should Sanford Health elect to lease the surgical facility rather than acquire it upon completion, the HR Ladco Holdings, LLC joint venture has the option to acquire the property;
 
    began funding in August 2010 a $12.4 million loan for the construction of a medical office building in Texas. At December 31, 2010, the Company had funded $2.5 million of the loan and expects to fund the remaining $9.9 million in 2011. The Company has the option to acquire the medical office building from the developer 12 months after the building is completed, which is expected to occur by mid-2011;
 
    began funding two mortgage notes receivable in August 2010 totaling $18.4 million to Ladco for the construction of two medical office buildings in Iowa as part of the development of a six-facility outpatient campus. As of December 31, 2010, the Company had funded $4.4 million of the notes and expects to fund the remaining $14.0 million during 2011 and 2012. The Company’s joint venture, HR Ladco Holdings, LLC, will have an option to purchase the two buildings at a fair market value price upon completion and full occupancy. Concurrently, and in conjunction with entering into the two mortgage notes, an existing mortgage note receivable due to the Company totaling $4.3 million was repaid by Ladco Properties XVIII, LLC;
 
    began funding in October 2010 a $2.1 million loan for the construction of a medical office building in Iowa by Ladco. At December 31, 2010, the Company had funded $0.3 million of the loan and expects to fund the remaining $1.8 million during 2011; and

58


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
    funded in November 2010 a $3.7 million loan to Ladco which was secured by a medical office building located in Iowa.
    A summary of the Company’s 2010 acquisitions and financings follows:
                                                         
    Dates                     Mortgage     Mortgage                
    Acquired/Initial     Cash     Real     Note     Notes Payable             Square  
(Dollars in millions)   Fundings     Consideration     Estate     Fundings     Assumed     Other     Footage  
 
Real estate acquisitions (1)
                                                       
Iowa (2)
    3/26/10     $ 2.9     $ 14.7     $     $     $ (11.8 )     68,534  
Ohio
    8/13/10       10.3       14.5             (4.2 )           73,331  
Indiana
    8/27/10       23.5       23.3                   0.2       134,032  
Colorado (3)
    8/31/10       14.8       31.0             (15.7 )     (0.5 )     112,155  
Texas
    9/23/10, 12/29/10       71.6       75.8             (4.4 )     0.2       302,094  
Colorado
    12/17/10       19.1       18.4                   0.7       80,125  
Texas
    12/29/10       134.0       133.8                   0.2       311,710  
                   
 
            276.2       311.5             (24.3 )     (11.0 )     1,081,981  
 
                                                       
Mortgage note financings (4)
                                                       
Iowa (5)
    1/27/10       2.3             2.3                    
South Dakota
    7/26/10       10.6             11.2             (0.6 )      
Texas
    8/02/10       2.5             2.5                    
Iowa
    8/27/10       4.4             4.4                    
Iowa
    10/29/10       0.3             0.3                    
Iowa
    11/23/10       3.7             3.7                    
                   
 
            23.8             24.4             (0.6 )      
                   
Total 2010 acquisitions and financings
          $ 300.0     $ 311.5     $ 24.4     $ (24.3 )   $ (11.6 )     1,081,981  
                   
 
(1)   The Company expensed $1.2 million in transaction costs during 2010 related to these acquisitions.
 
(2)   The Other column includes a $9.9 million mortgage note receivable that was repaid upon acquisition of the property.
 
(3)   The mortgage note payable assumed amount includes a fair value adjustment of $0.5 million.
 
(4)   Amounts in table include fundings through December 31, 2010.
 
(5)   This mortgage note was acquired and subsequently repaid during 2010.
     The following table summarizes the estimated fair values of the assets acquired and liabilities assumed in the real estate acquisitions as of the acquisition date:
                 
    Estimated     Estimated  
    Fair Value     Useful Life  
    (In millions)     (In years)  
Buildings
  $ 291.4       29.0 - 37.0  
Prepaid ground lease
    0.3       75.0  
Mortgage notes payable assumed, including fair value adjustment
    (24.3 )      
Mortgage notes payable repayments
    (9.9 )      
Accounts receivable and other assets assumed
    1.4        
Accounts payable, accrued liabilities and other liabilities assumed
    (3.4 )      
Prorated rent, net of expenses paid
    0.4        
Intangibles:
               
At-market lease intangibles
    20.1       3.0 - 16.4  
Above-market lease intangibles
    1.1       4.6 - 9.1  
Below-market lease intangibles
    (1.4 )     5.3 - 9.3  
Below-market ground lease intangibles
    0.5       75.0  
 
           
Total intangibles
    20.3       115.84  
 
           
 
  $ 276.2          
 
             

59


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
2009 Real Estate and Mortgage Note Acquisitions
    During 2009, the Company acquired the following properties:
    the remaining 50% equity interest in a joint venture (Unico 2006 MOB), which owned a 62,246 square foot on-campus medical office building in Oregon, for approximately $4.4 million in cash consideration. The building was approximately 97% occupied at the time of the acquisition with lease maturities through 2025. In connection with the acquisition, the Company assumed an outstanding mortgage note payable held by the joint venture totaling $12.8 million ($11.7 million including a $1.1 million fair value adjustment) which bears an effective interest rate of 6.43% and matures in 2021. Prior to the acquisition, the Company had a 50% equity investment in the joint venture totaling approximately $1.7 million which it accounted for under the equity method. In connection with the acquisition, the Company re-measured its previously held equity interest at the acquisition-date fair value and recognized a gain on the re-measurement of approximately $2.7 million which was recognized as income;
 
    a 51,903 square foot specialty inpatient facility in Arizona for a purchase price of approximately $15.5 million. The building was 100% occupied at the time of the acquisition by one tenant whose lease expires in 2024;
 
    a medical office building with 146,097 square feet in Indiana for a purchase price of approximately $25.8 million. The building was 100% occupied at the time of the acquisition with lease expiration dates ranging from 2011 to 2021;
 
    four medical office buildings in Iowa, aggregating 155,189 square feet, were acquired by the Company’s consolidated joint venture, HR Ladco Holdings, LLC, in which the Company has an 80% controlling interest, for a total purchase price of approximately $44.6 million. All four buildings were 100% leased at the time of the acquisition with lease expirations ranging from 2010 through 2029. Three of the buildings were constructed by Ladco, and the construction was funded by the Company through a construction loan. Upon the acquisition of the buildings by the joint venture, $30.8 million of the Company’s construction loan was converted to a permanent mortgage note payable to the Company, which is eliminated in consolidation, with the remaining balance of the construction loan of $5.0 million added to the Company’s equity investment in the joint venture; and
 
    a mortgage note receivable was originated for $9.9 million in connection with a medical office building in Iowa.
    A summary of the Company’s 2009 acquisitions follows:
                                                         
                            Mortgage     Mortgage                
    Dates     Cash     Real     Note     Notes Payable             Square  
(Dollars in millions)   Acquired     Consideration     Estate     Financing     Assumed     Other     Footage  
Real estate acquisitions
                                                       
Oregon (1)
    1/16/09     $ 4.4     $ 20.5     $     $ (11.7 )   $ (4.4 )     62,246  
Arizona
    10/20/09       16.0       16.0                         51,903  
Indiana
    12/18/09       28.2       26.0                   2.2       146,097  
Iowa
    2/23/09, 7/16/09       6.8       43.9       (35.7 )           (1.4 )     155,189  
 
    7/23/09, 12/8/09                                                  
 
                                           
 
            55.4       106.4       (35.7 )     (11.7 )     (3.6 )     415,435  
 
                                                       
Mortgage note financings
                                                       
Iowa
    12/30/09       9.9             9.9                    
 
                                           
 
                                                       
Total 2009 acquisitions and financings
          $ 65.3     $ 106.4     $ (25.8 )   $ (11.7 )   $ (3.6 )     415,435  
 
                                           
 
(1)   The mortgage notes payable assumed in the Oregon acquisition reflects a fair value adjustment of $1.1 million recorded by the Company upon acquisition.
     The Company assigned $8.2 million to real estate lease intangible assets, net of ground lease intangible liabilities, related to its 2009 acquisitions with amortization periods ranging from 7.3 years to 75 years.

60


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
     2010 Real Estate Dispositions and Mortgage Repayments
    During 2010, the Company disposed of the following properties:
    five medical office buildings in Virginia in which the Company had an aggregate gross investment of approximately $23.9 million ($16.0 million, net) were sold pursuant to purchase options in its leases with one operator. The Company received approximately $19.6 million in net proceeds and $0.8 million in lease termination fees. The Company recognized a gain on sale of approximately $2.7 million, net of receivables collected and straight-line rent receivables written off;
 
    a 14,563 square foot specialty outpatient facility in Florida in which the Company had a gross investment of $3.4 million ($2.4 million, net) was sold for approximately $4.0 million in net proceeds. The Company recognized a gain on sale of $1.5 million, net of straight-line rent receivables written off;
 
    a 25,000 square foot ambulatory surgery center in Florida in which the Company had an aggregate gross investment of $6.1 million ($5.0 million, net) was sold for approximately $9.7 million in net proceeds. The Company recognized a gain on sale of $4.1 million, net of straight-line rent receivables written off;
 
    an 11,963 square foot specialty outpatient facility in Arkansas in which the Company had a gross investment of approximately $2.1 million ($1.0 million, net) was sold for approximately $1.0 million in net proceeds. The Company recognized an immaterial gain on the disposition; and
 
    a 15,474 square foot physician clinic in Georgia in which the Company had a gross investment of approximately $1.6 million ($0.9 million, net) was sold for approximately $0.2 million in net proceeds. The Company also received $0.7 million in insurance proceeds to repair flood damage to the building. The Company recorded an immaterial gain on the disposition.
    Also, during 2010, three mortgage notes receivable totaling approximately $8.5 million were repaid.
 
    A summary of the Company’s 2010 dispositions follows:
                                                 
            Net Real     Other     Mortgage                
    Net     Estate     (Including     Notes             Square  
(Dollars in millions)   Proceeds     Investment     Receivables)     Receivable     Gain     Footage  
 
Real estate dispositions
                                               
Virginia
  $ 19.6     $ 16.0     $ 0.9     $     $ 2.7       222,045  
Florida
    4.0       2.4       0.1             1.5       14,563  
Florida
    9.7       5.0       0.6             4.1       25,000  
Arkansas
    1.0       1.0       (0.1 )           0.1       11,963  
Georgia
    0.2       0.9       (0.7 )                 15,474  
           
 
    34.5       25.3       0.8             8.4       289,045  
 
                                               
Mortgage note repayments
    8.5                   8.5              
           
 
                                               
Total 2010 dispositions and repayments
  $ 43.0     $ 25.3     $ 0.8     $ 8.5     $ 8.4       289,045  
           
     2009 Real Estate Dispositions and Mortgage Repayments
    During 2009, the Company disposed of the following properties:
    an 11,538 square foot medical office building in Florida in which the Company had a total gross investment of approximately $1.4 million ($1.0 million, net) was sold for approximately $1.4 million in net proceeds, and the Company recognized a $0.4 million net gain on the sale;
 
    a 139,647 square foot medical office building in Wyoming to the sponsor for $21.4 million. During 2008, the Company received a $2.4 million deposit from the sponsor on the sale and received a $7.2 million termination fee from the sponsor in accordance with its financial support agreement with the Company. In 2009, the Company received the remaining consideration of approximately $19.0 million (plus $0.2 million of interest). The Company had an aggregate investment of approximately $20.0 million ($15.8 million, net) in the medical office building and recognized a gain on sale of approximately $5.6 million;

61


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
    the Company’s membership interests in an entity which owns an 86,942 square foot medical office building in Washington. The Company acquired the entity in December 2008 and had an aggregate and net investment of approximately $10.7 million. The Company received approximately $5.3 million in net proceeds, and the purchaser assumed the mortgage note secured by the property of approximately $5.4 million. The Company recognized an insignificant impairment charge on the disposition related to closing costs;
 
    a 198,064 square foot medical office building in Nevada in which the Company had a gross investment of approximately $46.8 million ($32.7 million, net) was sold for approximately $38.0 million in net proceeds, and the Company concurrently paid off a $19.5 million mortgage note secured by the property. The Company recognized a gain on sale of approximately $6.5 million, net of liabilities of $1.2 million;
 
    a 113,555 square foot specialty inpatient facility in Michigan in which the Company had a gross investment of approximately $13.9 million ($10.8 million, net) was sold for approximately $18.5 million in net proceeds, and the Company recognized a gain on sale of approximately $7.5 million, net of liabilities of $0.2 million;
 
    a 10,255 square foot ambulatory surgery center in Florida in which the Company had a gross investment of approximately $3.4 million ($2.0 million, net) was sold for approximately $0.5 million in net cash proceeds and title to a land parcel adjoining another medical office building owned by the Company valued at $1.5 million. The Company recognized no gain on the transaction; and
 
    an 8,243 square foot physician clinic in Virginia in which the Company had a gross investment of approximately $0.7 million ($0.5 million, net) was sold for approximately $0.6 million in net proceeds, and the Company recognized a gain on sale of approximately $0.1 million.
          During 2009, one mortgage note receivable totaling approximately $12.6 million was repaid. This mortgage note, which provided financing for the construction of a building in Iowa, was repaid upon acquisition of the building by a third party.
          A summary of the Company’s 2009 dispositions follows:
                                                 
            Net Real     Other     Mortgage              
    Net     Estate     (Including     Note     Gain/     Square  
(Dollars in millions)   Proceeds     Investment     Receivables)     Receivable     (Loss)     Footage  
 
Real estate dispositions
                                               
Florida
  $ 1.4     $ 1.0     $     $     $ 0.4       11,538  
Wyoming (1)
    21.4       15.8                   5.6       139,647  
Washington
    5.3       10.7       (5.4 )                 86,942  
Nevada
    38.0       32.7       (1.2 )           6.5       198,064  
Michigan
    18.5       10.8       0.2             7.5       113,555  
Florida
    0.5       0.5                         10,255  
Virginia
    0.6       0.5                   0.1       8,243  
           
 
    85.7       72.0       (6.4 )           20.1       568,244  
 
Mortgage note repayments
    12.6                   12.6              
           
Total 2009 dispositions and repayments
  $ 98.3     $ 72.0     $ (6.4 )   $ 12.6     $ 20.1       568,244  
           
 
(1)   Net proceeds include $2.4 million in proceeds received in 2008 as a deposit for the Wyoming property sale.
     2011 Acquisition
          In January 2011, the Company originated with Ladco a $40.0 million mortgage loan that is secured by a multi-tenanted office building located in Iowa that was 94% leased at the time the mortgage was originated. The mortgage loan requires interest only payments through maturity, has a stated fixed interest rate and matures in January 2014.

62


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
     2011 Dispositions
          In January 2011, the Company disposed of a medical office building located in Maryland that was previously classified as held for sale and in which the Company had a $3.5 million net investment at December 31, 2010. The Company received approximately $3.4 million in net proceeds, net of expenses incurred at the time of the closing.
          In February 2011, the Company disposed of a physician clinic located in Florida that was previously classified as held for sale and in which the Company had a $3.1 million net investment at December 31, 2010. The Company received approximately $3.1 million in consideration on the sale.
     2011 Potential Dispositions
          During 2010, the Company received notice from a tenant of its intent to purchase six skilled nursing facilities in Michigan and Indiana pursuant to purchase options contained in its leases with the Company. The Company’s aggregate net investment in the buildings, which were classified as held for sale upon receiving notice of the purchase option exercise, was approximately $8.2 million at December 31, 2010. The aggregate purchase price for the properties is expected to be approximately $17.3 million, resulting in a net gain of approximately $9.1 million. The Company expects the sale to occur during the third quarter of 2011.
5. Discontinued Operations
          Assets and liabilities of properties sold or to be sold are classified as held for sale, to the extent not sold, on the Company’s Consolidated Balance Sheets, and the results of operations of such properties are included in discontinued operations on the Company’s Consolidated Statements of Income for all periods presented. Properties classified as held for sale at December 31, 2010 include the properties discussed in “2011 Potential Dispositions” in Note 4, as well as five other properties the Company had decided to sell.
          The tables below reflect the assets and liabilities of the properties classified as held for sale and discontinued operations as of December 31, 2010 and the results of operations of the properties included in discontinued operations on the Company’s Consolidated Statements of Income for the years ended December 31, 2010, 2009 and 2008.
                 
    December 31,  
(Dollars in thousands)   2010     2009  
Balance Sheet data (as of the period ended):
               
Land
  $ 7,099     $ 3,374  
Buildings, improvements and lease intangibles
    35,424       22,178  
Personal property
    429        
 
           
 
    42,952       25,552  
Accumulated depreciation
    (19,447 )     (8,697 )
 
           
Assets held for sale, net
    23,505       16,855  
 
               
Other assets, net (including receivables)
    410       890  
 
           
Assets of discontinued operations, net
    410       890  
 
               
Assets held for sale and discontinued operations, net
  $ 23,915     $ 17,745  
 
           
 
               
Accounts payable and accrued liabilities
  $ 229     $  
Other liabilities
    194       251  
 
           
Liabilities of discontinued operations
  $ 423     $ 251  
 
           

63


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
                         
    Year Ended December 31,  
(Dollars in thousands, except per share data)   2010     2009     2008  
Statements of Income data (for the period ended):
                       
Revenues (1)
                       
Master lease rent
  $ 4,230     $ 8,551     $ 12,488  
Property operating
    2,307       3,003       9,998  
Straight-line rent
    (37 )     (127 )     (74 )
Other operating
    1       223       8,017  
 
                 
 
    6,501       11,650       30,429  
 
                       
Expenses (2)
                       
General and administrative
    12       14       (27 )
Property operating
    2,231       2,862       6,394  
Other operating
    (135 )            
Bad debt, net
    20       (18 )     652  
Depreciation
    1,211       2,640       3,919  
Amortization
                25  
 
                 
 
    3,339       5,498       10,963  
 
                       
Other Income (Expense) (3)
                       
Interest expense
          (667 )     (2,009 )
Interest and other income, net
    223       359       26  
 
                 
 
    223       (308 )     (1,983 )
 
                       
Income from Discontinued Operations
    3,385       5,844       17,483  
 
Impairments (4)
    (7,511 )     (22 )     (886 )
Gain on sales of real estate properties (5)
    8,352       20,136       9,843  
 
                 
 
                       
Income from Discontinued Operations
  $ 4,226     $ 25,958     $ 26,440  
 
                 
 
                       
Income from Discontinued Operations per common share — basic
  $ 0.07     $ 0.45     $ 0.51  
 
                 
 
                       
Income from Discontinued Operations per common share — diluted
  $ 0.07     $ 0.44     $ 0.50  
 
                 
 
(1)   Total revenues for the years ended December 31, 2010, 2009 and 2008 included $1.6 million, $6.9 million and $25.8 million (including a $7.2 million fee received from an operator to terminate its financial support agreement with the Company), respectively, related to properties sold; and $4.9 million, $4.8 million and $4.6 million, respectively, related to 11 properties held for sale at December 31, 2010.
 
(2)   Total expenses for the years ended December 31, 2010, 2009 and 2008 included $0.4 million, $2.4 million and $7.8 million, respectively, related to properties sold; and $2.9 million, $3.1 million and $3.2 million, respectively, related to 11 properties held for sale at December 31, 2010.
 
(3)   Other income (expense) for the year ended December 31, 2010 included income of $0.2 million related to properties held for sale and the years ended December 31, 2009 and 2008 included net expenses of $0.3 million and $2.0 million, respectively, related to properties sold.
 
(4)   Impairments for the year ended December 31, 2010 included $1.0 million related to one property sold and $6.5 million related to five properties held for sale; December 31, 2009 included approximately $22,000 related to one property sold; and December 31, 2008 included $0.6 million related to one property held for sale and $0.3 million related to three properties sold.
 
(5)   Gain on sales of real estate properties for the years ended December 31, 2010, 2009 and 2008 included gains on the sale of eight, six and six properties, respectively.
6. Impairment Charges
          A Company must assess the potential for impairment of its long-lived assets, including real estate properties, whenever events occur or there is a change in circumstances, such as the sale of a property or the decision to sell a property, that indicate that the recorded value might not be fully recoverable. An asset is impaired when undiscounted cash flows expected to be generated by the asset are less than the carrying value of the asset.
          The Company recorded impairment charges on properties sold or classified as held for sale, which are included in discontinued operations, for the years ended December 31, 2010, 2009 and 2008 totaling $7.5 million, $22,000 and $0.9 million, respectively.

64


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
          The Company also recorded an impairment charge, which is included in continuing operations, for the year ended December 31, 2008 of $1.6 million related to changes in management’s estimate of fair value and collectibility of patient receivables assigned to the Company in late 2005, resulting from a lease termination and debt restructuring of a physician clinic owned by the Company.
          Both level 2 and level 3 fair value techniques were used to derive these impairment charges. Executed purchase and sale agreements, since they are binding agreements, are categorized as level 2. Brokerage estimates, letters of intent, or unexecuted purchase and sale agreements are considered to be level 3 as they are nonbinding in nature.
7. Other Assets
          Other assets consist primarily of straight-line rent receivables, prepaids, intangible assets, and receivables. Items included in other assets on the Company’s Consolidated Balance Sheets as of December 31, 2010 and 2009 are detailed in the table below.
                 
    December 31,  
(Dollars in millions)   2010     2009  
Prepaid assets
  $ 27.9     $ 24.7  
Straight-line rent receivables
    27.0       25.2  
Above-market intangible assets, net
    13.4       12.0  
Deferred financing costs, net
    12.0       12.1  
Accounts receivable
    6.1       9.0  
Notes receivable
    3.8       3.3  
Goodwill
    3.5       3.5  
Equity investment in joint venture — cost method
    1.3       1.3  
Customer relationship intangible assets, net
    1.2       1.2  
Allowance for uncollectible accounts
    (1.2 )     (3.7 )
Other
    1.5       0.9  
 
           
 
  $ 96.5     $ 89.5  
 
           
     Equity Investments in Joint Ventures
          At December 31, 2010 and 2009, the Company had an investment in an unconsolidated joint venture, which had investments in real estate properties. In January 2009, the Company acquired the remaining membership interest in one of its joint ventures previously accounted for under the equity method. The Company accounts for its remaining joint venture investment under the cost method. The Company recognized income related to the joint venture accounted for under the cost method of approximately $0.1 million, $0.3 million and $0.7 million, respectively, for the years ended December 31, 2010, 2009 and 2008. The Company’s net investments in the joint ventures are included in other assets on the Company’s Consolidated Balance Sheets, and the related income or loss is included in interest and other income, net on the Company’s Consolidated Statements of Income. The table below details the Company’s investments in its unconsolidated joint ventures.
                         
    December 31,  
(Dollars in thousands)   2010     2009     2008  
Net joint venture investments, beginning of year
  $ 1,266     $ 2,784     $ 18,356  
Equity in income (losses) recognized during the year
          (2 )     1,021  
Acquisition of remaining equity interest in a joint venture
          (1,700 )     (10,165 )
Partial redemption of preferred equity investment in an unconsolidated joint venture
                (5,546 )
Additional investment in a joint venture
          184        
Distributions received during the year
                (882 )
 
                 
Net joint venture investments, end of year
  $ 1,266     $ 1,266     $ 2,784  
 
                 

65


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
8. Intangible Assets and Liabilities
          The Company has several types of intangible assets and liabilities included in its Consolidated Balance Sheets, including goodwill, deferred financing costs, above-, below-, and at-market lease intangibles, and customer relationship intangibles. The Company’s intangible assets and liabilities as of December 31, 2010 and 2009 consisted of the following:
                                                 
    Gross     Accumulated              
    Balance at     Amortization     Weighted        
    December 31,     at December 31,     Avg. Life     Balance Sheet  
(Dollars in millions)   2010     2009     2010     2009     (Years)     Classification  
Goodwill
  $ 3.5     $ 3.5     $     $       N/A     Other assets
Deferred financing costs
    20.7       17.1       8.7       5.0       5.3     Other assets
Above-market lease intangibles
    14.6       12.8       1.2       0.8       58.4     Other assets
Customer relationship intangibles
    1.4       1.4       0.2       0.2       32.6     Other assets
Below-market lease intangibles
    (8.8 )     (7.2 )     (2.9 )     (1.8 )     11.5     Other liabilities
At-market lease intangibles
    93.0       72.9       49.0       43.7       8.4     Real estate properties
 
                                     
 
  $ 124.4     $ 100.5     $ 56.2     $ 47.9       18.6          
 
                                     
          Amortization of the Company’s intangible assets and liabilities, in place as of December 31, 2010, is expected to be approximately $9.9 million, $9.0 million, $6.4 million, $5.9 million, and $4.8 million, respectively, for the years ended December 31, 2011 through 2015.
9. Notes and Bonds Payable
          The table below details the Company’s notes and bonds payable.
                 
    December 31,  
(Dollars in thousands)   2010     2009  
Unsecured Credit Facility due 2012
  $     $ 50,000  
Senior Notes due 2011, including premium
    278,311       286,655  
Senior Notes due 2014, net of discount
    264,227       264,090  
Senior Notes due 2017, net of discount
    298,218       297,988  
Senior Notes due 2021, net of discount
    396,812        
Mortgage notes payable, net of discount and including premiums
    170,287       147,689  
 
           
 
  $ 1,407,855     $ 1,046,422  
 
           
          The Company’s various debt agreements contain certain representations, warranties, and financial and other covenants customary in such loan agreements. Among other things, these provisions require the Company to maintain certain financial ratios and minimum tangible net worth and impose certain limits on the Company’s ability to incur indebtedness and create liens or encumbrances. At December 31, 2010, the Company was in compliance with its financial covenant provisions under its various debt instruments.
     Unsecured Credit Facility due 2012
          On September 30, 2009, the Company entered into an amended and restated $550.0 million unsecured credit facility (the “Unsecured Credit Facility”) with a syndicate of 16 lenders that matures on September 30, 2012. Amounts outstanding under the Unsecured Credit Facility bear interest at a rate equal to (x) LIBOR or the base rate (defined as the highest of (i) the Federal Funds Rate plus 0.5%; (ii) the Bank of America prime rate and (iii) LIBOR) plus (y) a margin ranging from 2.15% to 3.20% (2.80% at December 31, 2010) for LIBOR-based loans and 0.90% to 1.95% (1.55% at December 31, 2010) for base rate loans, based upon the Company’s unsecured debt ratings. In addition, the Company pays a facility fee per annum on the aggregate amount of commitments. The facility fee is 0.40% per annum, unless the Company’s credit rating falls below a BBB-/Baa3, at which point the facility fee would be 0.50%. At December 31, 2009, the Company had $50.0 million outstanding under the facility with a weighted average interest rate of approximately 3.03% At December 31, 2010, the Company had no borrowings outstanding under the facility and had borrowing capacity remaining, under its financial covenants, of approximately $550.0 million.

66


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
     Senior Notes due 2011
          In 2001, the Company publicly issued $300.0 million of unsecured senior notes due 2011 (the “Senior Notes due 2011”). The Senior Notes due 2011 bear interest at 8.125%, payable semi-annually on May 1 and November 1, and are due on May 1, 2011, unless redeemed earlier by the Company. The Company repurchased $13.7 million during 2008 and $8.1 million during 2010 of the Senior Notes due 2011. The notes were originally issued at a discount of approximately $1.5 million, which yielded an 8.202% interest rate per annum upon issuance. The original discount is combined with the premium resulting from the termination of interest rate swaps in 2006 that were entered into to offset changes in the fair value of $125.0 million of the notes. The net premium is combined with the principal balance of the Senior Notes due 2011 on the Company’s Consolidated Balance Sheets and is being amortized against interest expense over the remaining term of the notes yielding an effective interest rate on the notes of 7.896%. For each of the years ended December 31, 2010, 2009 and 2008, the Company amortized approximately $0.3 million, $0.2 million and $0.2 million, respectively, of the net premium which is included in interest expense on the Company’s Consolidated Statements of Income. The following table reconciles the balance of the Senior Notes due 2011 on the Company’s Consolidated Balance Sheets as of December 31, 2010 and 2009.
                 
    December 31,  
(Dollars in thousands)   2010     2009  
Senior Notes due 2011 face value
  $ 278,221     $ 286,300  
Unamortized net gain (net of discount)
    90       355  
 
           
Senior Notes due 2011 carrying amount
  $ 278,311     $ 286,655  
 
           
          On February 17, 2011, the Company’s Board of Directors approved the redemption prior to maturity of all of the outstanding Senior Notes Due 2011. The terms of the notes and the related indenture require the Company to pay upon redemption an aggregate of $289.4 million to the holders of the notes consisting of: a) $278.2 million in outstanding principal; b) $9.3 million in interest accrued but not yet paid as of the redemption date; and c) $1.9 million in accordance with the “make-whole” provisions of the indenture, which is approximately equal to the interest that would otherwise be due through the stated maturity date. A formal notice of redemption is being sent separately to the affected holders of the Senior Notes Due 2011 in accordance with the terms of the indenture. The Company intends to redeem these notes on March 28, 2011. The Company will use cash on hand and the Unsecured Credit Facility to fund the redemption and expects to record a one-time charge of approximately $1.9 million in the first quarter of 2011 for early extinguishment of debt. As a result of the redemption, all interest expense for 2011 related to these notes will be recognized in the first quarter of 2011.
     Senior Notes due 2014
          In 2004, the Company publicly issued $300.0 million of unsecured senior notes due 2014 (the “Senior Notes due 2014”). The Senior Notes due 2014 bear interest at 5.125%, payable semi-annually on April 1 and October 1, and are due on April 1, 2014, unless redeemed earlier by the Company. During 2008, the Company repurchased approximately $35.3 million of the Senior Notes due 2014. The notes were issued at a discount of approximately $1.5 million, which yielded a 5.19% interest rate per annum upon issuance. For each of the years ended December 31, 2010, 2009 and 2008, the Company amortized approximately $0.1 million of the discount which is included in interest expense on the Company’s Consolidated Statements of Income. The following table reconciles the balance of the Senior Notes due 2014 on the Company’s Consolidated Balance Sheets as of December 31, 2010 and 2009.
                 
    December 31,  
(Dollars in thousands)   2010     2009  
Senior Notes due 2014 face value
  $ 264,737     $ 264,737  
Unaccreted discount
    (510 )     (647 )
 
           
Senior Notes due 2014 carrying amount
  $ 264,227     $ 264,090  
 
           
     Senior Notes due 2011 and 2014 Repurchases
          During 2010, the Company repurchased $8.1 million of the Senior Notes due 2011, amortized a pro-rata portion of the premium related to the notes and recognized a net loss of $0.5 million. During 2008, the Company repurchased $13.7 million of the Senior Notes due 2011 and $35.3 million of the Senior Notes due 2014, amortized a pro-rata portion of the premium or discount related to the notes and recognized a net gain of $4.1 million. The Company may elect, from time to time, to repurchase and retire its notes when market conditions are appropriate.

67


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
     Senior Notes due 2017
          On December 4, 2009, the Company publicly issued $300.0 million of unsecured senior notes due 2017 (the “Senior Notes due 2017”). The Senior Notes due 2017 bear interest at 6.50%, payable semi-annually on January 17 and July 17, and are due on January 17, 2017, unless redeemed earlier by the Company. The notes were issued at a discount of approximately $2.0 million, which yielded a 6.618% interest rate per annum upon issuance. For each of the years ended December 31, 2010 and 2009, the Company amortized approximately $0.2 million and $19,000, respectively, of the discount which is included in interest expense on the Company’s Consolidated Statements of Income. The following table reconciles the balance of the Senior Notes due 2017 on the Company’s Consolidated Balance Sheets as of December 31, 2010.
                 
    December 31,  
(Dollars in thousands)   2010     2009  
Senior Notes due 2017 face value
  $ 300,000     $ 300,000  
Unaccreted discount
    (1,782 )     (2,012 )
 
           
Senior Notes due 2017 carrying amount
  $ 298,218     $ 297,988  
 
           
     Senior Notes due 2021
          On December 13, 2010, the Company publicly issued $400.0 million of unsecured senior notes due 2021 (the “Senior Notes due 2021”). The Senior Notes due 2021 bear interest at 5.75%, payable semi-annually on January 15 and July 15, beginning July 15, 2011, and are due on January 15, 2021, unless redeemed earlier by the Company. The notes were issued at a discount of approximately $3.2 million, which yielded a 5.855% interest rate per annum upon issuance. For the year ended December 31, 2010, the Company amortized approximately $12,000 of the discount which is included in interest expense on the Company’s Consolidated Statement of Income. The following table reconciles the balance of the Senior Notes due 2021 on the Company’s Consolidated Balance Sheet as of December 31, 2010.
         
    December 31,  
(Dollars in thousands)   2010  
Senior Notes due 2021 face value
  $ 400,000  
Unaccreted discount
    (3,188 )
 
     
Senior Notes due 2021 carrying amount
  $ 396,812  
 
     
     Mortgage Notes Payable
          The following table reconciles the Company’s aggregate mortgage notes principal balance with the Company’s Consolidated Balance Sheets.
                 
    December 31,  
(Dollars in thousands)   2010     2009  
Mortgage notes payable principal balance
  $ 176,638     $ 155,355  
Unaccreted discount, net
    (6,351 )     (7,666 )
 
           
Mortgage notes payable carrying amount
  $ 170,287     $ 147,689  
 
           

68


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
          The following table details the Company’s mortgage notes payable, with related collateral.
                                                                 
                                            Investment in        
            Effective             Number             Collateral at     Balance at
    Original     Interest     Maturity     of Notes             December 31,     December 31,
(Dollars in millions)   Balance     Rate (13)     Date     Payable (14)     Collateral (15)     2010     2010     2009  
Life Insurance Co. (1)
  $ 4.7       7.765 %     1/17       1     MOB   $ 11.4     $ 2.2     $ 2.5  
Commercial Bank (2)
    1.8       5.550 %     10/30       1     OTH     7.9       1.7       1.7  
Life Insurance Co. (3)
    15.1       5.490 %     1/16       1     MOB     32.5       13.5       13.9  
Commercial Bank (4)
    17.4       6.480 %     5/15       1     MOB     19.9       14.5       14.4  
Commercial Bank (5)
    12.0       6.110 %     7/15       1     2 MOBs     19.5       9.7       9.7  
Commercial Bank (6)
    15.2       7.650 %     7/20       1     MOB     20.1       12.8       12.8  
Life Insurance Co. (7)
    1.5       6.810 %     7/16       1     SOP     2.2       1.2       1.2  
Commercial Bank (8)
    12.9       6.430 %     2/21       1     MOB     20.6       11.5       11.6  
Investment Fund (9)
    80.0       7.250 %     12/16       1     15 MOBs     153.9       79.2       79.9  
Life Insurance Co. (10)
    7.0       5.530 %     1/18       1     MOB     14.5       4.0        
Investment Co. (11)
    15.9       6.550 %     4/13       1     MOB     23.3       15.6        
Investment Co. (12)
    4.6       5.250 %     9/15       1     MOB     6.9       4.4        
                                           
 
                            12             $ 332.7     $ 170.3     $ 147.7  
                                           
 
(1)   Payable in monthly installments of principal and interest based on a 20-year amortization with the final payment due at maturity.
 
(2)   Payable in monthly installments of principal and interest based on a 27-year amortization with the final payment due at maturity.
 
(3)   Payable in monthly installments of principal and interest based on a 10-year amortization with the final payment due at maturity.
 
(4)   Payable in monthly installments of principal and interest based on a 10-year amortization with the final payment due at maturity. The Company recorded a $2.7 million discount on this note upon acquisition which is included in the balance above.
 
(5)   Payable in monthly installments of principal and interest based on a 10-year amortization with the final payment due at maturity. The Company recorded a $2.1 million discount on this note upon acquisition which is included in the balance above.
 
(6)   Payable in monthly installments of interest only for 24 months and then installments of principal and interest based on an 11-year amortization with the final payment due at maturity. The Company recorded a $2.4 million discount on this note upon acquisition which is included in the balance above.
 
(7)   Payable in monthly installments of principal and interest based on a 9-year amortization with the final payment due at maturity. The Company recorded a $0.2 million discount on this note upon acquisition which is included in the balance above.
 
(8)   Payable in monthly installments of principal and interest based on a 12-year amortization with the final payment due at maturity. The Company recorded a $1.0 million discount on this note upon acquisition which is included in the balance above.
 
(9)   Payable in monthly installments of principal and interest based on a 30-year amortization with a 7-year initial term (maturity 12/01/16) and the option to extend the initial term for two, one-year floating rate extension terms.
 
(10)   Payable in monthly installments of principal and interest based on a 15-year amortization with the final payment due at maturity. The Company acquired this mortgage note in an acquisition during the third quarter 2010.
 
(11)   Payable in monthly installments of principal and interest based on a 30-year amortization with the option to extend for three years at a fixed rate of 6.75%. The Company recorded a $0.5 million premium on this note upon acquisition which is included in the balance above.
 
(12)   Payable in monthly installments of principal and interest with a balloon payment of $4.0 million due at maturity.
 
(13)   The contractual interest rates for the nine outstanding mortgage notes ranged from 5.00% to 7.625% at December 31, 2010.
 
(14)   Number of mortgage notes payable outstanding at December 31, 2010.
 
(15)   MOB-Medical office building; SOP-Specialty outpatient; OTH-Other.

69


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Other Long-Term Debt Information
          Future maturities of the Company’s notes and bonds payable as of December 31, 2010 were as follows:
                                 
    Principal     Net Accretion/     Notes and        
(Dollars in thousands)   Maturities     Amortization (1)     Bonds Payable     %  
2011
  $ 281,502     $ (1,331 )   $ 280,171       19.9 %
2012
    3,491       (1,508 )     1,983       0.2 %
2013
    18,284       (1,738 )     16,546       1.2 %
2014
    268,460       (1,785 )     266,675       18.9 %
2015
    32,632       (1,443 )     31,189       2.2 %
2016 and thereafter
    815,227       (3,936 )     811,291       57.6 %
 
                       
 
                               
 
  $ 1,419,596     $ (11,741 )   $ 1,407,855       100.0 %
 
                       
 
(1)   Includes discount and premium amortization related to the Company’s Senior Notes due 2011, Senior Notes due 2014, Senior Notes due 2017, Senior Notes due 2021, and six mortgage notes payable.
10. Stockholders’ Equity
     Common Stock
          The Company had no preferred shares outstanding and had common shares outstanding for the three years ended December 31, 2010 as follows:
                         
    Year Ended December 31,  
    2010     2009     2008  
Balance, beginning of year
    60,614,931       59,246,284       50,691,331  
Issuance of stock
    5,287,098       1,244,914       8,373,014  
Restricted stock-based awards, net of forfeitures
    169,395       123,733       181,939  
 
                 
Balance, end of year
    66,071,424       60,614,931       59,246,284  
 
                 
     At-The-Market Equity Offering Program
          Since December 31, 2008, the Company has had in place an at-the-market equity offering program to sell shares of the Company’s common stock from time to time in at-the-market sales transactions. During 2010, the Company sold 5,258,700 shares of common stock under this program at prices ranging from $20.23 per share to $25.16 per share, generating approximately $117.7 million in net proceeds, and during 2009 sold 1,201,600 shares of common stock at prices ranging from $21.62 per share to $22.50 per share, generating approximately $25.7 million in net proceeds.
          During January 2011, the Company sold an additional 1,056,678 shares of common stock under this program for net proceeds totaling approximately $21.6 million, resulting in 2,383,322 authorized shares remaining to be sold under the program.
     Dividends Declared
          During 2010, the Company declared and paid quarterly common stock dividends in the amounts of $0.30 per share.
          On February 1, 2011, the Company declared a quarterly common stock dividend in the amount of $0.30 per share payable on March 3, 2011 to stockholders of record on February 17, 2011.
     Authorization to Repurchase Common Stock
          In 2006, the Company’s Board of Directors authorized management to repurchase up to 3,000,000 shares of the Company’s common stock. As of December 31, 2010, the Company had not repurchased any shares under this authorization. The Company may

70


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
elect, from time to time, to repurchase shares either when market conditions are appropriate or as a means to reinvest excess cash flows. Such purchases, if any, may be made either in the open market or through privately negotiated transactions.
     Accumulated Other Comprehensive Loss
          During the year ended December 31, 2010, the Company recorded a $0.7 million increase to future benefit obligations related to its pension plans, resulting in an increase to other liabilities, with an offset to accumulated other comprehensive loss which is included in stockholders’ equity on the Company’s Consolidated Balance Sheet. The future benefit obligation reflects an overall reduction, resulting in a decrease to other liabilities, due to the settlement and payout of benefits in 2010, totaling approximately $2.6 million, to the outside directors upon termination in late 2009 of the retirement plan for the directors. For the year ended December 31, 2009, the Company recorded $1.9 million reduction to future benefit obligations related to its pension plans, resulting in a decrease to other liabilities, with an offset to accumulated other comprehensive loss, included in stockholders’ equity, on the Company’s Consolidated Balance Sheet. The reduction to the benefit obligation is primarily due to the one-time cash payment of $2.3 million in January 2009 to its chief executive officer resulting from the curtailment and partial settlement of his future pension benefit.
11. Benefit Plans
     Executive Retirement Plan
          The Company has an Executive Retirement Plan, under which certain officers designated by the Compensation Committee of the Board of Directors may receive upon normal retirement (defined to be when the officer reaches age 65 and has completed five years of service with the Company) an amount equal to 60% of the officer’s final average earnings (defined as the average of the executive’s highest three years’ earnings) plus 6% of final average earnings multiplied by the years of service after age 60 (but not more than five years), less 100% of certain other retirement benefits received by the officer to be paid either in lump sum or in monthly installments over a period not to exceed the greater of the life of the retired officer or his surviving spouse.
          In December 2008, the Company froze the maximum annual benefits payable under the plan at $896,000 as a cost savings measure. This revision resulted in a curtailment of benefits under the retirement plan for the Company’s chief executive officer. In consideration of the curtailment and as partial settlement of benefits under the retirement plan, the Company paid a one-time cash payment of $2.3 million to its chief executive officer in January 2009. Also, in connection with the partial settlement, the chief executive officer agreed to receive his remaining retirement benefits under the plan in installment payments upon retirement, rather than in a lump sum. Of the two remaining officers in the plan, one has elected to receive their benefits in monthly installments and one has elected a lump sum payment upon retirement.
          At December 31, 2010, only the Company’s chief executive officer was eligible to retire under the plan. Upon retirement, the chief executive officer will be paid in annual installments of approximately $0.9 million, increasing annually based on CPI. The Company also has one other officer to whom it is currently making benefit payments of approximately $84,000 per year that retired under the plan.
          Also, in November 2008, an officer and participant in the Executive Retirement Plan voluntarily resigned from employment. The officer was eligible to receive a lump-sum distribution of earned benefits under this plan of approximately $4.5 million. The Company granted the officer an equivalent number of shares of common stock in satisfaction of this pension benefit, resulting in a curtailment and partial settlement of the plan. The Company also recognized $1.1 million in additional compensation expense, a component of general and administrative expense, related to the settlement of the officer’s pension benefit. See Note 12.
     Retirement Plan for Outside Directors
          In November 2009, the Company terminated the Outside Director Plan. During 2010, the Company paid to each outside director who participated in the plan a lump sum payment, which aggregated to approximately $2.6 million, in full settlement of the directors’ benefits payable under the Outside Director Plan.

71


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
     Retirement Plan Information
          Net periodic benefit cost for both the Executive Retirement Plan and the Outside Director Plan (the “Plans”) for the three years in the period ended December 31, 2010 is comprised of the following:
                         
(Dollars in thousands)   2010     2009     2008  
Service cost
  $ 51     $ 286     $ 1,288  
Interest cost
    933       926       1,190  
Effect of settlement
    (243 )     1,005       1,143  
Amortization of net gain/loss
    671       669       758  
 
                 
 
  $ 1,412     $ 2,886     $ 4,379  
Net loss (gain) recognized in other comprehensive income
    676       (1,868 )     2,115  
 
                 
Total recognized in net periodic benefit cost and accumulated other comprehensive loss
  $ 2,088     $ 1,018     $ 6,494  
 
                 
          The Company estimates that approximately $0.9 million of the net loss recognized in accumulated other comprehensive loss will be amortized to expense in 2011.
          The Plans are unfunded, and benefits will be paid from earnings of the Company. The following table sets forth the benefit obligations as of December 31, 2010 and 2009.
                 
(Dollars in thousands)   2010     2009  
Benefit obligation at beginning of year
  $ 16,122     $ 17,488  
Service cost
    51       286  
Interest cost
    933       926  
Benefits paid
    (2,666 )     (2,384 )
Curtailment gain
          (14 )
Settlement (gain) loss
    (243 )     1,005  
Actuarial (gain) loss, net
    1,348       (1,185 )
 
           
Benefit obligation at end of year
  $ 15,545     $ 16,122  
 
           
          Amounts recognized in the Consolidated Balance Sheets are as follows:
                 
(Dollars in thousands)   2010     2009  
Net liabilities included in accrued liabilities
  $ (10,276 )   $ (11,529 )
Amounts recognized in accumulated other comprehensive loss
    (5,269 )     (4,593 )
          The Company assumed discount rates of 5.5% for 2010 and 6.0% for 2009 and 2008 and compensation increases of 2.7% for 2010, 2009 and 2008 related to the Plans to measure the year-end benefit obligations and the earnings effects for the subsequent year related to the Plans.
12. Stock and Other Incentive Plans
     2007 Employees Stock Incentive Plan
          The Incentive Plan authorizes the Company to issue 2,390,272 shares of common stock to its employees and directors. The Incentive Plan will continue until terminated by the Company’s Board of Directors. As of December 31, 2010, 2009 and 2008, the Company had issued, net of forfeitures, a total of 1,091,007, 921,612 and 822,706 shares, respectively, under the Incentive Plan for compensation-related awards to employees and directors, with a total of 1,299,265, 1,468,660 and 1,567,566 authorized shares, respectively, remaining which had not been issued. Under the Incentive Plan’s predecessor plans, 329,404 shares were forfeited during 2008. Restricted shares issued under the Incentive Plan are generally subject to fixed vesting periods varying from three to 10 years beginning on the date of issue. If an employee voluntarily terminates employment with the Company before the end of the vesting period, the shares are forfeited, at no cost to the Company. Once the shares have been issued, the employee has the right to receive dividends and the right to vote the shares. Compensation expense recognized during the years ended December 31, 2010, 2009 and 2008 from the amortization of the value of restricted shares issued to employees was $1.6 million, $2.9 million and $3.7 million, respectively.
          In the fourth quarters of 2010, 2009 and 2008, the Company released performance-based awards to 30, 30 and 31, respectively, of its officers under the Incentive Plan totaling approximately $1.4 million, $0.9 million and $3.3 million, respectively, which were

72


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
granted in the form of restricted shares totaling approximately 67,800 shares, 39,500 shares and 130,400 shares, respectively. The shares have vesting periods ranging from three to eight years with a weighted average vesting period of approximately six years. The Company expects the issuance of the 67,800 restricted shares in 2010 will increase amortization expense in 2011 by approximately $0.3 million.
          In November 2008, an officer of the Company voluntarily resigned from employment. As a result of his resignation, the officer forfeited 329,404 in unvested restricted shares, resulting in the reversal of $1.7 million (net) in compensation expense previously recognized pertaining to these unvested shares. The officer was also a participant in the Executive Retirement Plan and was eligible to receive a lump-sum distribution of earned benefits under this plan of approximately $4.5 million. The Company granted the officer 616,500 in unrestricted common shares under the Incentive Plan, which were valued at $15.90 per share on the date of grant, in satisfaction of the lump-sum pension benefit earned under the Executive Retirement Plan of approximately $4.5 million and an additional award.
          The Incentive Plan also authorizes the Company’s Compensation Committee of its Board of Directors to grant restricted stock units or other performance awards to eligible employees. Such awards, if issued, will also be subject to restrictions and other conditions as determined appropriate by the Compensation Committee. Grantees of restricted stock units will not have stockholder voting rights and will not receive dividend payments. The award of performance units does not create any stockholder rights. Upon satisfaction of certain performance targets as determined by the Compensation Committee, payment of the performance units may be made in cash, shares of common stock, or a combination of cash and common stock, at the option of the Compensation Committee. As of December 31, 2010, the Company had not granted any restricted stock units or other performance awards under the Incentive Plan.
          The Company also, beginning in 2009, began issuing shares to its non-employee directors under the Incentive Plan. Previously, the Company issued shares to its directors under the 1995 Restricted Stock Plan for Non-Employee Directors (the “1995 Directors’ Plan”) but all shares authorized for issuance have been issued. The directors’ stock issued generally has a three-year vesting period and is subject to forfeiture prior to such date upon termination of the director’s service, at no cost to the Company. During 2010, 2009 and 2008, the Company issued 25,392, 36,688, and 16,000 shares, respectively, to its non-employee directors through the Incentive Plan or the 1995 Directors’ Plan. For 2010, 2009 and 2008, compensation expense resulting from the amortization of the value of these shares was $0.6 million, $0.5 million, and $0.5 million, respectively.
     Non-Employee Directors’ Stock Plan
          The 1995 Restricted Stock Plan for Non-Employee Directors (the “1995 Directors’ Plan”) authorizes the Company to issue 100,000 shares to its directors. As of December 31, 2009, the Company had issued all shares authorized under the plan and had issued 75,173 shares as of December 31, 2008 pursuant to the 1995 Directors’ Plan. As of December 31, 2008, a total of 24,827 authorized shares had not been issued. Upon issuance of all authorized shares under the 1995 Directors’ Plan, a portion of the directors’ 2009 restricted stock grant was issued under the Incentive Plan. Beginning in 2010, all shares granted to the directors will be issued under the Incentive Plan. For 2010, 2009 and 2008, compensation expense resulting from the amortization of the value of these shares was $0.6 million, $0.5 million, and $0.5 million, respectively.
          A summary of the activity under the Incentive Plan, and its predecessor plan, and the 1995 Directors’ Plan and related information for the three years in the period ended December 31, 2010 follows:
                         
    2010     2009     2008  
Stock-based awards, beginning of year
    1,224,779       1,111,728       1,289,646  
Granted
    175,412       124,587       812,654  
Vested
    (20,948 )     (11,536 )     (657,888 )
Forfeited
                (332,684 )
 
                 
Stock-based awards, end of year
    1,379,243       1,224,779       1,111,728  
 
                 
 
Weighted-average grant date fair value of:
                       
Stock-based awards, beginning of year
  $ 25.16     $ 25.71     $ 25.12  
Stock-based awards granted during the year
  $ 21.19     $ 21.01     $ 18.18  
Stock-based awards vested during the year
  $ 22.60     $ 32.80     $ 16.54  
Stock-based awards forfeited during the year
  $     $     $ 24.06  
Stock-based awards, end of year
  $ 24.71     $ 25.16     $ 25.71  
Grant date fair value of shares granted during the year
  $ 3,600,160     $ 2,617,678     $ 14,773,448  
          The vesting periods for the restricted shares granted during 2010 ranged from three to eight years with a weighted-average amortization period remaining at December 31, 2010 of approximately 6.2 years.

73


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
          During 2010, 2009 and 2008, the Company withheld 520 shares, 854 shares and 10,935 shares, respectively, of common stock from its officers to pay estimated withholding taxes related to restricted stock that vested. Also, during 2010, 6,586 restricted shares vested upon the retirement of a member of the board of directors.
     401(k) Plan
          The Company maintains a 401(k) plan that allows eligible employees to defer salary, subject to certain limitations imposed by the Code. The Company provides a matching contribution of up to 3% of each eligible employee’s salary, subject to certain limitations. The Company’s matching contributions were approximately $0.3 million for each of the three years ended December 31, 2010.
     Dividend Reinvestment Plan
          The Company is authorized to issue 1,000,000 shares of common stock to stockholders under the Dividend Reinvestment Plan. As of December 31, 2010, the Company had 467,520 shares issued under the plan of which 19,267 shares were issued in 2010, 33,511 shares were issued in 2009 and 24,970 shares were issued in 2008.
     Employee Stock Purchase Plan
          In January 2000, the Company adopted the Employee Stock Purchase Plan, pursuant to which the Company is authorized to issue shares of common stock. As of December 31, 2010, 2009 and 2008, the Company had a total of 278,978, 344,838 and 439,382 shares authorized under the Employee Stock Purchase Plan, respectively, which had not been issued or optioned. Under the Employee Stock Purchase Plan, each eligible employee in January of each year is able to purchase up to $25,000 of common stock at the lesser of 85% of the market price on the date of grant or 85% of the market price on the date of exercise of such option (the “Exercise Date”). The number of shares subject to each year’s option becomes fixed on the date of grant. Options granted under the Employee Stock Purchase Plan expire if not exercised 27 months after each such option’s date of grant. Cash received from employees upon exercising options under the Employee Stock Purchase Plan was $0.2 million for each of the three years ended December 31, 2010.
          A summary of the Employee Stock Purchase Plan activity and related information for the three years in the period ended December 31, 2010 is as follows:
                         
    2010     2009     2008  
Outstanding, beginning of year
    335,608       250,868       179,603  
Granted
    256,080       219,184       194,832  
Exercised
    (9,131 )     (9,803 )     (10,948 )
Forfeited
    (53,504 )     (42,032 )     (38,325 )
Expired
    (136,536 )     (82,609 )     (74,294 )
 
                 
Outstanding and exercisable, end of year
    392,517       335,608       250,868  
 
                 
 
                       
Weighted-average exercise price of:
                       
Options outstanding, beginning of year
  $ 18.24     $ 19.96     $ 21.58  
Options granted during the year
  $ 18.24     $ 19.96     $ 21.58  
Options exercised during the year
  $ 18.19     $ 15.43     $ 21.24  
Options forfeited during the year
  $ 18.69     $ 16.87     $ 21.02  
Options expired during the year
  $ 19.80     $ 12.74     $ 20.20  
Options outstanding, end of year
  $ 17.99     $ 18.24     $ 19.96  
 
Weighted-average fair value of options granted during the year (calculated as of the grant date)
  $ 8.07     $ 7.75     $ 5.82  
 
Intrinsic value of options exercised during the year
  $ 29,037     $ 31,566     $ 38,537  
 
Intrinsic value of options outstanding and exercisable (calculated as of December 31)
  $ 1,248,204     $ 1,080,658     $ 883,055  
 
Exercise prices of options outstanding (calculated as of December 31)
  $ 17.99     $ 18.24     $ 19.96  
 
Weighted-average contractual life of outstanding options (calculated as of December 31, in years)
    0.8       0.8       0.9  

74


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
          The fair values for these options were estimated at the date of grant using a Black-Scholes options pricing model with the weighted-average assumptions for the options granted during the period noted in the following table. The risk-free interest rate was based on the U.S. Treasury constant maturity-nominal two-year rate whose maturity is nearest to the date of the expiration of the latest option outstanding and exercisable; the expected life of each option was estimated using the historical exercise behavior of employees; expected volatility was based on historical volatility of the Company’s stock; and expected forfeitures were based on historical forfeiture rates within the look-back period.
                         
    2010     2009     2008  
Risk-free interest rates
    1.14 %     0.76 %     3.05 %
Expected dividend yields
    5.68 %     6.05 %     5.92 %
Expected life (in years)
    1.50       1.50       1.43  
Expected volatility
    69.5 %     58.2 %     26.2 %
Expected forfeiture rates
    91 %     84 %     82 %
13. Earnings Per Share
          The table below sets forth the computation of basic and diluted earnings per Common share for the three years in the period ended December 31, 2010.
                         
    Year Ended December 31,  
(Dollars in thousands, except per share data)   2010     2009     2008  
Weighted Average Common Shares
                       
Weighted average Common Shares outstanding
    63,038,663       59,385,018       52,846,988  
Unvested restricted stock
    (1,315,877 )     (1,185,426 )     (1,299,709 )
 
                 
Weighted average Common Shares — Basic
    61,722,786       58,199,592       51,547,279  
 
                 
 
                       
Weighted average Common Shares — Basic
    61,722,786       58,199,592       51,547,279  
Dilutive effect of restricted stock
    979,260       790,291       973,353  
Dilutive effect of employee stock purchase plan
    68,780       57,431       44,312  
 
                 
Weighted average Common Shares — Diluted
    62,770,826       59,047,314       52,564,944  
 
                 
 
                       
Net Income
                       
Income from continuing operations
  $ 4,021     $ 25,190     $ 15,320  
Noncontrolling interests’ share in earnings
    (47 )     (57 )     (68 )
 
                 
Income from continuing operations attributable to common stockholders
    3,974       25,133       15,252  
Discontinued operations
    4,226       25,958       26,440  
 
                 
Net income attributable to common stockholders
  $ 8,200     $ 51,091     $ 41,692  
 
                 
 
                       
Basic Earnings Per Common Share
                       
Income from continuing operations
  $ 0.06     $ 0.43     $ 0.30  
Discontinued operations
    0.07       0.45       0.51  
 
                 
Net income attributable to common stockholders
  $ 0.13     $ 0.88     $ 0.81  
 
                 
 
                       
Diluted Earnings Per Common Share
                       
Income from continuing operations
  $ 0.06     $ 0.43     $ 0.29  
Discontinued operations
    0.07       0.44       0.50  
 
                 
Net income attributable to common stockholders
  $ 0.13     $ 0.87     $ 0.79  
 
                 

75


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
14. Commitments and Contingencies
     Construction in Progress
          During 2010, one building located in Hawaii that was previously under construction commenced operations. The Company is in the process of leasing this building and anticipates an aggregate investment of approximately $86.0 million upon completion of tenant improvements.
          As of December 31, 2010, the Company had three medical office buildings under construction with estimated completion dates in the third quarter of 2011. The table below details the Company’s construction in progress and land held for development at December 31, 2010. The information included in the table below represents management’s estimates and expectations at December 31, 2010 which are subject to change. The Company’s disclosures regarding certain projections or estimates of completion dates and leasing may not reflect actual results.
                                                         
    Estimated                             CIP at     Estimated     Estimated  
    Completion     Property             Approximate     Dec. 31,     Remaining     Total  
State   Date     Type (1)     Properties     Square Feet     2010     Fundings     Investment  
(Dollars in thousands)
                                                       
Under construction:
                                                       
Washington
    3Q 2011     MOB     1       206,000     $ 44,997     $ 47,203     $ 92,200  
Colorado
    3Q 2011     MOB     2       199,000       14,493       40,407       54,900  
 
                                                       
Land held for development:
                                                       
Texas
                                    20,772                  
 
                                             
 
                    3       405,000     $ 80,262     $ 87,610     $ 147,100  
 
                                             
 
(1)   MOB-Medical office building
     Other Construction
          The Company had approximately $32.3 million in various first-generation tenant improvement budgeted amounts remaining as of December 31, 2010 related to properties that were developed by the Company.
          Further, as of December 31, 2010, the Company had remaining funding commitments totaling $54.6 million on five construction loans. The Company expects the remaining commitments on the loans will be funded during 2011 and 2012.
     Operating Leases
          As of December 31, 2010, the Company was obligated under operating lease agreements consisting primarily of the Company’s corporate office lease and ground leases related to 45 real estate investments with expiration dates through 2101. The Company’s corporate office lease covers approximately 30,934 square feet of rented space and expires on October 31, 2020. Annual base rent on the corporate office lease increases approximately 3.25% annually with an additional base rental increase possible in the fifth year depending on changes in CPI. The Company’s ground leases generally increase annually based on increases in CPI. Rental expense relating to the operating leases for the years ended December 31, 2010, 2009 and 2008 was $4.0 million, $3.8 million and $3.3 million, respectively. The Company has prepaid certain of its ground leases which represented approximately $0.3 million, $0.3 million and $0.2 million, respectively, of the Company’s rental expense for the years ended December 31, 2010, 2009 and 2008. The Company’s future minimum lease payments for its operating leases, excluding leases that the Company has prepaid and leases in which an operator pays or fully reimburses the Company, as of December 31, 2010 were as follows (in thousands):

76


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
         
2011
  $ 4,264  
2012
    4,309  
2013
    4,323  
2014
    4,399  
2015
    4,468  
2016 and thereafter
    255,021  
 
     
 
  $ 276,784  
 
     
     Legal Proceedings
          Two affiliates of the Company, HR Acquisition of Virginia Limited Partnership and HRT Holdings, Inc., are defendants in a lawsuit brought by Fork Union Medical Investors Limited Partnership, Goochland Medical Investors Limited Partnership, and Life Care Centers of America, Inc., as plaintiffs, in the Circuit Court of Davidson County, Tennessee. The plaintiffs allege that they overpaid rent between 1991 and 2003 under leases for two skilled nursing facilities in Virginia and seek a refund of such overpayments. Plaintiffs have not specified their damages in the complaint, but based on written discovery responses, the Company estimates the plaintiffs are seeking up to $2.0 million, plus pre- and post-judgment interest. The two leases were terminated by agreement with the plaintiffs in 2003. The Company denies that it is liable to the plaintiffs for any refund of rent paid and will continue to defend the case vigorously. A trial is scheduled for April 2011.
          The Company is, from time to time, involved in litigation arising out of the ordinary course of business or which is expected to be covered by insurance. The Company is not aware of any other pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company’s consolidated financial position, results of operations, or cash flows.
15. Other Data
     Taxable Income (unaudited)
          The Company has elected to be taxed as a REIT, as defined under the Internal Revenue Code of 1986, as amended. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement that it currently distribute at least 90% of its taxable income to its stockholders.
          As a REIT, the Company generally will not be subject to federal income tax on taxable income it distributes currently to its stockholders. Accordingly, no provision for federal income taxes has been made in the accompanying Consolidated Financial Statements. If the Company fails to qualify as a REIT for any taxable year, then it will be subject to federal income taxes at regular corporate rates, including any applicable alternative minimum tax, and may not be able to qualify as a REIT for four subsequent taxable years. Even if the Company qualifies as a REIT, it may be subject to certain state and local taxes on its income and property and to federal income and excise tax on its undistributed taxable income.
          Earnings and profits, the current and accumulated amounts of which determine the taxability of distributions to stockholders, vary from net income attributable to common stockholders and taxable income because of different depreciation recovery periods and methods, and other items.
          On a tax-basis, the Company’s gross real estate assets totaled approximately $2.5 billion, $2.1 billion, and $2.0 billion, respectively, for the three years ended December 31, 2010.

77


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
          The following table reconciles the Company’s consolidated net income attributable to common stockholders to taxable income for the three years ended December 31, 2010:
                         
    Year Ended December 31,  
(In thousands)   2010     2009     2008  
Net income attributable to common stockholders
  $ 8,200     $ 51,091     $ 41,692  
Reconciling items to taxable income:
                       
Depreciation and amortization
    19,603       17,196       12,667  
Gain or loss on disposition of depreciable assets
    6,916       8,549       (3,762 )
Straight-line rent
    (1,520 )     (1,623 )     528  
Receivable allowances
    (3,652 )     523       2,713  
Stock-based compensation
    1,977       9,323       7,651  
Other
    4,752       (4,104 )     (5,206 )
 
                 
 
    28,076       29,864       14,591  
 
                 
Taxable income (1)
  $ 36,276     $ 80,955     $ 56,283  
 
                 
Dividends paid
  $ 75,821     $ 91,385     $ 81,301  
 
                 
 
(1)   Before REIT dividend paid deduction.
     Characterization of Distributions (unaudited)
          Distributions in excess of earnings and profits generally constitute a return of capital. The following table gives the characterization of the distributions on the Company’s common stock for the three years ended December 31, 2010.
          For the three years ended December 31, 2010, there were no preferred shares outstanding. As such, no dividends were distributed related to preferred shares for those periods.
                                                 
    2010     2009     2008  
    Per Share     %     Per Share     %     Per Share     %  
Common stock:
                                               
Ordinary income
  $ 0.40       33.8 %   $ 0.90       58.7 %   $ 1.05       68.4 %
Return of capital
    0.56       46.4 %     0.16       10.1 %     0.41       26.5 %
Unrecaptured section 1250 gain
    0.24       19.8 %     0.48       31.2 %     0.08       5.1 %
 
                                   
Common stock distributions
  $ 1.20       100.0 %   $ 1.54       100.0 %   $ 1.54       100.0 %
 
                                   
     State Income Taxes
          The Company must pay certain state income taxes, which are included in general and administrative expense on the Company’s Consolidated Statements of Income.
          Certain states have implemented new state tax laws in the past few years that have impacted the Company. The state of Texas implemented in 2007 a gross margins tax on gross receipts from operations in Texas at 1%, less a 30% deduction for expenses. The Company understands that the Securities and Exchange Commission views this gross margins tax as an income tax. As such, the Company has disclosed the gross margins tax in the table below. The State of Michigan signed into law in 2008 the Michigan Business Tax Act (“MBTA”), which replaced the Michigan single business tax with a combined business income tax and modified gross receipts tax. The enactment of the MBTA resulted in the creation of a deferred tax liability for the Company which at the end of December 31, 2010 totaled $0.2 million.

78


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
          State income tax expense and state income tax payments for the three years ended December 31, 2010 are detailed in the table below:
                         
(Dollars in thousands)   2010     2009     2008  
State income tax expense:
                       
Texas gross margins tax (1)
  $ 528     $ 464     $ 686  
Michigan gross receipts deferred tax liability
    (90 )     45        
Other
    116       57       123  
 
                 
Total state income tax expense
  $ 554     $ 566     $ 809  
 
                 
State income tax payments, net of refunds and collections
  $ 533     $ 674     $ 612  
 
                 
 
(1)   In the table above, income tax expense for 2009 and 2008 includes $0.1 million and $0.3 million, respectively, that was recorded to the gain on sale of real estate properties sold, which is included in discontinued operations rather than general and administrative expenses on the Company’s Consolidated Statements of Income.
16. Fair Value of Financial Instruments
          The carrying amounts of cash and cash equivalents, receivables and payables are a reasonable estimate of their fair value as of December 31, 2010 and 2009 due to their short-term nature. The fair value of notes and bonds payable is estimated using cash flow analyses as of December 31, 2010 and 2009, based on the Company’s current interest rates for similar types of borrowing arrangements. The fair value of the mortgage notes and notes receivable is estimated based either on cash flow analyses at an assumed market rate of interest or at a rate consistent with the rates on mortgage notes acquired by the Company or notes receivable entered into by the Company recently. The table below details the fair value and carrying values for notes and bonds payable, mortgage notes receivable and notes receivable at December 31, 2010 and 2009.
                                 
    December 31, 2010     December 31, 2009  
    Carrying     Fair     Carrying     Fair  
(Dollars in millions)   Value     Value     Value     Value  
Notes and bonds payable
  $ 1,407.9     $ 1,460.2     $ 1,046.4     $ 1,088.6  
Mortgage notes receivable
  $ 36.6     $ 35.9     $ 31.0     $ 30.8  
Notes receivable, net of allowances
  $ 3.8     $ 3.8     $ 3.3     $ 3.3  

79


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
17. Selected Quarterly Financial Data (unaudited)
          Quarterly financial information for the years ended December 31, 2010 and 2009 is summarized below. The results of operations have been restated, as applicable, to show the effect of reclassifying properties sold or to be sold as discontinued operations.
                                 
    Quarter Ended  
(Dollars in thousands, except per share data)   March 31     June 30     September 30     December 31  
2010
                               
Revenues from continuing operations
  $ 62,995     $ 63,932     $ 64,465     $ 67,002  
 
                       
Income (loss) from continuing operations
  $ 433     $ 4,280     $ (447 )   $ (245 )
Discontinued operations
    4,225       2,234       (2,860 )     627  
 
                       
Net income (loss)
    4,658       6,514       (3,307 )     382  
Less: (Income) loss from noncontrolling interests
    (64 )     (40 )     59       (2 )
 
                       
Net income (loss) attributable to common stockholders
  $ 4,594     $ 6,474     $ (3,248 )   $ 380  
 
                       
 
                               
Basic earnings (loss) per common share
                               
Income (loss) from continuing operations
  $ 0.01     $ 0.07     $ (0.01 )   $ 0.00  
Discontinued operations
    0.07       0.04       (0.04 )     0.01  
 
                       
Net income (loss) attributable to common stockholders
  $ 0.08     $ 0.11     $ (0.05 )   $ 0.01  
 
                       
 
                               
Diluted earnings (loss) per common share
                               
Income (loss) from continuing operations
  $ 0.01     $ 0.07     $ (0.01 )   $ 0.00  
Discontinued operations
    0.07       0.03       (0.04 )     0.01  
 
                       
Net income (loss) attributable to common stockholders
  $ 0.08     $ 0.10     $ (0.05 )   $ 0.01  
 
                       
 
                               
2009
                               
Revenues from continuing operations
  $ 60,390     $ 62,634     $ 61,688     $ 62,126  
 
                       
Income from continuing operations
  $ 6,736     $ 7,919     $ 7,328     $ 3,207  
Discontinued operations
    14,144       8,895       1,711       1,208  
 
                       
Net income
    20,880       16,814       9,039       4,415  
Less: (Income) loss from noncontrolling interests
    (15 )     (62 )     65       (45 )
 
                       
Net income attributable to common stockholders
  $ 20,865     $ 16,752     $ 9,104     $ 4,370  
 
                       
 
                               
Basic earnings per common share
                               
Income from continuing operations
  $ 0.12     $ 0.14     $ 0.13     $ 0.05  
Discontinued operations
    0.24       0.15       0.03       0.02  
 
                       
Net income attributable to common stockholders
  $ 0.36     $ 0.29     $ 0.16     $ 0.07  
 
                       
 
                               
Diluted earnings per common share
                               
Income from continuing operations
  $ 0.11     $ 0.13     $ 0.12     $ 0.05  
Discontinued operations
    0.24       0.15       0.03       0.02  
 
                       
Net income attributable to common stockholders
  $ 0.35     $ 0.28     $ 0.15     $ 0.07  
 
                       

80


 

ITEM 9.   CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
          None.
ITEM 9A.   CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
          The Company maintains disclosure controls and procedures designed to ensure that information required to be disclosed in the Company’s reports under the Securities Exchange Act of 1934, as amended (the “Securities Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. These disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that the information required to be disclosed is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, to allow for timely decisions regarding required disclosure.
          The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Annual Report on Form 10-K. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act.
Changes in the Company’s Internal Control over Financial Reporting
          None.
Management’s Annual Report on Internal Control Over Financial Reporting
          The management of Healthcare Realty Trust Incorporated is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
          Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
          Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2010 using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on that assessment, management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2010. The Company’s independent registered public accounting firm, BDO USA, LLP, has also issued an attestation report on the effectiveness of the Company’s internal control over financial reporting included herein.

81


 

Report of
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Healthcare Realty Trust Incorporated
Nashville, Tennessee
          We have audited Healthcare Realty Trust Incorporated’s internal control over financial reporting as of December 31, 2010, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). Healthcare Realty Trust Incorporated’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Item 9A, Management’s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.
          We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
          A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
          Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
          In our opinion, Healthcare Realty Trust Incorporated maintained, in all material respects, effective internal control over financial reporting as of December 31, 2010, based on the COSO criteria.
          We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Healthcare Realty Trust Incorporated as of December 31, 2010 and 2009 and the related consolidated statements of income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2010 and our report dated February 22, 2011 expressed an unqualified opinion thereon.
         
     
  /s/ BDO USA, LLP    
     
Nashville, Tennessee
February 22, 2011

82


 

ITEM 9B.   OTHER INFORMATION
          None.
PART III
ITEM 10.   DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Directors
          Information with respect to directors, set forth in the Company’s Proxy Statement relating to the Annual Meeting of Stockholders to be held on May 17, 2011 under the caption “Election of Directors,” is incorporated herein by reference.
Executive Officers
          The executive officers of the Company are:
             
Name   Age   Position
David R. Emery
    66     Chairman of the Board & Chief Executive Officer
Scott W. Holmes
    56     Executive Vice President & Chief Financial Officer
John M. Bryant, Jr.
    44     Executive Vice President & General Counsel
B. Douglas Whitman, II
    42     Executive Vice President — Corporate Finance
Todd J. Meredith
    36     Executive Vice President — Investments
          Mr. Emery formed the Company and has held his current positions since May 1992. Prior to 1992, Mr. Emery was engaged in the development and management of commercial real estate in Nashville, Tennessee. Mr. Emery has been active in the real estate industry for nearly 40 years.
          Mr. Holmes has served as the Chief Financial Officer since January 1, 2003 and was the Senior Vice President — Financial Reporting (principal accounting officer) from October 1998 until January 1, 2003. Mr. Holmes is a Certified Public Accountant. Prior to joining the Company, he was with Ernst & Young LLP for more than 13 years. His extensive audit and financial reporting experience included healthcare and real estate companies in addition to public companies in other industries. Mr. Holmes has previously served in a management capacity with two other public companies.
          Mr. Bryant became the Company’s General Counsel on November 1, 2003. From April 22, 2002 until November 1, 2003, Mr. Bryant was Vice President and Assistant General Counsel. Prior to joining the Company, Mr. Bryant was a shareholder with the law firm of Baker Donelson Bearman & Caldwell in Nashville, Tennessee.
          Mr. Whitman joined the Company in 1998 and became the Executive Vice President — Corporate Finance on February 17, 2011 and is responsible for all aspects of the Company’s financing activities, including capital raises, debt compliance, banking relationships and investor relations. Previously, Mr. Whitman served as the Company’s Chief Operating Officer from March 1, 2007 until February 17, 2011. Prior to joining the Company, Mr. Whitman worked for the University of Michigan Health System and HCA Inc.
          Mr. Meredith was appointed Executive Vice President — Investments on February 17, 2011 and is responsible for overseeing the Company’s investment activities, including the acquisition, financing and development of medical office and other primarily outpatient medical facilities. From 2006 through February 2011, he led the Company’s development activities as a Senior Vice President. Prior to joining the Company in 2001, Mr. Meredith worked in investment banking and corporate finance, most recently with Robert W. Baird & Co.
Code of Ethics
          The Company has adopted a Code of Business Conduct and Ethics (the “Code of Ethics”) that applies to its principal executive officer, principal financial officer, principal accounting officer and controller, or persons performing similar functions, as well as all directors, officers and employees of the Company. The Code of Ethics is posted on the Company’s website (www.healthcarerealty.com) and is available in print free of charge to any stockholder who requests a copy. Interested parties may address a written request for a printed copy of the Code of Ethics to: Investor Relations: Healthcare Realty Trust Incorporated, 3310 West End Avenue, Suite 700, Nashville, Tennessee 37203. The Company intends to satisfy the disclosure requirement regarding any amendment to, or a waiver of, a provision of the Code of Ethics for the Company’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions by posting such information on the Company’s website.

83


 

Section 16(a)   Compliance
          Information with respect to compliance with Section 16(a) of the Securities Exchange Act set forth in the Company’s Proxy Statement relating to the Annual Meeting of Stockholders to be held on May 17, 2011 under the caption “Security Ownership of Certain Beneficial Owners and Management — Section 16(a) Beneficial Ownership Reporting Compliance,” is incorporated herein by reference.
Stockholder Recommendation of Director Candidates
          There have been no material changes with respect to the Company’s policy relating to stockholder recommendations of director candidates. Such information is set forth in the Company’s Proxy Statement relating to the Annual Meeting of Stockholders to be held on May 17, 2011 under the caption “Shareholder Recommendation or Nomination of Director Candidates,” and is incorporated herein by reference.
Audit Committee
          Information relating to the Company’s Audit Committee, its members and the Audit Committee’s financial expert is set forth in the Company’s Proxy Statement relating to the Annual Meeting of Stockholders to be held on May 17, 2011 under the caption “Committee Membership,” and is incorporated herein by reference.
ITEM 11.   EXECUTIVE COMPENSATION
          Information relating to executive compensation, set forth in the Company’s Proxy Statement relating to the Annual Meeting of Stockholders to be held on May 17, 2011 under the captions “Compensation Discussion and Analysis,” “Executive Compensation,” “Compensation Committee Interlocks and Insider Participation,” “Compensation Committee Report” and “Director Compensation,” is incorporated herein by reference.
ITEM 12.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
          Information relating to the security ownership of management and certain beneficial owners, set forth in the Company’s Proxy Statement relating to the Annual Meeting of Stockholders to be held on May 17, 2011 under the caption “Security Ownership of Certain Beneficial Owners and Management,” is incorporated herein by reference.
          Information relating to securities authorized for issuance under the Company’s equity compensation plans, set forth in Item 5 of this report under the caption “Equity Compensation Plan Information,” is incorporated herein by reference.
ITEM 13.   CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
          Information relating to certain relationships and related transactions, and director independence, set forth in the Company’s Proxy Statement relating to the Annual Meeting of Stockholders to be held on May 17, 2011 under the captions “Certain Relationships and Related Transactions,” and “Corporate Governance — Independence of Directors,” are incorporated herein by reference.
ITEM 14.   PRINCIPAL ACCOUNTANT FEES AND SERVICES
          Information relating to the fees paid to the Company’s accountants, set forth in the Company’s Proxy Statement relating to the Annual Meeting of Stockholders to be held on May 17, 2011 under the caption “Ratification of Appointment of Independent Registered Public Accounting Firm,” is incorporated herein by reference.
ITEM 15.   EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) Index to Historical Financial Statements, Financial Statement Schedules and Exhibits
(1) Financial Statements:
          The following financial statements of Healthcare Realty Trust Incorporated are incorporated herein by reference to Item 8 of this Annual Report on Form 10-K.
    Consolidated Balance Sheets — December 31, 2010 and 2009.
 
    Consolidated Statements of Income for the years ended December 31, 2010, December 31, 2009 and December 31, 2008.

84


 

    Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2010, December 31, 2009 and December 31, 2008.
    Consolidated Statements of Cash Flows for the years ended December 31, 2010, December 31, 2009 and December 31, 2008.
    Notes to Consolidated Financial Statements.
(2) Financial Statement Schedules:
                 
 
  Schedule II  — Valuation and Qualifying Accounts at December 31, 2010     89  
 
  Schedule III  — Real Estate and Accumulated Depreciation at December 31, 2010     90  
 
  Schedule IV  — Mortgage Loans on Real Estate at December 31, 2010     91  
          All other schedules are omitted because they are either not applicable, not required or because the information is included in the consolidated financial statements or notes thereto.
(3) Exhibits:
Exhibit Index
         
Exhibit        
Number       Description of Exhibits
1.1
    Controlled Equity Offering Sales Agreement, dated as of January 11, 2011, between the Company and Cantor Fitzgerald & Co. (1)
 
1.2
    Sales Agreement, dated as of January 11, 2011, between the Company and Credit Agricole Securities (USA) Inc. (1)
 
1.3
    Controlled Equity Offering Sales Agreement, dated as of February 22, 2010, between the Company and Cantor Fitzgerald &
Co. (2)
 
1.4
    Controlled Equity Offering Sales Agreement, dated as of December 31, 2008, between the Company and Cantor Fitzgerald & Co. This agreement was terminated on February 19, 2010 and superseded by Exhibit 1.2 hereto. (3)
 
1.5
    Underwriting Agreement, dated as of December 8, 2010, by and among the Company and Barclays Capital Inc. and UBS Securities LLC, as representatives of the several underwriters named herein. (4)
 
3.1
    Second Articles of Amendment and Restatement of the Company. (5)
 
3.2
    Amended and Restated Bylaws of the Company. (6)
 
4.1
    Specimen stock certificate. (5)
 
4.2
    Indenture, dated as of May 15, 2001, by and between the Company and Regions Bank, as Trustee (as successor to the trustee named therein). (7)
 
4.3
    First Supplemental Indenture, dated as of May 15, 2001, by the Company to Regions Bank, as Trustee (as successor to the trustee named therein). (7)
 
4.4
    Form of 8.125% Senior Note Due 2011. (7)
 
4.5
    Second Supplemental Indenture, dated as of March 30, 2004, by the Company to Regions Bank, as Trustee (as successor to the trustee named therein). (8)
 
4.6
    Form of 5.125% Senior Note Due 2014. (8)
 
4.7
    Third Supplemental Indenture, dated December 4, 2009, by and between the Company and Regions Bank as Trustee. (9)
 
4.8
    Form of 6.50% Senior Note due 2017 (set forth in Exhibit B to the Third Supplemental Indenture filed as Exhibit 4.7 thereto). (9)
 
4.9
    Fourth Supplemental Indenture, dated December 13, 2010, by and between the Company and Regions Bank as Trustee. (4)
 
4.10
    Form of 5.750% Senior Note due 2021 (set forth in Exhibit B to the Fourth Supplemental Indenture filed as Exhibit 4.9 thereto). (4)
 
10.1
    1995 Restricted Stock Plan for Non-Employee Directors of the Company. (10)
 
10.2
    Amendment to 1995 Restricted Stock Plan for Non-Employee Directors of the Company. (3)
 
10.3
    Second Amended and Restated Executive Retirement Plan. (3)
 
10.4
    Amended and Restated Retirement Plan for Outside Directors. (3)
 
10.5
    2000 Employee Stock Purchase Plan. (11)
 
10.6
    Dividend Reinvestment Plan, as Amended. (12)
 
10.7
    Amended and Restated Employment Agreement by and between David R. Emery and the Company. (13)
 
10.8
    Employment Agreement by and between John M. Bryant, Jr. and the Company. (14)
 
10.9
    Employment Agreement by and between Scott W. Holmes and the Company. (15)
 
10.10
    Employment Agreement by and between B. Douglas Whitman, II and the Company. (16)

85


 

         
Exhibit        
Number       Description of Exhibits
10.11
    Amended and Restated Credit Agreement, dated as of September 30, 2009, by and among the Company, Bank of America, N.A., as Administrative Agent, and the other lenders named herein. (17)
 
10.12
    Amendment No. 1, dated as of May 12, 2010, to the Amended and Restated Credit Agreement, dated as of September 30, 2009, by and among the Company, Bank of America, N.A., as Administrative Agent, and the other lenders named therein. (18)
 
10.13
    2007 Employees Stock Incentive Plan. (19)
 
10.14
    The Company’s Long-Term Incentive Program. (20)
 
10.15
    Amendment, dated December 21, 2007, to 2007 Employees Stock Incentive Plan. (21)
 
10.16
    Purchase and sale agreement, dated December 29, 2010, between the Company and Frisco Surgery Center Limited, Frisco POB I Limited, Frisco POB II Limited, and Medland L.P. (filed herewith)
 
11
    Statement re: computation of per share earnings (contained in Note 13 to the Notes to the Consolidated Financial Statements for the year ended December 31, 2009 in Item 8 to this Annual Report on Form 10-K).
 
21
    Subsidiaries of the Registrant. (filed herewith)
 
23
    Consent of BDO USA, LLP, independent registered public accounting firm. (filed herewith)
 
31.1
    Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (filed herewith)
 
31.2
    Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (filed herewith)
 
32
    Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (filed herewith)
 
101.INS
    XBRL Instance Document. (furnished herewith)
 
101.SCH
    XBRL Taxonomy Extension Schema Document. (furnished herewith)
 
101.CAL
    XBRL Taxonomy Extension Calculation Linkbase Document. (furnished herewith)
 
101.LAB
    XBRL Taxonomy Extension Labels Linkbase Document. (furnished herewith)
 
101.PRE
    XBRL Taxonomy Extension Presentation Linkbase Document. (furnished herewith)
 
(1)   Filed as an exhibit to the Company’s Form 8-K filed January 11, 2011 and hereby incorporated by reference.
 
(2)   Filed as an exhibit to the Company’s Form 10-K filed February 22, 2010 and hereby incorporated by reference.
 
(3)   Filed as an exhibit to the Company’s Form 8-K filed December 31, 2008 and hereby incorporated by reference.
 
(4)   Filed as an exhibit to the Company’s Form 8-K filed December 13, 2010 and hereby incorporated by reference.
 
(5)   Filed as an exhibit to the Company’s Registration Statement on Form S-11 (Registration No. 33-60506) previously filed pursuant to the Securities Act of 1933 and hereby incorporated by reference.
 
(6)   Filed as an exhibit to the Company’s Form 10-Q for the quarter ended September 30, 2007 and hereby incorporated by reference.
 
(7)   Filed as an exhibit to the Company’s Form 8-K filed May 17, 2001 and hereby incorporated by reference.
 
(8)   Filed as an exhibit to the Company’s Form 8-K filed March 29, 2004 and hereby incorporated by reference.
 
(9)   Filed as an exhibit to the Company’s Form 8-K filed December 4, 2009 and hereby incorporated by reference.
 
(10)   Filed as an exhibit to the Company’s Form 10-K for the year ended December 31, 1995 and hereby incorporated by reference.
 
(11)   Filed as an exhibit to the Company’s Form 10-K for the year ended December 31, 1999 and hereby incorporated by reference.
 
(12)   Filed as an exhibit to the Company’s Registration Statement on Form S-3 (Registration No. 33-79452) previously filed on September 26, 2003 pursuant to the Securities Act of 1933 and hereby incorporated by reference.
 
(13)   Filed as an exhibit to the Company’s Form 10-Q for the quarter ended September 30, 2004 and hereby incorporated by reference.
 
(14)   Filed as an exhibit to the Company’s Form 10-Q for the quarter ended September 30, 2003 and hereby incorporated by reference.
 
(15)   Filed as an exhibit to the Company’s Form 10-K for the year ended December 31, 2002 and hereby incorporated by reference.
 
(16)   Filed as an exhibit to the Company’s Form 10-K filed March 1, 2007 and hereby incorporated by reference.
 
(17)   Filed as an exhibit to the Company’s Form 10-Q for the quarter ended September 30, 2009 and hereby incorporated by reference.
 
(18)   Filed as an exhibit to the Company’s Form 10-Q for the quarter ended June 30, 2010 and hereby incorporated by reference.
 
(19)   Filed as an exhibit to the Company’s Form 8-K filed May 21, 2007 and hereby incorporated by reference.
 
(20)   Filed as an exhibit to the Company’s Form 8-K filed December 14, 2007 and hereby incorporated by reference.
 
(21)   Filed as an exhibit to the Company’s Form 10-K for the year ended December 31, 2007 and hereby incorporated by reference.
Executive Compensation Plans and Arrangements
     The following is a list of all executive compensation plans and arrangements filed as exhibits to this Annual Report on Form 10-K:
  1.   1995 Restricted Stock Plan for Non-Employee Directors of the Company (filed as Exhibit 10.1)
 
  2.   Amendment to 1995 Restricted Stock Plan for Non-Employee Directors of the Company (filed as Exhibit 10.2)
 
  3.   Second Amended and Restated Executive Retirement Plan (filed as Exhibit 10.3)
 
  4.   Amended and Restated Retirement Plan for Outside Directors (filed as Exhibit 10.4)
 
  5.   2000 Employee Stock Purchase Plan (filed as Exhibit 10.5)
 
  6.   Amended and Restated Employment Agreement by and between David R. Emery and the Company (filed as Exhibit 10.7)

86


 

  7.   Employment Agreement by and between John M. Bryant, Jr. and the Company (filed as Exhibit 10.8)
 
  8.   Employment Agreement by and between Scott W. Holmes and the Company (filed as Exhibit 10.9)
 
  9.   Employment Agreement by and between B. Douglas Whitman, II and the Company (filed as Exhibit 10.10)
 
  10.   2007 Employees Stock Incentive Plan (filed as Exhibit 10.13)
 
  11.   The Company’s Long-Term Incentive Program (filed as Exhibit 10.14)
 
  12.   Amendment, dated December 21, 2007, to 2007 Employees Stock Incentive Plan (filed as Exhibit 10.15)

87


 

SIGNATURES
          Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Nashville, State of Tennessee, on February 22, 2011.
         
  HEALTHCARE REALTY TRUST INCORPORATED
 
 
  By:   /s/ David R. Emery    
    David R. Emery   
    Chairman of the Board and Chief Executive Officer   
 
          Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed by the following persons on behalf of the Company and in the capacities and on the date indicated.
         
Signature   Title   Date
 
       
/s/ David R. Emery
  Chairman of the Board and Chief Executive   February 22, 2011
 
       
David R. Emery
  Officer (Principal Executive Officer)    
 
       
/s/ Scott W. Holmes
  Executive Vice President and Chief Financial   February 22, 2011
 
       
Scott W. Holmes
  Officer (Principal Financial Officer)    
 
       
/s/ David L. Travis
  Senior Vice President and Chief Accounting   February 22, 2011
 
       
David L. Travis
  Officer (Principal Accounting Officer)    
 
       
/s/ Errol L. Biggs, Ph.D.
  Director   February 22, 2011
 
       
Errol L. Biggs, Ph.D.
       
 
       
/s/ Charles Raymond Fernandez, M.D.
  Director   February 22, 2011
 
       
Charles Raymond Fernandez, M.D.
       
 
       
/s/ Batey M. Gresham, Jr.
  Director   February 22, 2011
 
       
Batey M. Gresham, Jr.
       
 
       
/s/ Edwin B. Morris, III
  Director   February 22, 2011
 
       
Edwin B. Morris, III
       
 
       
/s/ John Knox Singleton
  Director   February 22, 2011
 
       
John Knox Singleton
       
 
       
/s/ Bruce D. Sullivan
  Director   February 22, 2011
 
       
Bruce D. Sullivan
       
 
       
/s/ Roger O. West
  Director   February 22, 2011
 
       
Roger O. West
       
 
       
/s/ Dan S. Wilford
  Director   February 22, 2011
 
       
Dan S. Wilford
       

88


 

Schedule
Schedule II — Valuation and Qualifying Accounts at December 31, 2010
(Dollars in thousands)
                                         
    Balance at     Additions     Uncollectible     Balance at  
    Beginning     Charged to Costs     Charged to Other     Accounts     End  
Description   of Period     and Expenses     Accounts     Written-off     of Period  
2010 Accounts and notes receivable allowance
  $ 3,674     $ (409 )   $     $ 2,080     $ 1,185  
 
                             
 
  $ 3,674     $ (409 )   $     $ 2,080     $ 1,185  
 
                             
 
2009 Accounts and notes receivable allowance
  $ 3,323     $ 517     $     $ 166     $ 3,674  
 
                             
 
  $ 3,323     $ 517     $     $ 166     $ 3,674  
 
                             
 
2008 Accounts and notes receivable allowance
  $ 1,499     $ 1,904     $     $ 80     $ 3,323  
Preferred stock investment reserve
    1,000                   1,000        
 
                             
 
  $ 2,499     $ 1,904     $     $ 1,080     $ 3,323  
 
                             

89


 

     
Schedule III — Real Estate and Accumulated Depreciation at December 31, 2010
                                                                                                     
                                        Buildings, Improvements,                                
                Land   Lease Intangibles and CIP                                
                        Cost Capitalized                   Cost Capitalized                           (1) (4)            
                        Subsequent to                   Subsequent to                   (1) (3) (4)   Accumulated   (5)   Date    
Property Type   Number of Properties   State   Initial Investment   Acquisition   Total   Initial Investment   Acquisition   Total   Personal Property   Total Assets   Depreciation   Encumbrances   Acquired   Date Constructed
Medical Office
    148     AL, AZ, CA, CO, DC,
FL, GA, HI, IA, IL,
IN, KS, LA, MD, MI,
MO, MS, NC, NV, OH,
OR, PA, SC, TN, TX,
VA, WA
  $ 124,032     $ 1,996     $ 126,028     $ 1,673,602     $ 176,223     $ 1,849,825     $ 2,277     $ 1,978,130     $ 339,214     $ 167,462     1993-2010   1905 — 2010
3 Under Const. (2)
 
Physician Clinics
    29     AL, AZ, CA, FL, GA,
IA, IN, MA, TX, VA
    17,379       449       17,828       133,672       6,281       139,953       394       158,175       45,620           1993-2008   1968-2003
 
Surgical Facilities
    10     CA, GA, IL, IN, MO,
NV, TX
    17,181       443       17,624       174,861       5,269       180,130       101       197,855       27,827           1993-2010   1985-2006
 
Specialty Outpatient
    3     AL, IA, VA           260       260       6,773       252       7,025             7,285       2,098       1,146     1998-2008   1993-2006
 
Inpatient Rehab
    11     AL, AZ, FL, PA, TN,
TX
    6,328       150       6,478       172,051       110       172,161             178,639       57,227           1994-2009   1983-2009
 
Other
    11     AL, CA, TN, VA     1,828       73       1,901       49,011       7,213       56,224       636       58,761       24,687       1,679     1993-2007   1967-1995
                         
 
Total Real Estate
    212           166,748       3,371       170,119       2,209,970       195,348       2,405,318       3,408       2,578,845       496,673       170,287          
Land Held for Development
                                20,772             20,772             20,772       13                
 
Corporate Property
                                                  14,940       14,940       7,402                
                         
 
Total Properties
    212         $ 166,748     $ 3,371     $ 170,119     $ 2,230,742     $ 195,348     $ 2,426,090     $ 18,348     $ 2,614,557     $ 504,088     $ 170,287          
                         
 
(1)   Includes 11 assets held for sale at December 31, 2010 of approximately $43.0 million (gross) and accumulated depreciation of $19.5 million; six assets at December 31, 2009 of $25.6 million (gross) and accumulated depreciation of $8.7 million; and twelve assets at December 31, 2008 of $119.1 million (gross) and accumulated depreciation of $29.9 million.
 
(2)   Development at December 31, 2010.
 
(3)   Total assets at December 31, 2010 have an estimated aggregate total cost of $2.5 billion for federal income tax purposes.
 
(4)   Depreciation is provided for on a straight-line basis on buildings and improvements over 1.3 to 39.0 years, lease intangibles over 2.6 to 93.1 years, personal property over 3.0 to 15.8 years, and land improvements over 15.0 years.
 
(5)   Includes discounts and premiums totaling $6.4 million as of December 31, 2010.
 
(6)   A reconciliation of Total Property and Accumulated Depreciation for the twelve months ended December 31, 2010, 2009 and 2008 follows:
                                                 
    Year to Date     Year to Date     Year to Date  
    Ending 12/31/10 (1)     Ending 12/31/09 (1)     Ending 12/31/08 (1)  
    Total     Accumulated     Total     Accumulated     Total     Accumulated  
(Dollars in thousands)   Property     Depreciation     Property     Depreciation     Property     Depreciation  
Beginning Balance
  $ 2,250,879     $ 442,331     $ 2,120,853     $ 397,265     $ 1,722,491     $ 355,919  
Additions during the period:
                                               
Real Estate
    337,223       72,825       141,579       67,680       362,073       52,451  
Corporate Property
    316       740       284       784       320       651  
Construction in Progress
    63,301             85,120             74,085        
Retirement/dispositions:
                                               
Real Estate
    (37,155 )     (11,801 )     (96,954 )     (23,395 )     (38,103 )     (11,746 )
Corporate Property
    (7 )     (7 )     (3 )     (3 )     (13 )     (10 )
 
                                   
Ending Balance
  $ 2,614,557     $ 504,088     $ 2,250,879     $ 442,331     $ 2,120,853     $ 397,265  
 
                                   

90


 

Schedule IV — Mortgage Loans on Real Estate at December 31, 2010
(Dollars in thousands)
                                                 
                    Periodic     Original              
    Interest     Maturity     Payment     Face     Carrying        
Description   Rate     Date     Terms     Amount     Amount     Balloon  
 
Mortgage Notes Receivables:
                                               
Physician clinic facility located in California
    8.30 %     05/12/2016       (1 )   $ 14,920     $ 14,920     $ 13,895  (2)
Medical office building in Iowa
    8.00 %     12/01/2020       (3 )     3,700       3,700       3,230  (3)
 
                                               
Construction Loans:
                                               
Surgical facility in South Dakota
    7.00 %     05/01/2012       (4 )     40,000       10,746       11,175  (5)
Medical office building in Iowa
    6.50 % (6)     05/31/2012       (4 )     4,392       1,136       1,136  
Medical office building in Iowa
    6.50 % (6)     02/29/2012       (4 )     14,045       3,234       3,234  
Medical office building in Iowa
    11.00 %     03/31/2012       (4 )     2,136       377       377  
Medical office building in Texas
    7.50 % (7)     08/01/2012       (8 )     12,444       2,486       2,486  
 
                                             
 
Total Mortgage Notes Receivable
                                  $ 36,599          
 
                                             
 
(1)   Interest only until May 12, 2011, then principal and interest amortized monthly based on a 25-year amortization schedule.
 
(2)   Prepayment of all or part of the principal, with premium, may be made after May 12, 2008. The balloon amount above represents the principal amount due at maturity.
 
(3)   Interest only until maturity. However, the borrower must pay an amount sufficient to reduce the principal sum of the note to $3.2 million on the earlier of 270 days after the date of the Note, which is November 23, 2010, or on the date any third party acquires any interest in the borrower or property.
 
(4)   Interest only until maturity. Principal payments may be made during term without penalty with remaining principal balance due at maturity.
 
(5)   The carrying amount is net of an unamortized loan origination fee of $0.4 million at December 31, 2010 that is being amortized through the maturity of the loan.
 
(6)   The interest rate is the greater of 6.00% plus LIBOR or 6.50%.
 
(7)   The interest rate is 7.50% per annum through the construction completion date and is 8.10% thereafter.
 
(8)   The initial maturity date is 365 days after the construction completion date. If the payee has not exercised its purchase option and the maker exercises the extension option, the loan will be due on the second anniversary of the initial maturity date. Prepayments may be made at any time after the initial maturity date.
 
(9)   A rollforward of Mortgage loans on real estate for the three years ended December 31, 2010 follows:
                         
    Years Ended December 31,  
(Dollars in thousands)   2010     2009     2008  
Balance at beginning of period
  $ 31,008     $ 59,001     $ 30,117  
 
                       
Additions during period:
                       
New or acquired mortgages
    24,440       9,900       7,996  
Amortization of loan origination fee (5)
    153              
Increased funding on existing mortgages
          10,616       28,974  
 
                 
 
    24,593       20,516       36,970  
 
                       
Deductions during period:
                       
Scheduled principal payments
    (27 )     (26 )     (29 )
Principal repayments and reductions (10)
    (9,075 )     (12,747 )     (8,057 )
Principal reductions due to acquisitions (11)
    (9,900 )     (35,736 )      
 
                 
 
    (19,002 )     (48,509 )     (8,086 )
 
                 
Balance at end of period
  $ 36,599     $ 31,008     $ 59,001  
 
                 
     
(10)   Principal repayments for the years ended December 31, 2010, 2009 and 2008 include unscheduled principal reductions on mortgage notes of $1.9 million, $0.1 million and $5.6 million, respectively.
 
(11)   A consolidated joint venture, in which the Company owns an 80% controlling interest, purchased three medical office buildings in 2009 and one medical office building in 2010 which are located in Iowa. Ladco constructed the medical office buildings which were financed by the Company through a construction loan. Upon acquisition of the buildings by the Company’s consolidated joint venture, the construction loan was partially converted to additional equity investment by the Company in the joint venture with the balance remaining converting to a permanent mortgage

91


 

    note payable to the Company by the consolidated joint venture, which is eliminated in consolidation in the Company’s Consolidated Financial Statements.
 
(12)   Total mortgages at December 31, 2010 have an aggregate total cost of $36.6 million for federal income tax purposes.

92